id	sid	tid	token	lemma	pos
aji-145	1	1	_	_	PUNCT
aji-145	2	1	_	_	PUNCT
aji-145	3	1	_	_	PUNCT
aji-145	4	1	_	_	PUNCT
aji-145	5	1	_	_	PUNCT
aji-145	6	1	_	_	PUNCT
aji-145	7	1	_	_	PUNCT
aji-145	8	1	_	_	PUNCT
aji-145	9	1	_	_	PUNCT
aji-145	10	1	_	_	PUNCT
aji-145	11	1	_	_	PUNCT
aji-145	12	1	_	_	PUNCT
aji-145	13	1	_	_	PUNCT
aji-145	14	1	_	_	PUNCT
aji-145	15	1	_	_	PUNCT
aji-145	16	1	_	_	PUNCT
aji-145	17	1	_	_	PUNCT
aji-145	18	1	_	_	PUNCT
aji-145	19	1	_	_	PUNCT
aji-145	20	1	_	_	PUNCT
aji-145	21	1	_	_	PUNCT
aji-145	22	1	_	_	PUNCT
aji-145	23	1	_	_	PUNCT
aji-145	24	1	_	_	PUNCT
aji-145	25	1	_	_	PUNCT
aji-145	26	1	_	_	PUNCT
aji-145	27	1	_	_	PUNCT
aji-145	28	1	_	_	PUNCT
aji-145	29	1	_	_	PUNCT
aji-145	30	1	_	_	PUNCT
aji-145	31	1	_	_	PUNCT
aji-145	32	1	_	_	PUNCT
aji-145	33	1	_	_	PUNCT
aji-145	34	1	_	_	PUNCT
aji-145	35	1	_	_	PUNCT
aji-145	36	1	_	_	PUNCT
aji-145	37	1	_	_	PUNCT
aji-145	38	1	_	_	PUNCT
aji-145	39	1	_	_	PUNCT
aji-145	40	1	_	_	PUNCT
aji-145	41	1	_	_	PUNCT
aji-145	42	1	_	_	PUNCT
aji-145	43	1	_	_	PUNCT
aji-145	44	1	_	_	PUNCT
aji-145	45	1	_	_	PUNCT
aji-145	46	1	_	_	PUNCT
aji-145	47	1	_	_	PUNCT
aji-145	48	1	_	_	PUNCT
aji-145	49	1	_	_	PUNCT
aji-145	50	1	_	_	PUNCT
aji-145	51	1	_	_	PUNCT
aji-145	52	1	_	_	PUNCT
aji-145	53	1	_	_	PUNCT
aji-145	54	1	_	_	PUNCT
aji-145	55	1	_	_	PUNCT
aji-145	56	1	_	_	PUNCT
aji-145	57	1	_	_	PUNCT
aji-145	58	1	_	_	PUNCT
aji-145	59	1	_	_	PUNCT
aji-145	60	1	_	_	PUNCT
aji-145	61	1	_	_	PUNCT
aji-145	62	1	_	_	PUNCT
aji-145	63	1	_	_	PUNCT
aji-145	64	1	_	_	PUNCT
aji-145	65	1	_	_	PUNCT
aji-145	66	1	_	_	PUNCT
aji-145	67	1	_	_	PUNCT
aji-145	68	1	_	_	PUNCT
aji-145	69	1	_	_	PUNCT
aji-145	70	1	_	_	PUNCT
aji-145	71	1	_	_	PUNCT
aji-145	72	1	_	_	PUNCT
aji-145	73	1	_	_	PUNCT
aji-145	74	1	_	_	PUNCT
aji-145	75	1	_	_	PUNCT
aji-145	76	1	_	_	PUNCT
aji-145	77	1	_	_	PUNCT
aji-145	78	1	_	_	PUNCT
aji-145	79	1	_	_	PUNCT
aji-145	80	1	_	_	PUNCT
aji-145	81	1	_	_	PUNCT
aji-145	82	1	_	_	PUNCT
aji-145	83	1	_	_	PUNCT
aji-145	84	1	_	_	PUNCT
aji-145	85	1	_	_	PUNCT
aji-145	86	1	_	_	PUNCT
aji-145	87	1	_	_	PUNCT
aji-145	88	1	_	_	PUNCT
aji-145	89	1	_	_	PUNCT
aji-145	90	1	_	_	PUNCT
aji-145	91	1	_	_	PUNCT
aji-145	92	1	_	_	PUNCT
aji-145	93	1	_	_	PUNCT
aji-145	94	1	_	_	PUNCT
aji-145	95	1	_	_	PUNCT
aji-145	96	1	_	_	PUNCT
aji-145	97	1	_	_	PUNCT
aji-145	98	1	_	_	PUNCT
aji-145	99	1	_	_	PUNCT
aji-145	100	1	_	_	PUNCT
aji-145	101	1	_	_	PUNCT
aji-145	102	1	*	*	PUNCT
aji-145	102	2	corresponding	correspond	VERB
aji-145	102	3	author	author	NOUN
aji-145	102	4	:	:	PUNCT
aji-145	102	5	e	e	NOUN
aji-145	102	6	-	-	NOUN
aji-145	102	7	mail	mail	NOUN
aji-145	102	8	:	:	PUNCT
aji-145	102	9	chidisteve.cn@gmail.com	chidisteve.cn@gmail.com	X
aji-145	102	10	;	;	PUNCT
aji-145	102	11	cite	cite	VERB
aji-145	102	12	as	as	ADP
aji-145	102	13	:	:	PUNCT
aji-145	102	14	ndukwu	ndukwu	ADJ
aji-145	102	15	,	,	PUNCT
aji-145	102	16	chidi	chidi	PROPN
aji-145	102	17	l.c	l.c	PROPN
aji-145	102	18	.	.	PROPN
aji-145	102	19	,	,	PUNCT
aji-145	102	20	and	and	CCONJ
aji-145	102	21	jane	jane	PROPN
aji-145	102	22	ugochi	ugochi	PROPN
aji-145	102	23	chinedu	chinedu	PROPN
aji-145	102	24	-	-	PUNCT
aji-145	102	25	madu	madu	NOUN
aji-145	102	26	.	.	PUNCT
aji-145	103	1	2024	2024	NUM
aji-145	103	2	.	.	PUNCT
aji-145	104	1	“	"	PUNCT
aji-145	104	2	seroprevalence	seroprevalence	NOUN
aji-145	104	3	of	of	ADP
aji-145	104	4	hepatitis	hepatitis	PROPN
aji-145	104	5	b	b	PROPN
aji-145	104	6	and	and	CCONJ
aji-145	104	7	hepatitis	hepatitis	PROPN
aji-145	104	8	c	c	PROPN
aji-145	104	9	viral	viral	ADJ
aji-145	104	10	infections	infection	NOUN
aji-145	104	11	in	in	ADP
aji-145	104	12	port	port	NOUN
aji-145	104	13	harcourt	harcourt	PROPN
aji-145	104	14	,	,	PUNCT
aji-145	104	15	nigeria	nigeria	PROPN
aji-145	104	16	”	"	PUNCT
aji-145	104	17	.	.	PUNCT
aji-145	105	1	asian	asian	ADJ
aji-145	105	2	journal	journal	NOUN
aji-145	105	3	of	of	ADP
aji-145	105	4	immunology	immunology	NOUN
aji-145	105	5	7	7	NUM
aji-145	105	6	(	(	PUNCT
aji-145	105	7	1):209	1):209	NUM
aji-145	105	8	-	-	SYM
aji-145	105	9	16	16	NUM
aji-145	105	10	.	.	PUNCT
aji-145	106	1	https://journalaji.com/index.php/aji/article/view/145	https://journalaji.com/index.php/aji/article/view/145	PROPN
aji-145	106	2	.	.	PUNCT
aji-145	106	3	asian	asian	ADJ
aji-145	106	4	journal	journal	PROPN
aji-145	106	5	of	of	ADP
aji-145	106	6	immunology	immunology	NOUN
aji-145	106	7	volume	volume	NOUN
aji-145	106	8	7	7	NUM
aji-145	106	9	,	,	PUNCT
aji-145	106	10	issue	issue	NOUN
aji-145	106	11	1	1	NUM
aji-145	106	12	,	,	PUNCT
aji-145	106	13	page	page	NOUN
aji-145	106	14	209	209	NUM
aji-145	106	15	-	-	SYM
aji-145	106	16	216	216	NUM
aji-145	106	17	,	,	PUNCT
aji-145	106	18	2024	2024	NUM
aji-145	106	19	;	;	PUNCT
aji-145	106	20	article	article	NOUN
aji-145	106	21	no.aji.125624	no.aji.125624	VERB
aji-145	106	22	seroprevalence	seroprevalence	NOUN
aji-145	106	23	of	of	ADP
aji-145	106	24	hepatitis	hepatitis	PROPN
aji-145	106	25	b	b	PROPN
aji-145	106	26	and	and	CCONJ
aji-145	106	27	hepatitis	hepatitis	PROPN
aji-145	106	28	c	c	PROPN
aji-145	106	29	viral	viral	ADJ
aji-145	106	30	infections	infection	NOUN
aji-145	106	31	in	in	ADP
aji-145	106	32	port	port	NOUN
aji-145	106	33	harcourt	harcourt	PROPN
aji-145	106	34	,	,	PUNCT
aji-145	106	35	nigeria	nigeria	PROPN
aji-145	106	36	chidi	chidi	PROPN
aji-145	106	37	l.c	l.c	PROPN
aji-145	106	38	.	.	PROPN
aji-145	106	39	ndukwu	ndukwu	PROPN
aji-145	106	40	a	a	PROPN
aji-145	106	41	*	*	PUNCT
aji-145	106	42	and	and	CCONJ
aji-145	106	43	jane	jane	PROPN
aji-145	106	44	ugochi	ugochi	PROPN
aji-145	106	45	chinedu	chinedu	PROPN
aji-145	106	46	-	-	PUNCT
aji-145	106	47	madu	madu	NOUN
aji-145	106	48	a	a	DET
aji-145	106	49	a	a	DET
aji-145	106	50	faculty	faculty	NOUN
aji-145	106	51	of	of	ADP
aji-145	106	52	medical	medical	ADJ
aji-145	106	53	laboratory	laboratory	NOUN
aji-145	106	54	science	science	NOUN
aji-145	106	55	,	,	PUNCT
aji-145	106	56	federal	federal	ADJ
aji-145	106	57	university	university	NOUN
aji-145	106	58	,	,	PUNCT
aji-145	106	59	otuoke	otuoke	NOUN
aji-145	106	60	,	,	PUNCT
aji-145	106	61	nigeria	nigeria	PROPN
aji-145	106	62	.	.	PUNCT
aji-145	107	1	authors	author	NOUN
aji-145	107	2	’	'	PUNCT
aji-145	107	3	contributions	contribution	NOUN
aji-145	107	4	this	this	DET
aji-145	107	5	work	work	NOUN
aji-145	107	6	was	be	AUX
aji-145	107	7	carried	carry	VERB
aji-145	107	8	out	out	ADP
aji-145	107	9	in	in	ADP
aji-145	107	10	collaboration	collaboration	NOUN
aji-145	107	11	between	between	ADP
aji-145	107	12	both	both	DET
aji-145	107	13	authors	author	NOUN
aji-145	107	14	.	.	PUNCT
aji-145	108	1	both	both	DET
aji-145	108	2	authors	author	NOUN
aji-145	108	3	read	read	VERB
aji-145	108	4	and	and	CCONJ
aji-145	108	5	approved	approve	VERB
aji-145	108	6	the	the	DET
aji-145	108	7	final	final	ADJ
aji-145	108	8	manuscript	manuscript	NOUN
aji-145	108	9	.	.	PUNCT
aji-145	109	1	article	article	NOUN
aji-145	109	2	information	information	PROPN
aji-145	109	3	doi	doi	PROPN
aji-145	109	4	:	:	PUNCT
aji-145	109	5	https://doi.org/10.9734/aji/2024/v7i1145	https://doi.org/10.9734/aji/2024/v7i1145	ADJ
aji-145	109	6	open	open	ADJ
aji-145	109	7	peer	peer	NOUN
aji-145	109	8	review	review	NOUN
aji-145	109	9	history	history	NOUN
aji-145	109	10	:	:	PUNCT
aji-145	109	11	this	this	DET
aji-145	109	12	journal	journal	NOUN
aji-145	109	13	follows	follow	VERB
aji-145	109	14	the	the	DET
aji-145	109	15	advanced	advance	VERB
aji-145	109	16	open	open	ADJ
aji-145	109	17	peer	peer	NOUN
aji-145	109	18	review	review	NOUN
aji-145	109	19	policy	policy	NOUN
aji-145	109	20	.	.	PUNCT
aji-145	110	1	identity	identity	NOUN
aji-145	110	2	of	of	ADP
aji-145	110	3	the	the	DET
aji-145	110	4	reviewers	reviewer	NOUN
aji-145	110	5	,	,	PUNCT
aji-145	110	6	editor(s	editor(s	NOUN
aji-145	110	7	)	)	PUNCT
aji-145	110	8	and	and	CCONJ
aji-145	110	9	additional	additional	ADJ
aji-145	110	10	reviewers	reviewer	NOUN
aji-145	110	11	,	,	PUNCT
aji-145	110	12	peer	peer	NOUN
aji-145	110	13	review	review	NOUN
aji-145	110	14	comments	comment	NOUN
aji-145	110	15	,	,	PUNCT
aji-145	110	16	different	different	ADJ
aji-145	110	17	versions	version	NOUN
aji-145	110	18	of	of	ADP
aji-145	110	19	the	the	DET
aji-145	110	20	manuscript	manuscript	NOUN
aji-145	110	21	,	,	PUNCT
aji-145	110	22	comments	comment	NOUN
aji-145	110	23	of	of	ADP
aji-145	110	24	the	the	DET
aji-145	110	25	editors	editor	NOUN
aji-145	110	26	,	,	PUNCT
aji-145	110	27	etc	etc	X
aji-145	110	28	are	be	AUX
aji-145	110	29	available	available	ADJ
aji-145	110	30	here	here	ADV
aji-145	110	31	:	:	PUNCT
aji-145	110	32	https://www.sdiarticle5.com/review-history/125624	https://www.sdiarticle5.com/review-history/125624	NOUN
aji-145	110	33	received	receive	VERB
aji-145	110	34	:	:	PUNCT
aji-145	110	35	20/08/2024	20/08/2024	NUM
aji-145	110	36	accepted	accept	VERB
aji-145	110	37	:	:	PUNCT
aji-145	110	38	24/10/2024	24/10/2024	NUM
aji-145	110	39	published	publish	VERB
aji-145	110	40	:	:	PUNCT
aji-145	110	41	30/10/2024	30/10/2024	NUM
aji-145	110	42	abstract	abstract	ADJ
aji-145	110	43	introduction	introduction	NOUN
aji-145	110	44	:	:	PUNCT
aji-145	110	45	viral	viral	ADJ
aji-145	110	46	hepatitis	hepatitis	NOUN
aji-145	110	47	which	which	PRON
aji-145	110	48	includes	include	VERB
aji-145	110	49	five	five	NUM
aji-145	110	50	the	the	DET
aji-145	110	51	main	main	ADJ
aji-145	110	52	strains	strain	NOUN
aji-145	110	53	of	of	ADP
aji-145	110	54	hepatotropic	hepatotropic	NOUN
aji-145	110	55	viruses	virus	NOUN
aji-145	110	56	,	,	PUNCT
aji-145	110	57	hepatitis	hepatitis	NOUN
aji-145	110	58	a	a	PRON
aji-145	110	59	(	(	PUNCT
aji-145	110	60	hav	hav	PROPN
aji-145	110	61	)	)	PUNCT
aji-145	110	62	,	,	PUNCT
aji-145	110	63	hepatitis	hepatitis	PROPN
aji-145	110	64	b	b	PROPN
aji-145	110	65	(	(	PUNCT
aji-145	110	66	hbv	hbv	NOUN
aji-145	110	67	)	)	PUNCT
aji-145	110	68	,	,	PUNCT
aji-145	110	69	(	(	PUNCT
aji-145	110	70	hba	hba	NOUN
aji-145	110	71	)	)	PUNCT
aji-145	110	72	,	,	PUNCT
aji-145	110	73	hepatitis	hepatitis	PROPN
aji-145	110	74	c	c	PROPN
aji-145	110	75	(	(	PUNCT
aji-145	110	76	hcv	hcv	PROPN
aji-145	110	77	)	)	PUNCT
aji-145	110	78	,	,	PUNCT
aji-145	110	79	hepatitis	hepatitis	PROPN
aji-145	110	80	d(hdv	d(hdv	PROPN
aji-145	110	81	)	)	PUNCT
aji-145	110	82	,	,	PUNCT
aji-145	110	83	and	and	CCONJ
aji-145	110	84	hepatitis	hepatitis	PROPN
aji-145	110	85	e	e	PROPN
aji-145	110	86	(	(	PUNCT
aji-145	110	87	hev	hev	PROPN
aji-145	110	88	)	)	PUNCT
aji-145	110	89	,	,	PUNCT
aji-145	110	90	are	be	AUX
aji-145	110	91	leading	lead	VERB
aji-145	110	92	causes	cause	NOUN
aji-145	110	93	of	of	ADP
aji-145	110	94	morbidity	morbidity	NOUN
aji-145	110	95	and	and	CCONJ
aji-145	110	96	mortality	mortality	NOUN
aji-145	110	97	globally	globally	ADV
aji-145	110	98	.	.	PUNCT
aji-145	111	1	much	much	ADJ
aji-145	111	2	public	public	ADJ
aji-145	111	3	health	health	NOUN
aji-145	111	4	attention	attention	NOUN
aji-145	111	5	is	be	AUX
aji-145	111	6	however	however	ADV
aji-145	111	7	focused	focused	ADJ
aji-145	111	8	on	on	ADP
aji-145	111	9	the	the	DET
aji-145	111	10	two	two	NUM
aji-145	111	11	blood	blood	NOUN
aji-145	111	12	-	-	PUNCT
aji-145	111	13	borne	bear	VERB
aji-145	111	14	hepatitis	hepatitis	NOUN
aji-145	111	15	viruses	virus	NOUN
aji-145	111	16	hbv	hbv	NOUN
aji-145	111	17	and	and	CCONJ
aji-145	111	18	hcv	hcv	NOUN
aji-145	111	19	,	,	PUNCT
aji-145	111	20	due	due	ADJ
aji-145	111	21	largely	largely	ADV
aji-145	111	22	to	to	ADP
aji-145	111	23	their	their	PRON
aji-145	111	24	high	high	ADJ
aji-145	111	25	prevalence	prevalence	NOUN
aji-145	111	26	and	and	CCONJ
aji-145	111	27	pervasive	pervasive	ADJ
aji-145	111	28	rates	rate	NOUN
aji-145	111	29	of	of	ADP
aji-145	111	30	morbidity	morbidity	NOUN
aji-145	111	31	and	and	CCONJ
aji-145	111	32	mortality	mortality	NOUN
aji-145	111	33	.	.	PUNCT
aji-145	112	1	this	this	DET
aji-145	112	2	study	study	NOUN
aji-145	112	3	was	be	AUX
aji-145	112	4	thus	thus	ADV
aji-145	112	5	aimed	aim	VERB
aji-145	112	6	at	at	ADP
aji-145	112	7	determining	determine	VERB
aji-145	112	8	the	the	DET
aji-145	112	9	prevalence	prevalence	NOUN
aji-145	112	10	of	of	ADP
aji-145	112	11	hbv	hbv	NOUN
aji-145	112	12	and	and	CCONJ
aji-145	112	13	hcv	hcv	PROPN
aji-145	112	14	.	.	PUNCT
aji-145	113	1	materials	material	NOUN
aji-145	113	2	and	and	CCONJ
aji-145	113	3	methods	method	NOUN
aji-145	113	4	:	:	PUNCT
aji-145	113	5	this	this	DET
aji-145	113	6	retrospective	retrospective	ADJ
aji-145	113	7	study	study	NOUN
aji-145	113	8	was	be	AUX
aji-145	113	9	conducted	conduct	VERB
aji-145	113	10	in	in	ADP
aji-145	113	11	diobu	diobu	NOUN
aji-145	113	12	,	,	PUNCT
aji-145	113	13	a	a	DET
aji-145	113	14	high	high	ADJ
aji-145	113	15	-	-	PUNCT
aji-145	113	16	density	density	NOUN
aji-145	113	17	group	group	NOUN
aji-145	113	18	of	of	ADP
aji-145	113	19	urban	urban	ADJ
aji-145	113	20	communities	community	NOUN
aji-145	113	21	situated	situate	VERB
aji-145	113	22	in	in	ADP
aji-145	113	23	the	the	DET
aji-145	113	24	heart	heart	NOUN
aji-145	113	25	of	of	ADP
aji-145	113	26	port	port	NOUN
aji-145	113	27	harcourt	harcourt	PROPN
aji-145	113	28	metropolis	metropolis	PROPN
aji-145	113	29	in	in	ADP
aji-145	113	30	the	the	DET
aji-145	113	31	niger	niger	NOUN
aji-145	113	32	delta	delta	NOUN
aji-145	113	33	of	of	ADP
aji-145	113	34	nigeria	nigeria	PROPN
aji-145	113	35	.	.	PUNCT
aji-145	114	1	the	the	DET
aji-145	114	2	medical	medical	ADJ
aji-145	114	3	laboratory	laboratory	NOUN
aji-145	114	4	records	record	VERB
aji-145	114	5	206	206	NUM
aji-145	114	6	patients	patient	NOUN
aji-145	114	7	,	,	PUNCT
aji-145	114	8	including	include	VERB
aji-145	114	9	123	123	NUM
aji-145	114	10	males	male	NOUN
aji-145	114	11	and	and	CCONJ
aji-145	114	12	83	83	NUM
aji-145	114	13	females	female	NOUN
aji-145	114	14	of	of	ADP
aji-145	114	15	various	various	ADJ
aji-145	114	16	ages	age	NOUN
aji-145	114	17	,	,	PUNCT
aji-145	114	18	residing	reside	VERB
aji-145	114	19	in	in	ADP
aji-145	114	20	diobu	diobu	NOUN
aji-145	114	21	and	and	CCONJ
aji-145	114	22	closely	closely	ADV
aji-145	114	23	adjoining	adjoining	ADJ
aji-145	114	24	urban	urban	ADJ
aji-145	114	25	communities	community	NOUN
aji-145	114	26	of	of	ADP
aji-145	114	27	port	port	NOUN
aji-145	114	28	harcourt	harcourt	PROPN
aji-145	114	29	metropolis	metropolis	PROPN
aji-145	114	30	were	be	AUX
aji-145	114	31	reviewed	review	VERB
aji-145	114	32	;	;	PUNCT
aji-145	114	33	to	to	PART
aji-145	114	34	extract	extract	VERB
aji-145	114	35	data	datum	NOUN
aji-145	114	36	on	on	ADP
aji-145	114	37	the	the	DET
aji-145	114	38	hbv	hbv	NOUN
aji-145	114	39	and	and	CCONJ
aji-145	114	40	hcv	hcv	NOUN
aji-145	114	41	tests	test	NOUN
aji-145	114	42	.	.	PUNCT
aji-145	115	1	results	result	NOUN
aji-145	115	2	:	:	PUNCT
aji-145	115	3	the	the	DET
aji-145	115	4	mean	mean	ADJ
aji-145	115	5	age	age	NOUN
aji-145	115	6	in	in	ADP
aji-145	115	7	years	year	NOUN
aji-145	115	8	was	be	AUX
aji-145	115	9	37.04±	37.04±	NUM
aji-145	115	10	12.06	12.06	NUM
aji-145	115	11	the	the	DET
aji-145	115	12	median	median	ADJ
aji-145	115	13	age	age	NOUN
aji-145	115	14	:	:	PUNCT
aji-145	115	15	36	36	NUM
aji-145	115	16	,	,	PUNCT
aji-145	115	17	mode	mode	NOUN
aji-145	115	18	:	:	PUNCT
aji-145	115	19	33	33	NUM
aji-145	115	20	,	,	PUNCT
aji-145	115	21	while	while	SCONJ
aji-145	115	22	the	the	DET
aji-145	115	23	minimum	minimum	ADJ
aji-145	115	24	and	and	CCONJ
aji-145	115	25	maximum	maximum	ADJ
aji-145	115	26	ages	age	NOUN
aji-145	115	27	were	be	AUX
aji-145	115	28	12	12	NUM
aji-145	115	29	and	and	CCONJ
aji-145	115	30	69	69	NUM
aji-145	115	31	years	year	NOUN
aji-145	115	32	,	,	PUNCT
aji-145	115	33	respectively	respectively	ADV
aji-145	115	34	.	.	PUNCT
aji-145	116	1	the	the	DET
aji-145	116	2	seroprevalence	seroprevalence	NOUN
aji-145	116	3	of	of	ADP
aji-145	116	4	hepatitis	hepatitis	PROPN
aji-145	116	5	original	original	ADJ
aji-145	116	6	research	research	NOUN
aji-145	116	7	article	article	NOUN
aji-145	116	8	https://doi.org/10.9734/aji/2024/v7i1145	https://doi.org/10.9734/aji/2024/v7i1145	PROPN
aji-145	116	9	https://www.sdiarticle5.com/review-history/125624	https://www.sdiarticle5.com/review-history/125624	VERB
aji-145	116	10	ndukwu	ndukwu	ADJ
aji-145	116	11	and	and	CCONJ
aji-145	116	12	chinedu	chinedu	NOUN
aji-145	116	13	-	-	PUNCT
aji-145	116	14	madu	madu	NOUN
aji-145	116	15	;	;	PUNCT
aji-145	116	16	asian	asian	PROPN
aji-145	116	17	j.	j.	PROPN
aji-145	116	18	immunol	immunol	PROPN
aji-145	116	19	.	.	PROPN
aji-145	116	20	,	,	PUNCT
aji-145	116	21	vol	vol	NOUN
aji-145	116	22	.	.	PROPN
aji-145	117	1	7	7	NUM
aji-145	117	2	,	,	PUNCT
aji-145	117	3	no	no	INTJ
aji-145	117	4	.	.	NOUN
aji-145	117	5	1	1	NUM
aji-145	117	6	,	,	PUNCT
aji-145	117	7	pp	pp	ADJ
aji-145	117	8	.	.	PUNCT
aji-145	118	1	209	209	NUM
aji-145	118	2	-	-	SYM
aji-145	118	3	216	216	NUM
aji-145	118	4	,	,	PUNCT
aji-145	118	5	2024	2024	NUM
aji-145	118	6	;	;	PUNCT
aji-145	118	7	article	article	NOUN
aji-145	118	8	no.aji.125624	no.aji.125624	VERB
aji-145	118	9	210	210	NUM
aji-145	118	10	b	b	NOUN
aji-145	118	11	in	in	ADP
aji-145	118	12	the	the	DET
aji-145	118	13	study	study	NOUN
aji-145	118	14	area	area	NOUN
aji-145	118	15	was	be	AUX
aji-145	118	16	found	find	VERB
aji-145	118	17	to	to	PART
aji-145	118	18	be	be	AUX
aji-145	118	19	5.8	5.8	NUM
aji-145	118	20	%	%	NOUN
aji-145	118	21	,	,	PUNCT
aji-145	118	22	while	while	SCONJ
aji-145	118	23	that	that	PRON
aji-145	118	24	for	for	ADP
aji-145	118	25	hepatitis	hepatitis	PROPN
aji-145	118	26	c	c	PROPN
aji-145	118	27	was	be	AUX
aji-145	118	28	0.5	0.5	NUM
aji-145	118	29	%	%	NOUN
aji-145	118	30	.	.	PUNCT
aji-145	119	1	the	the	DET
aji-145	119	2	males	male	NOUN
aji-145	119	3	had	have	VERB
aji-145	119	4	a	a	DET
aji-145	119	5	seroprevalence	seroprevalence	NOUN
aji-145	119	6	of	of	ADP
aji-145	119	7	7.3	7.3	NUM
aji-145	119	8	%	%	NOUN
aji-145	119	9	and	and	CCONJ
aji-145	119	10	females	female	NOUN
aji-145	119	11	3.6	3.6	NUM
aji-145	119	12	%	%	NOUN
aji-145	119	13	for	for	ADP
aji-145	119	14	hepatitis	hepatitis	PROPN
aji-145	119	15	b.	b.	PROPN
aji-145	119	16	among	among	ADP
aji-145	119	17	the	the	DET
aji-145	119	18	age	age	NOUN
aji-145	119	19	groups	group	NOUN
aji-145	119	20	,	,	PUNCT
aji-145	119	21	the	the	DET
aji-145	119	22	highest	high	ADJ
aji-145	119	23	prevalence	prevalence	NOUN
aji-145	119	24	was	be	AUX
aji-145	119	25	found	find	VERB
aji-145	119	26	in	in	ADP
aji-145	119	27	the	the	DET
aji-145	119	28	31	31	NUM
aji-145	119	29	-	-	SYM
aji-145	119	30	40	40	NUM
aji-145	119	31	years	year	NOUN
aji-145	119	32	age	age	NOUN
aji-145	119	33	bracket	bracket	NOUN
aji-145	119	34	at	at	ADP
aji-145	119	35	10.6	10.6	NUM
aji-145	119	36	%	%	NOUN
aji-145	119	37	,	,	PUNCT
aji-145	119	38	followed	follow	VERB
aji-145	119	39	by	by	ADP
aji-145	119	40	11	11	NUM
aji-145	119	41	-	-	SYM
aji-145	119	42	20	20	NUM
aji-145	119	43	years	year	NOUN
aji-145	119	44	(	(	PUNCT
aji-145	119	45	59	59	NUM
aji-145	119	46	%	%	NOUN
aji-145	119	47	)	)	PUNCT
aji-145	119	48	,	,	PUNCT
aji-145	119	49	2130	2130	NUM
aji-145	119	50	years	year	NOUN
aji-145	119	51	,	,	PUNCT
aji-145	119	52	(	(	PUNCT
aji-145	119	53	5.0	5.0	NUM
aji-145	119	54	%	%	NOUN
aji-145	119	55	)	)	PUNCT
aji-145	119	56	and	and	CCONJ
aji-145	119	57	41	41	NUM
aji-145	119	58	-	-	SYM
aji-145	119	59	50	50	NUM
aji-145	119	60	%	%	NOUN
aji-145	119	61	(	(	PUNCT
aji-145	119	62	3.6	3.6	NUM
aji-145	119	63	%	%	NOUN
aji-145	119	64	)	)	PUNCT
aji-145	119	65	conclusion	conclusion	NOUN
aji-145	119	66	:	:	PUNCT
aji-145	119	67	the	the	DET
aji-145	119	68	prevalence	prevalence	NOUN
aji-145	119	69	of	of	ADP
aji-145	119	70	5.8	5.8	NUM
aji-145	119	71	%	%	NOUN
aji-145	119	72	for	for	ADP
aji-145	119	73	hbv	hbv	NOUN
aji-145	119	74	in	in	ADP
aji-145	119	75	this	this	DET
aji-145	119	76	study	study	NOUN
aji-145	119	77	,	,	PUNCT
aji-145	119	78	represents	represent	VERB
aji-145	119	79	an	an	DET
aji-145	119	80	intermediate	intermediate	ADJ
aji-145	119	81	level	level	NOUN
aji-145	119	82	of	of	ADP
aji-145	119	83	transmission	transmission	NOUN
aji-145	119	84	on	on	ADP
aji-145	119	85	the	the	PRON
aji-145	119	86	who	who	PRON
aji-145	119	87	criteria	criterion	NOUN
aji-145	119	88	of	of	ADP
aji-145	119	89	endemicity	endemicity	NOUN
aji-145	119	90	,	,	PUNCT
aji-145	119	91	while	while	SCONJ
aji-145	119	92	the	the	DET
aji-145	119	93	0.5	0.5	NUM
aji-145	119	94	%	%	NOUN
aji-145	119	95	is	be	AUX
aji-145	119	96	low	low	ADJ
aji-145	119	97	level	level	NOUN
aji-145	119	98	of	of	ADP
aji-145	119	99	transmission	transmission	NOUN
aji-145	119	100	.	.	PUNCT
aji-145	120	1	there	there	PRON
aji-145	120	2	is	be	VERB
aji-145	120	3	need	need	NOUN
aji-145	120	4	for	for	ADP
aji-145	120	5	concerted	concerted	ADJ
aji-145	120	6	public	public	ADJ
aji-145	120	7	health	health	NOUN
aji-145	120	8	policy	policy	NOUN
aji-145	120	9	makers	maker	NOUN
aji-145	120	10	and	and	CCONJ
aji-145	120	11	all	all	DET
aji-145	120	12	stakeholders	stakeholder	NOUN
aji-145	120	13	to	to	PART
aji-145	120	14	put	put	VERB
aji-145	120	15	more	more	ADJ
aji-145	120	16	efforts	effort	NOUN
aji-145	120	17	curtail	curtail	VERB
aji-145	120	18	the	the	DET
aji-145	120	19	menace	menace	NOUN
aji-145	120	20	of	of	ADP
aji-145	120	21	viral	viral	ADJ
aji-145	120	22	hepatitis	hepatitis	NOUN
aji-145	120	23	.	.	PUNCT
aji-145	121	1	keywords	keyword	NOUN
aji-145	121	2	:	:	PUNCT
aji-145	121	3	blood	blood	NOUN
aji-145	121	4	-	-	PUNCT
aji-145	121	5	borne	bear	VERB
aji-145	121	6	infections	infection	NOUN
aji-145	121	7	;	;	PUNCT
aji-145	121	8	hepatitis	hepatitis	PROPN
aji-145	121	9	b	b	PROPN
aji-145	121	10	;	;	PUNCT
aji-145	121	11	hepatitis	hepatitis	PROPN
aji-145	121	12	c.	c.	PROPN
aji-145	121	13	1	1	NUM
aji-145	121	14	.	.	PUNCT
aji-145	122	1	introduction	introduction	NOUN
aji-145	122	2	hepatitis	hepatitis	NOUN
aji-145	122	3	is	be	AUX
aji-145	122	4	an	an	DET
aji-145	122	5	inflammation	inflammation	NOUN
aji-145	122	6	of	of	ADP
aji-145	122	7	the	the	DET
aji-145	122	8	liver	liver	NOUN
aji-145	122	9	which	which	PRON
aji-145	122	10	may	may	AUX
aji-145	122	11	be	be	AUX
aji-145	122	12	caused	cause	VERB
aji-145	122	13	by	by	ADP
aji-145	122	14	a	a	DET
aji-145	122	15	number	number	NOUN
aji-145	122	16	of	of	ADP
aji-145	122	17	viruses	virus	NOUN
aji-145	122	18	and	and	CCONJ
aji-145	122	19	noninfectious	noninfectious	ADJ
aji-145	122	20	factors	factor	NOUN
aji-145	122	21	including	include	VERB
aji-145	122	22	excessive	excessive	ADJ
aji-145	122	23	use	use	NOUN
aji-145	122	24	alcohol	alcohol	NOUN
aji-145	122	25	,	,	PUNCT
aji-145	122	26	drugs	drug	NOUN
aji-145	122	27	,	,	PUNCT
aji-145	122	28	toxins	toxin	NOUN
aji-145	122	29	and	and	CCONJ
aji-145	122	30	autoimmune	autoimmune	ADJ
aji-145	122	31	disorders	disorder	NOUN
aji-145	122	32	;	;	PUNCT
aji-145	122	33	the	the	DET
aji-145	122	34	commonest	commonest	NOUN
aji-145	122	35	type	type	NOUN
aji-145	122	36	of	of	ADP
aji-145	122	37	hepatitis	hepatitis	NOUN
aji-145	122	38	however	however	ADV
aji-145	122	39	,	,	PUNCT
aji-145	122	40	are	be	AUX
aji-145	122	41	the	the	DET
aji-145	122	42	viral	viral	ADJ
aji-145	122	43	hepatitis	hepatitis	NOUN
aji-145	122	44	.	.	PUNCT
aji-145	123	1	the	the	DET
aji-145	123	2	viral	viral	ADJ
aji-145	123	3	hepatitis	hepatitis	NOUN
aji-145	123	4	infections	infection	NOUN
aji-145	123	5	are	be	AUX
aji-145	123	6	caused	cause	VERB
aji-145	123	7	by	by	ADP
aji-145	123	8	five	five	NUM
aji-145	123	9	main	main	ADJ
aji-145	123	10	strains	strain	NOUN
aji-145	123	11	of	of	ADP
aji-145	123	12	hepatitis	hepatitis	NOUN
aji-145	123	13	viruses	virus	NOUN
aji-145	123	14	namely	namely	ADV
aji-145	123	15	,	,	PUNCT
aji-145	123	16	hepatitis	hepatitis	PROPN
aji-145	123	17	a	a	PRON
aji-145	123	18	,	,	PUNCT
aji-145	123	19	b	b	PROPN
aji-145	123	20	,	,	PUNCT
aji-145	123	21	c	c	NOUN
aji-145	123	22	,	,	PUNCT
aji-145	123	23	d	d	NOUN
aji-145	123	24	,	,	PUNCT
aji-145	123	25	and	and	CCONJ
aji-145	123	26	e	e	NOUN
aji-145	123	27	viruses	virus	NOUN
aji-145	123	28	[	[	X
aji-145	123	29	1,2	1,2	NUM
aji-145	123	30	]	]	PUNCT
aji-145	123	31	.	.	PUNCT
aji-145	124	1	though	though	SCONJ
aji-145	124	2	all	all	DET
aji-145	124	3	the	the	DET
aji-145	124	4	hepatitis	hepatitis	NOUN
aji-145	124	5	viruses	virus	NOUN
aji-145	124	6	cause	cause	VERB
aji-145	124	7	liver	liver	NOUN
aji-145	124	8	diseases	disease	NOUN
aji-145	124	9	,	,	PUNCT
aji-145	124	10	they	they	PRON
aji-145	124	11	vary	vary	VERB
aji-145	124	12	in	in	ADP
aji-145	124	13	modes	mode	NOUN
aji-145	124	14	of	of	ADP
aji-145	124	15	transmission	transmission	NOUN
aji-145	124	16	,	,	PUNCT
aji-145	124	17	nature	nature	NOUN
aji-145	124	18	and	and	CCONJ
aji-145	124	19	severity	severity	NOUN
aji-145	124	20	of	of	ADP
aji-145	124	21	the	the	DET
aji-145	124	22	illness	illness	NOUN
aji-145	124	23	,	,	PUNCT
aji-145	124	24	geographical	geographical	ADJ
aji-145	124	25	distribution	distribution	NOUN
aji-145	124	26	and	and	CCONJ
aji-145	124	27	prevention	prevention	NOUN
aji-145	124	28	methods	method	NOUN
aji-145	124	29	.	.	PUNCT
aji-145	125	1	while	while	SCONJ
aji-145	125	2	types	type	NOUN
aji-145	125	3	a	a	PRON
aji-145	125	4	,	,	PUNCT
aji-145	125	5	b	b	NOUN
aji-145	125	6	and	and	CCONJ
aji-145	125	7	c	c	PROPN
aji-145	125	8	are	be	AUX
aji-145	125	9	the	the	DET
aji-145	125	10	most	most	ADV
aji-145	125	11	prevalent	prevalent	ADJ
aji-145	125	12	,	,	PUNCT
aji-145	125	13	types	type	NOUN
aji-145	125	14	b	b	NOUN
aji-145	125	15	and	and	CCONJ
aji-145	125	16	c	c	PROPN
aji-145	125	17	attracts	attract	VERB
aji-145	125	18	more	more	ADJ
aji-145	125	19	public	public	ADJ
aji-145	125	20	health	health	NOUN
aji-145	125	21	attention	attention	NOUN
aji-145	125	22	because	because	SCONJ
aji-145	125	23	they	they	PRON
aji-145	125	24	cause	cause	VERB
aji-145	125	25	chronic	chronic	ADJ
aji-145	125	26	disease	disease	NOUN
aji-145	125	27	in	in	ADP
aji-145	125	28	hundreds	hundred	NOUN
aji-145	125	29	of	of	ADP
aji-145	125	30	millions	million	NOUN
aji-145	125	31	of	of	ADP
aji-145	125	32	people	people	NOUN
aji-145	125	33	and	and	CCONJ
aji-145	125	34	together	together	ADV
aji-145	125	35	are	be	AUX
aji-145	125	36	the	the	DET
aji-145	125	37	most	most	ADV
aji-145	125	38	common	common	ADJ
aji-145	125	39	cause	cause	NOUN
aji-145	125	40	of	of	ADP
aji-145	125	41	liver	liver	NOUN
aji-145	125	42	cirrhosis	cirrhosis	NOUN
aji-145	125	43	,	,	PUNCT
aji-145	125	44	liver	liver	NOUN
aji-145	125	45	cancer	cancer	NOUN
aji-145	125	46	and	and	CCONJ
aji-145	125	47	viral	viral	ADJ
aji-145	125	48	hepatitis	hepatitis	NOUN
aji-145	125	49	-	-	PUNCT
aji-145	125	50	related	relate	VERB
aji-145	125	51	deaths	death	NOUN
aji-145	125	52	worldwide	worldwide	ADV
aji-145	126	1	[	[	X
aji-145	126	2	1,2	1,2	NUM
aji-145	126	3	]	]	PUNCT
aji-145	126	4	.	.	PUNCT
aji-145	127	1	about	about	ADV
aji-145	127	2	354	354	NUM
aji-145	127	3	million	million	NUM
aji-145	127	4	people	people	NOUN
aji-145	127	5	across	across	ADP
aji-145	127	6	the	the	DET
aji-145	127	7	globe	globe	NOUN
aji-145	127	8	are	be	AUX
aji-145	127	9	living	live	VERB
aji-145	127	10	with	with	ADP
aji-145	127	11	hepatitis	hepatitis	PROPN
aji-145	127	12	b	b	PROPN
aji-145	127	13	or	or	CCONJ
aji-145	127	14	c	c	NOUN
aji-145	127	15	,	,	PUNCT
aji-145	127	16	and	and	CCONJ
aji-145	127	17	most	most	ADJ
aji-145	127	18	of	of	ADP
aji-145	127	19	them	they	PRON
aji-145	127	20	are	be	AUX
aji-145	127	21	ignorant	ignorant	ADJ
aji-145	127	22	of	of	ADP
aji-145	127	23	the	the	DET
aji-145	127	24	condition	condition	NOUN
aji-145	127	25	and	and	CCONJ
aji-145	127	26	could	could	AUX
aji-145	127	27	not	not	PART
aji-145	127	28	access	access	VERB
aji-145	127	29	treatment	treatment	NOUN
aji-145	127	30	[	[	X
aji-145	127	31	2	2	NUM
aji-145	127	32	]	]	PUNCT
aji-145	127	33	.	.	PUNCT
aji-145	128	1	the	the	DET
aji-145	128	2	global	global	ADJ
aji-145	128	3	prevalence	prevalence	NOUN
aji-145	128	4	hepatitis	hepatitis	PROPN
aji-145	128	5	b	b	PROPN
aji-145	128	6	virus	virus	NOUN
aji-145	128	7	(	(	PUNCT
aji-145	128	8	hbv	hbv	NOUN
aji-145	128	9	)	)	PUNCT
aji-145	128	10	or	or	CCONJ
aji-145	128	11	hepatitis	hepatitis	PROPN
aji-145	128	12	c	c	PROPN
aji-145	128	13	virus	virus	NOUN
aji-145	128	14	(	(	PUNCT
aji-145	128	15	hcv	hcv	NOUN
aji-145	128	16	)	)	PUNCT
aji-145	128	17	infections	infection	NOUN
aji-145	128	18	are	be	AUX
aji-145	128	19	put	put	VERB
aji-145	128	20	at	at	ADP
aji-145	128	21	296	296	NUM
aji-145	128	22	million	million	NUM
aji-145	128	23	and	and	CCONJ
aji-145	128	24	58	58	NUM
aji-145	128	25	million	million	NUM
aji-145	128	26	persons	person	NOUN
aji-145	128	27	,	,	PUNCT
aji-145	128	28	respectively	respectively	ADV
aji-145	128	29	[	[	X
aji-145	128	30	3,4,5	3,4,5	NOUN
aji-145	128	31	]	]	PUNCT
aji-145	128	32	.	.	PUNCT
aji-145	129	1	while	while	SCONJ
aji-145	129	2	hepatitis	hepatitis	PROPN
aji-145	129	3	b	b	PROPN
aji-145	129	4	is	be	AUX
aji-145	129	5	estimated	estimate	VERB
aji-145	129	6	to	to	PART
aji-145	129	7	cause	cause	VERB
aji-145	129	8	780,000	780,000	NUM
aji-145	129	9	deaths	death	NOUN
aji-145	129	10	annually	annually	ADV
aji-145	129	11	,	,	PUNCT
aji-145	129	12	the	the	DET
aji-145	129	13	estimate	estimate	NOUN
aji-145	129	14	for	for	ADP
aji-145	129	15	hepatitis	hepatitis	PROPN
aji-145	129	16	c	c	PROPN
aji-145	129	17	is	be	AUX
aji-145	129	18	about	about	ADV
aji-145	129	19	400,000	400,000	NUM
aji-145	129	20	deaths	death	NOUN
aji-145	129	21	every	every	DET
aji-145	129	22	year	year	NOUN
aji-145	129	23	[	[	X
aji-145	129	24	1	1	NUM
aji-145	129	25	]	]	PUNCT
aji-145	129	26	.	.	PUNCT
aji-145	130	1	in	in	ADP
aji-145	130	2	nigeria	nigeria	PROPN
aji-145	130	3	,	,	PUNCT
aji-145	130	4	it	it	PRON
aji-145	130	5	is	be	AUX
aji-145	130	6	estimated	estimate	VERB
aji-145	130	7	that	that	SCONJ
aji-145	130	8	about	about	ADV
aji-145	130	9	20	20	NUM
aji-145	130	10	million	million	NUM
aji-145	130	11	people	people	NOUN
aji-145	130	12	are	be	AUX
aji-145	130	13	chronically	chronically	ADV
aji-145	130	14	infected	infect	VERB
aji-145	130	15	with	with	ADP
aji-145	130	16	hepatitis	hepatitis	PROPN
aji-145	130	17	b	b	PROPN
aji-145	130	18	and	and	CCONJ
aji-145	130	19	c	c	NOUN
aji-145	130	20	;	;	PUNCT
aji-145	130	21	with	with	ADP
aji-145	130	22	prevalence	prevalence	NOUN
aji-145	130	23	of	of	ADP
aji-145	130	24	8.1	8.1	NUM
aji-145	130	25	%	%	NOUN
aji-145	130	26	and	and	CCONJ
aji-145	130	27	!	!	PUNCT
aji-145	131	1	.1	.1	NUM
aji-145	131	2	%	%	NOUN
aji-145	131	3	respectively	respectively	ADV
aji-145	131	4	[	[	X
aji-145	131	5	6	6	NUM
aji-145	131	6	]	]	PUNCT
aji-145	131	7	.	.	PUNCT
aji-145	132	1	hepatitis	hepatitis	PROPN
aji-145	132	2	b	b	PROPN
aji-145	132	3	is	be	AUX
aji-145	132	4	spread	spread	VERB
aji-145	132	5	through	through	ADP
aji-145	132	6	contact	contact	NOUN
aji-145	132	7	with	with	ADP
aji-145	132	8	infected	infected	ADJ
aji-145	132	9	body	body	NOUN
aji-145	132	10	fluids	fluid	NOUN
aji-145	132	11	including	include	VERB
aji-145	132	12	infected	infect	VERB
aji-145	132	13	blood	blood	NOUN
aji-145	132	14	and	and	CCONJ
aji-145	132	15	blood	blood	NOUN
aji-145	132	16	products	product	NOUN
aji-145	132	17	,	,	PUNCT
aji-145	132	18	saliva	saliva	NOUN
aji-145	132	19	,	,	PUNCT
aji-145	132	20	vaginal	vaginal	ADJ
aji-145	132	21	fluids	fluid	NOUN
aji-145	132	22	and	and	CCONJ
aji-145	132	23	semen	semen	NOUN
aji-145	132	24	.	.	PUNCT
aji-145	133	1	it	it	PRON
aji-145	133	2	can	can	AUX
aji-145	133	3	also	also	ADV
aji-145	133	4	be	be	AUX
aji-145	133	5	transmitted	transmit	VERB
aji-145	133	6	from	from	ADP
aji-145	133	7	a	a	DET
aji-145	133	8	mother	mother	NOUN
aji-145	133	9	to	to	ADP
aji-145	133	10	her	she	PRON
aji-145	133	11	to	to	ADP
aji-145	133	12	child	child	NOUN
aji-145	133	13	during	during	ADP
aji-145	133	14	pregnancy	pregnancy	NOUN
aji-145	133	15	,	,	PUNCT
aji-145	133	16	childbirth	childbirth	NOUN
aji-145	133	17	or	or	CCONJ
aji-145	133	18	breastfeeding	breastfeed	VERB
aji-145	133	19	[	[	X
aji-145	133	20	7	7	NUM
aji-145	133	21	]	]	PUNCT
aji-145	133	22	.	.	PUNCT
aji-145	134	1	over	over	ADP
aji-145	134	2	95	95	NUM
aji-145	134	3	%	%	NOUN
aji-145	134	4	of	of	ADP
aji-145	134	5	immunocompetent	immunocompetent	ADJ
aji-145	134	6	adults	adult	NOUN
aji-145	134	7	infected	infect	VERB
aji-145	134	8	with	with	ADP
aji-145	134	9	the	the	DET
aji-145	134	10	virus	virus	NOUN
aji-145	134	11	are	be	AUX
aji-145	134	12	able	able	ADJ
aji-145	134	13	to	to	PART
aji-145	134	14	have	have	VERB
aji-145	134	15	it	it	PRON
aji-145	134	16	cleared	clear	VERB
aji-145	134	17	from	from	ADP
aji-145	134	18	the	the	DET
aji-145	134	19	system	system	NOUN
aji-145	134	20	even	even	ADV
aji-145	134	21	without	without	ADP
aji-145	134	22	knowing	know	VERB
aji-145	134	23	about	about	ADP
aji-145	134	24	the	the	DET
aji-145	134	25	infection	infection	NOUN
aji-145	134	26	[	[	X
aji-145	134	27	8	8	NUM
aji-145	134	28	]	]	PUNCT
aji-145	134	29	.	.	PUNCT
aji-145	135	1	the	the	DET
aji-145	135	2	infection	infection	NOUN
aji-145	135	3	is	be	AUX
aji-145	135	4	preventable	preventable	ADJ
aji-145	135	5	by	by	ADP
aji-145	135	6	a	a	DET
aji-145	135	7	safe	safe	ADJ
aji-145	135	8	and	and	CCONJ
aji-145	135	9	effective	effective	ADJ
aji-145	135	10	vaccine	vaccine	NOUN
aji-145	135	11	.	.	PUNCT
aji-145	136	1	the	the	DET
aji-145	136	2	vaccine	vaccine	NOUN
aji-145	136	3	gives	give	VERB
aji-145	136	4	almost	almost	ADV
aji-145	136	5	full	full	ADJ
aji-145	136	6	protection	protection	NOUN
aji-145	136	7	against	against	ADP
aji-145	136	8	the	the	DET
aji-145	136	9	virus	virus	NOUN
aji-145	136	10	,	,	PUNCT
aji-145	136	11	and	and	CCONJ
aji-145	136	12	is	be	AUX
aji-145	136	13	usually	usually	ADV
aji-145	136	14	given	give	VERB
aji-145	136	15	soon	soon	ADV
aji-145	136	16	after	after	ADP
aji-145	136	17	birth	birth	NOUN
aji-145	136	18	with	with	ADP
aji-145	136	19	boosters	booster	NOUN
aji-145	136	20	within	within	ADP
aji-145	136	21	few	few	ADJ
aji-145	136	22	weeks	week	NOUN
aji-145	137	1	[	[	X
aji-145	137	2	7	7	NUM
aji-145	137	3	]	]	PUNCT
aji-145	137	4	.	.	PUNCT
aji-145	138	1	hepatitis	hepatitis	PROPN
aji-145	138	2	c	c	PROPN
aji-145	138	3	is	be	AUX
aji-145	138	4	a	a	DET
aji-145	138	5	bloodborne	bloodborne	ADJ
aji-145	138	6	infection	infection	NOUN
aji-145	138	7	,	,	PUNCT
aji-145	138	8	transmitted	transmit	VERB
aji-145	138	9	through	through	ADP
aji-145	138	10	contact	contact	NOUN
aji-145	138	11	with	with	ADP
aji-145	138	12	infected	infected	ADJ
aji-145	138	13	blood	blood	NOUN
aji-145	138	14	,	,	PUNCT
aji-145	138	15	which	which	PRON
aji-145	138	16	may	may	AUX
aji-145	138	17	be	be	AUX
aji-145	138	18	through	through	ADP
aji-145	138	19	the	the	DET
aji-145	138	20	sharing	sharing	NOUN
aji-145	138	21	needles	needle	NOUN
aji-145	138	22	or	or	CCONJ
aji-145	138	23	syringes	syrinx	NOUN
aji-145	138	24	,	,	PUNCT
aji-145	138	25	or	or	CCONJ
aji-145	138	26	from	from	ADP
aji-145	138	27	unsafe	unsafe	ADJ
aji-145	138	28	medical	medical	ADJ
aji-145	138	29	procedures	procedure	NOUN
aji-145	138	30	such	such	ADJ
aji-145	138	31	as	as	ADP
aji-145	138	32	unsafe	unsafe	ADJ
aji-145	138	33	blood	blood	NOUN
aji-145	138	34	transfusions	transfusion	NOUN
aji-145	138	35	and	and	CCONJ
aji-145	138	36	blood	blood	NOUN
aji-145	138	37	products	product	NOUN
aji-145	138	38	[	[	X
aji-145	138	39	9	9	NUM
aji-145	138	40	]	]	PUNCT
aji-145	138	41	.	.	PUNCT
aji-145	139	1	the	the	DET
aji-145	139	2	symptoms	symptom	NOUN
aji-145	139	3	of	of	ADP
aji-145	139	4	hcv	hcv	ADJ
aji-145	139	5	infection	infection	NOUN
aji-145	139	6	may	may	AUX
aji-145	139	7	include	include	VERB
aji-145	139	8	fever	fever	NOUN
aji-145	139	9	,	,	PUNCT
aji-145	139	10	fatigue	fatigue	NOUN
aji-145	139	11	,	,	PUNCT
aji-145	139	12	loss	loss	NOUN
aji-145	139	13	of	of	ADP
aji-145	139	14	appetite	appetite	NOUN
aji-145	139	15	,	,	PUNCT
aji-145	139	16	nausea	nausea	NOUN
aji-145	139	17	,	,	PUNCT
aji-145	139	18	vomiting	vomiting	NOUN
aji-145	139	19	,	,	PUNCT
aji-145	139	20	abdominal	abdominal	ADJ
aji-145	139	21	pain	pain	NOUN
aji-145	139	22	,	,	PUNCT
aji-145	139	23	dark	dark	ADJ
aji-145	139	24	urine	urine	NOUN
aji-145	139	25	and	and	CCONJ
aji-145	139	26	jaundice	jaundice	NOUN
aji-145	139	27	.	.	PUNCT
aji-145	140	1	though	though	SCONJ
aji-145	140	2	there	there	PRON
aji-145	140	3	is	be	VERB
aji-145	140	4	no	no	DET
aji-145	140	5	vaccine	vaccine	NOUN
aji-145	140	6	for	for	ADP
aji-145	140	7	hepatitis	hepatitis	PROPN
aji-145	140	8	c	c	NOUN
aji-145	140	9	,	,	PUNCT
aji-145	140	10	but	but	CCONJ
aji-145	140	11	it	it	PRON
aji-145	140	12	can	can	AUX
aji-145	140	13	be	be	AUX
aji-145	140	14	treated	treat	VERB
aji-145	140	15	with	with	ADP
aji-145	140	16	antiviral	antiviral	ADJ
aji-145	140	17	medications	medication	NOUN
aji-145	140	18	;	;	PUNCT
aji-145	140	19	early	early	ADJ
aji-145	140	20	detection	detection	NOUN
aji-145	140	21	and	and	CCONJ
aji-145	140	22	treatment	treatment	NOUN
aji-145	140	23	are	be	AUX
aji-145	140	24	important	important	ADJ
aji-145	140	25	to	to	PART
aji-145	140	26	prevent	prevent	VERB
aji-145	140	27	serious	serious	ADJ
aji-145	140	28	liver	liver	NOUN
aji-145	140	29	damage	damage	NOUN
aji-145	140	30	and	and	CCONJ
aji-145	140	31	wellbeing	wellbee	VERB
aji-145	140	32	[	[	X
aji-145	140	33	9	9	NUM
aji-145	140	34	]	]	PUNCT
aji-145	140	35	.	.	PUNCT
aji-145	141	1	though	though	SCONJ
aji-145	141	2	the	the	DET
aji-145	141	3	prevalence	prevalence	NOUN
aji-145	141	4	of	of	ADP
aji-145	141	5	hcv	hcv	ADJ
aji-145	141	6	infection	infection	NOUN
aji-145	141	7	in	in	ADP
aji-145	141	8	nigeria	nigeria	PROPN
aji-145	141	9	is	be	AUX
aji-145	141	10	considerably	considerably	ADV
aji-145	141	11	low	low	ADJ
aji-145	141	12	,	,	PUNCT
aji-145	141	13	some	some	DET
aji-145	141	14	scholars	scholar	NOUN
aji-145	141	15	opined	opine	VERB
aji-145	141	16	that	that	SCONJ
aji-145	141	17	the	the	DET
aji-145	141	18	prevalence	prevalence	NOUN
aji-145	141	19	is	be	AUX
aji-145	141	20	on	on	ADP
aji-145	141	21	the	the	DET
aji-145	141	22	increase	increase	NOUN
aji-145	141	23	[	[	X
aji-145	141	24	10	10	NUM
aji-145	141	25	]	]	PUNCT
aji-145	141	26	.	.	PUNCT
aji-145	142	1	this	this	PRON
aji-145	142	2	is	be	AUX
aji-145	142	3	an	an	DET
aji-145	142	4	indication	indication	NOUN
aji-145	142	5	for	for	ADP
aji-145	142	6	concerted	concerted	ADJ
aji-145	142	7	efforts	effort	NOUN
aji-145	142	8	in	in	ADP
aji-145	142	9	the	the	DET
aji-145	142	10	monitoring	monitoring	NOUN
aji-145	142	11	and	and	CCONJ
aji-145	142	12	control	control	NOUN
aji-145	142	13	of	of	ADP
aji-145	142	14	the	the	DET
aji-145	142	15	spread	spread	NOUN
aji-145	142	16	of	of	ADP
aji-145	142	17	the	the	DET
aji-145	142	18	virus	virus	NOUN
aji-145	142	19	.	.	PUNCT
aji-145	143	1	there	there	PRON
aji-145	143	2	is	be	VERB
aji-145	143	3	currently	currently	ADV
aji-145	143	4	inadequate	inadequate	ADJ
aji-145	143	5	data	datum	NOUN
aji-145	143	6	on	on	ADP
aji-145	143	7	the	the	DET
aji-145	143	8	prevalence	prevalence	NOUN
aji-145	143	9	of	of	ADP
aji-145	143	10	hepatitis	hepatitis	PROPN
aji-145	143	11	b	b	PROPN
aji-145	143	12	and	and	CCONJ
aji-145	143	13	hepatis	hepatis	PROPN
aji-145	143	14	c	c	NOUN
aji-145	143	15	in	in	ADP
aji-145	143	16	port	port	NOUN
aji-145	143	17	harcourt	harcourt	PROPN
aji-145	143	18	,	,	PUNCT
aji-145	143	19	nigeria	nigeria	PROPN
aji-145	143	20	.	.	PUNCT
aji-145	144	1	this	this	DET
aji-145	144	2	study	study	NOUN
aji-145	144	3	was	be	AUX
aji-145	144	4	thus	thus	ADV
aji-145	144	5	aimed	aim	VERB
aji-145	144	6	at	at	ADP
aji-145	144	7	filling	fill	VERB
aji-145	144	8	the	the	DET
aji-145	144	9	gap	gap	NOUN
aji-145	144	10	by	by	ADP
aji-145	144	11	determining	determine	VERB
aji-145	144	12	the	the	DET
aji-145	144	13	prevalence	prevalence	NOUN
aji-145	144	14	of	of	ADP
aji-145	144	15	hbv	hbv	NOUN
aji-145	144	16	and	and	CCONJ
aji-145	144	17	hcv	hcv	PROPN
aji-145	144	18	in	in	ADP
aji-145	144	19	urban	urban	ADJ
aji-145	144	20	communities	community	NOUN
aji-145	144	21	in	in	ADP
aji-145	144	22	port	port	NOUN
aji-145	144	23	harcourt	harcourt	PROPN
aji-145	144	24	.	.	PUNCT
aji-145	145	1	2	2	X
aji-145	145	2	.	.	X
aji-145	145	3	materials	material	NOUN
aji-145	145	4	and	and	CCONJ
aji-145	145	5	methods	method	NOUN
aji-145	145	6	2.1	2.1	NUM
aji-145	145	7	study	study	NOUN
aji-145	145	8	area	area	NOUN
aji-145	145	9	this	this	DET
aji-145	145	10	retrospective	retrospective	ADJ
aji-145	145	11	study	study	NOUN
aji-145	145	12	was	be	AUX
aji-145	145	13	conducted	conduct	VERB
aji-145	145	14	in	in	ADP
aji-145	145	15	diobu	diobu	NOUN
aji-145	145	16	,	,	PUNCT
aji-145	145	17	a	a	DET
aji-145	145	18	high	high	ADJ
aji-145	145	19	-	-	PUNCT
aji-145	145	20	density	density	NOUN
aji-145	145	21	group	group	NOUN
aji-145	145	22	of	of	ADP
aji-145	145	23	urban	urban	ADJ
aji-145	145	24	communities	community	NOUN
aji-145	145	25	situated	situate	VERB
aji-145	145	26	in	in	ADP
aji-145	145	27	the	the	DET
aji-145	145	28	heart	heart	NOUN
aji-145	145	29	of	of	ADP
aji-145	145	30	port	port	NOUN
aji-145	145	31	harcourt	harcourt	PROPN
aji-145	145	32	metropolis	metropolis	PROPN
aji-145	145	33	in	in	ADP
aji-145	145	34	the	the	DET
aji-145	145	35	niger	niger	NOUN
aji-145	145	36	delta	delta	NOUN
aji-145	145	37	of	of	ADP
aji-145	145	38	nigeria	nigeria	PROPN
aji-145	145	39	.	.	PUNCT
aji-145	146	1	the	the	DET
aji-145	146	2	notable	notable	ADJ
aji-145	146	3	urban	urban	ADJ
aji-145	146	4	communities	community	NOUN
aji-145	146	5	are	be	AUX
aji-145	146	6	mile	mile	NOUN
aji-145	146	7	i	i	PRON
aji-145	146	8	,	,	PUNCT
aji-145	146	9	mile	mile	PROPN
aji-145	146	10	ii	ii	NOUN
aji-145	146	11	and	and	CCONJ
aji-145	146	12	mile	mile	PROPN
aji-145	146	13	iii	iii	NUM
aji-145	146	14	urban	urban	ADJ
aji-145	146	15	communities	community	NOUN
aji-145	146	16	of	of	ADP
aji-145	146	17	diobu	diobu	NOUN
aji-145	146	18	.	.	PUNCT
aji-145	147	1	the	the	DET
aji-145	147	2	coordinates	coordinate	NOUN
aji-145	147	3	of	of	ADP
aji-145	147	4	the	the	DET
aji-145	147	5	area	area	NOUN
aji-145	147	6	are	be	AUX
aji-145	147	7	:	:	PUNCT
aji-145	147	8	4	4	NUM
aji-145	147	9	°	°	NUM
aji-145	147	10	47'24"n	47'24"n	NOUN
aji-145	147	11	,	,	PUNCT
aji-145	147	12	6	6	NUM
aji-145	147	13	°	°	NUM
aji-145	147	14	59'36"e	59'36"e	NOUN
aji-145	147	15	(	(	PUNCT
aji-145	147	16	latitude:4.772152	latitude:4.772152	PROPN
aji-145	147	17	;	;	PUNCT
aji-145	147	18	longitude:6.994514	longitude:6.994514	PROPN
aji-145	147	19	)	)	PUNCT
aji-145	147	20	.	.	PUNCT
aji-145	148	1	the	the	DET
aji-145	148	2	communities	community	NOUN
aji-145	148	3	are	be	AUX
aji-145	148	4	bordered	border	VERB
aji-145	148	5	on	on	ADP
aji-145	148	6	the	the	DET
aji-145	148	7	north	north	NOUN
aji-145	148	8	by	by	ADP
aji-145	148	9	the	the	DET
aji-145	148	10	port	port	NOUN
aji-145	148	11	harcourt	harcourt	PROPN
aji-145	148	12	new	new	PROPN
aji-145	148	13	gra	gra	PROPN
aji-145	148	14	,	,	PUNCT
aji-145	148	15	on	on	ADP
aji-145	148	16	the	the	DET
aji-145	148	17	northeast	northeast	NOUN
aji-145	148	18	by	by	ADP
aji-145	148	19	dline	dline	NOUN
aji-145	148	20	,	,	PUNCT
aji-145	148	21	on	on	ADP
aji-145	148	22	the	the	DET
aji-145	148	23	northwest	northwest	PROPN
aji-145	148	24	rivers	river	NOUN
aji-145	148	25	state	state	PROPN
aji-145	148	26	university	university	PROPN
aji-145	148	27	,	,	PUNCT
aji-145	148	28	nkpolu	nkpolu	PROPN
aji-145	148	29	-	-	PUNCT
aji-145	148	30	oroworukwu	oroworukwu	PROPN
aji-145	148	31	,	,	PUNCT
aji-145	148	32	port	port	NOUN
aji-145	148	33	harcourt	harcourt	PROPN
aji-145	148	34	,	,	PUNCT
aji-145	148	35	on	on	ADP
aji-145	148	36	the	the	DET
aji-145	148	37	east	east	NOUN
aji-145	148	38	https://en.wikipedia.org/wiki/new_gra,_port_harcourt	https://en.wikipedia.org/wiki/new_gra,_port_harcourt	PROPN
aji-145	148	39	https://en.wikipedia.org/wiki/d-line,_port_harcourt	https://en.wikipedia.org/wiki/d-line,_port_harcourt	PROPN
aji-145	148	40	https://en.wikipedia.org/wiki/d-line,_port_harcourt	https://en.wikipedia.org/wiki/d-line,_port_harcourt	PROPN
aji-145	148	41	https://en.wikipedia.org/wiki/rivers_state_university	https://en.wikipedia.org/wiki/rivers_state_university	PRON
aji-145	148	42	ndukwu	ndukwu	NOUN
aji-145	148	43	and	and	CCONJ
aji-145	148	44	chinedu	chinedu	NOUN
aji-145	148	45	-	-	PUNCT
aji-145	148	46	madu	madu	NOUN
aji-145	148	47	;	;	PUNCT
aji-145	148	48	asian	asian	PROPN
aji-145	148	49	j.	j.	PROPN
aji-145	148	50	immunol	immunol	PROPN
aji-145	148	51	.	.	PROPN
aji-145	148	52	,	,	PUNCT
aji-145	148	53	vol	vol	NOUN
aji-145	148	54	.	.	PROPN
aji-145	149	1	7	7	NUM
aji-145	149	2	,	,	PUNCT
aji-145	149	3	no	no	INTJ
aji-145	149	4	.	.	NOUN
aji-145	149	5	1	1	NUM
aji-145	149	6	,	,	PUNCT
aji-145	149	7	pp	pp	ADJ
aji-145	149	8	.	.	PUNCT
aji-145	150	1	209	209	NUM
aji-145	150	2	-	-	SYM
aji-145	150	3	216	216	NUM
aji-145	150	4	,	,	PUNCT
aji-145	150	5	2024	2024	NUM
aji-145	150	6	;	;	PUNCT
aji-145	150	7	article	article	NOUN
aji-145	150	8	no.aji.125624	no.aji.125624	VERB
aji-145	150	9	211	211	NUM
aji-145	150	10	by	by	ADP
aji-145	150	11	the	the	DET
aji-145	150	12	poth	poth	NOUN
aji-145	150	13	harcourt	harcourt	PROPN
aji-145	150	14	old	old	PROPN
aji-145	150	15	gra	gra	PROPN
aji-145	150	16	,	,	PUNCT
aji-145	150	17	on	on	ADP
aji-145	150	18	the	the	DET
aji-145	150	19	southeast	southeast	NOUN
aji-145	150	20	by	by	ADP
aji-145	150	21	kidney	kidney	NOUN
aji-145	150	22	island	island	NOUN
aji-145	150	23	,	,	PUNCT
aji-145	150	24	and	and	CCONJ
aji-145	150	25	on	on	ADP
aji-145	150	26	the	the	DET
aji-145	150	27	southwest	southwest	NOUN
aji-145	150	28	by	by	ADP
aji-145	150	29	eagle	eagle	PROPN
aji-145	150	30	island	island	PROPN
aji-145	150	31	.	.	PUNCT
aji-145	151	1	the	the	PRON
aji-145	151	2	are	be	AUX
aji-145	151	3	a	a	DET
aji-145	151	4	number	number	NOUN
aji-145	151	5	of	of	ADP
aji-145	151	6	public	public	ADJ
aji-145	151	7	and	and	CCONJ
aji-145	151	8	privatelyowned	privatelyowne	VERB
aji-145	151	9	hospitals	hospital	NOUN
aji-145	151	10	and	and	CCONJ
aji-145	151	11	other	other	ADJ
aji-145	151	12	healthcare	healthcare	NOUN
aji-145	151	13	facilities	facility	NOUN
aji-145	151	14	in	in	ADP
aji-145	151	15	the	the	DET
aji-145	151	16	area	area	NOUN
aji-145	151	17	,	,	PUNCT
aji-145	151	18	including	include	VERB
aji-145	151	19	primary	primary	ADJ
aji-145	151	20	health	health	NOUN
aji-145	151	21	centres	centre	NOUN
aji-145	151	22	,	,	PUNCT
aji-145	151	23	maternity	maternity	NOUN
aji-145	151	24	homes	home	NOUN
aji-145	151	25	,	,	PUNCT
aji-145	151	26	medical	medical	ADJ
aji-145	151	27	laboratory	laboratory	NOUN
aji-145	151	28	facilities	facility	NOUN
aji-145	151	29	and	and	CCONJ
aji-145	151	30	community	community	NOUN
aji-145	151	31	pharmacy	pharmacy	NOUN
aji-145	151	32	outlets	outlet	NOUN
aji-145	151	33	patronized	patronize	VERB
aji-145	151	34	by	by	ADP
aji-145	151	35	many	many	ADJ
aji-145	151	36	residents	resident	NOUN
aji-145	151	37	.	.	PUNCT
aji-145	152	1	on	on	ADP
aji-145	152	2	the	the	DET
aji-145	152	3	other	other	ADJ
aji-145	152	4	end	end	NOUN
aji-145	152	5	,	,	PUNCT
aji-145	152	6	harsh	harsh	ADJ
aji-145	152	7	economic	economic	ADJ
aji-145	152	8	climates	climate	NOUN
aji-145	152	9	and	and	CCONJ
aji-145	152	10	pervasive	pervasive	ADJ
aji-145	152	11	ignorance	ignorance	NOUN
aji-145	152	12	and	and	CCONJ
aji-145	152	13	economic	economic	ADJ
aji-145	152	14	have	have	AUX
aji-145	152	15	made	make	VERB
aji-145	152	16	many	many	ADJ
aji-145	152	17	residents	resident	NOUN
aji-145	152	18	,	,	PUNCT
aji-145	152	19	particularly	particularly	ADV
aji-145	152	20	those	those	PRON
aji-145	152	21	in	in	ADP
aji-145	152	22	overcrowded	overcrowded	ADJ
aji-145	152	23	area	area	NOUN
aji-145	152	24	,	,	PUNCT
aji-145	152	25	who	who	PRON
aji-145	152	26	lack	lack	VERB
aji-145	152	27	amenities	amenity	NOUN
aji-145	152	28	like	like	ADP
aji-145	152	29	clean	clean	ADJ
aji-145	152	30	water	water	NOUN
aji-145	152	31	and	and	CCONJ
aji-145	152	32	decent	decent	ADJ
aji-145	152	33	housing	housing	NOUN
aji-145	152	34	;	;	PUNCT
aji-145	152	35	such	such	ADJ
aji-145	152	36	as	as	ADP
aji-145	152	37	water	water	NOUN
aji-145	152	38	fronts	front	NOUN
aji-145	152	39	to	to	PART
aji-145	152	40	resort	resort	VERB
aji-145	152	41	to	to	ADP
aji-145	152	42	self	self	NOUN
aji-145	152	43	-	-	PUNCT
aji-145	152	44	medication	medication	NOUN
aji-145	152	45	and	and	CCONJ
aji-145	152	46	patronizing	patronize	VERB
aji-145	152	47	different	different	ADJ
aji-145	152	48	kinds	kind	NOUN
aji-145	152	49	of	of	ADP
aji-145	152	50	purveyors	purveyor	NOUN
aji-145	152	51	of	of	ADP
aji-145	152	52	unregulated	unregulated	ADJ
aji-145	152	53	healthcare	healthcare	NOUN
aji-145	152	54	products	product	NOUN
aji-145	152	55	.	.	PUNCT
aji-145	153	1	2.2	2.2	NUM
aji-145	153	2	design	design	NOUN
aji-145	153	3	of	of	ADP
aji-145	153	4	the	the	DET
aji-145	153	5	study	study	NOUN
aji-145	153	6	this	this	DET
aji-145	153	7	study	study	NOUN
aji-145	153	8	was	be	AUX
aji-145	153	9	conducted	conduct	VERB
aji-145	153	10	between	between	ADP
aji-145	153	11	january	january	PROPN
aji-145	153	12	2022	2022	NUM
aji-145	153	13	to	to	ADP
aji-145	153	14	december	december	PROPN
aji-145	153	15	2023	2023	NUM
aji-145	153	16	among	among	ADP
aji-145	153	17	206	206	NUM
aji-145	153	18	males	male	NOUN
aji-145	153	19	and	and	CCONJ
aji-145	153	20	female	female	NOUN
aji-145	153	21	of	of	ADP
aji-145	153	22	all	all	DET
aji-145	153	23	ages	age	NOUN
aji-145	153	24	,	,	PUNCT
aji-145	153	25	residents	resident	NOUN
aji-145	153	26	of	of	ADP
aji-145	153	27	diobu	diobu	NOUN
aji-145	153	28	and	and	CCONJ
aji-145	153	29	closely	closely	ADV
aji-145	153	30	adjoining	adjoining	ADJ
aji-145	153	31	urban	urban	ADJ
aji-145	153	32	communities	community	NOUN
aji-145	153	33	of	of	ADP
aji-145	153	34	port	port	PROPN
aji-145	153	35	harcourt	harcourt	PROPN
aji-145	153	36	metropolis	metropolis	PROPN
aji-145	153	37	;	;	PUNCT
aji-145	153	38	attending	attend	VERB
aji-145	153	39	public	public	ADJ
aji-145	153	40	and	and	CCONJ
aji-145	153	41	private	private	ADJ
aji-145	153	42	healthcare	healthcare	NOUN
aji-145	153	43	facilities	facility	NOUN
aji-145	153	44	within	within	ADP
aji-145	153	45	the	the	DET
aji-145	153	46	area	area	NOUN
aji-145	153	47	.	.	PUNCT
aji-145	154	1	the	the	DET
aji-145	154	2	inclusion	inclusion	NOUN
aji-145	154	3	criteria	criterion	NOUN
aji-145	154	4	include	include	VERB
aji-145	154	5	persons	person	NOUN
aji-145	154	6	who	who	PRON
aji-145	154	7	live	live	VERB
aji-145	154	8	within	within	ADP
aji-145	154	9	mile	mile	NOUN
aji-145	154	10	i	i	PROPN
aji-145	154	11	,	,	PUNCT
aji-145	154	12	mile	mile	PROPN
aji-145	154	13	ii	ii	NOUN
aji-145	154	14	and	and	CCONJ
aji-145	154	15	mile	mile	NOUN
aji-145	154	16	iii	iii	NOUN
aji-145	154	17	and	and	CCONJ
aji-145	154	18	closely	closely	ADV
aji-145	154	19	adjoining	adjoining	ADJ
aji-145	154	20	neighborhoods	neighborhood	NOUN
aji-145	154	21	such	such	ADJ
aji-145	154	22	as	as	ADP
aji-145	154	23	agip	agip	PROPN
aji-145	154	24	,	,	PUNCT
aji-145	154	25	eagle	eagle	PROPN
aji-145	154	26	island	island	NOUN
aji-145	154	27	,	,	PUNCT
aji-145	154	28	d	d	X
aji-145	154	29	-	-	PUNCT
aji-145	154	30	line	line	NOUN
aji-145	154	31	etc	etc	X
aji-145	154	32	.	.	X
aji-145	154	33	;	;	PUNCT
aji-145	154	34	and	and	CCONJ
aji-145	154	35	who	who	PRON
aji-145	154	36	within	within	ADP
aji-145	154	37	the	the	DET
aji-145	154	38	study	study	NOUN
aji-145	154	39	period	period	NOUN
aji-145	154	40	,	,	PUNCT
aji-145	154	41	conducted	conduct	VERB
aji-145	154	42	serological	serological	ADJ
aji-145	154	43	laboratory	laboratory	NOUN
aji-145	154	44	investigations	investigation	NOUN
aji-145	154	45	for	for	ADP
aji-145	154	46	hbv	hbv	NOUN
aji-145	154	47	and	and	CCONJ
aji-145	154	48	hcv	hcv	PROPN
aji-145	154	49	antibodies	antibody	NOUN
aji-145	154	50	(	(	PUNCT
aji-145	154	51	sd	sd	ADP
aji-145	154	52	bioline	bioline	NOUN
aji-145	154	53	,	,	PUNCT
aji-145	154	54	korea	korea	PROPN
aji-145	154	55	)	)	PUNCT
aji-145	154	56	at	at	ADP
aji-145	154	57	diagnostix	diagnostix	NOUN
aji-145	154	58	and	and	CCONJ
aji-145	154	59	scientifique	scientifique	PROPN
aji-145	154	60	laboratories	laboratory	NOUN
aji-145	154	61	,	,	PUNCT
aji-145	154	62	port	port	NOUN
aji-145	154	63	harcourt	harcourt	PROPN
aji-145	154	64	.	.	PUNCT
aji-145	155	1	persons	person	NOUN
aji-145	155	2	living	live	VERB
aji-145	155	3	far	far	ADV
aji-145	155	4	from	from	ADP
aji-145	155	5	diobu	diobu	NOUN
aji-145	155	6	or	or	CCONJ
aji-145	155	7	did	do	AUX
aji-145	155	8	not	not	PART
aji-145	155	9	perform	perform	VERB
aji-145	155	10	the	the	DET
aji-145	155	11	two	two	NUM
aji-145	155	12	tests	test	NOUN
aji-145	155	13	and	and	CCONJ
aji-145	155	14	those	those	PRON
aji-145	155	15	with	with	ADP
aji-145	155	16	incomplete	incomplete	ADJ
aji-145	155	17	records	record	NOUN
aji-145	155	18	were	be	AUX
aji-145	155	19	excluded	exclude	VERB
aji-145	155	20	.	.	PUNCT
aji-145	156	1	2.3	2.3	NUM
aji-145	156	2	data	datum	NOUN
aji-145	156	3	collection	collection	NOUN
aji-145	156	4	patients	patient	NOUN
aji-145	156	5	’	'	PUNCT
aji-145	156	6	data	datum	NOUN
aji-145	156	7	were	be	AUX
aji-145	156	8	obtained	obtain	VERB
aji-145	156	9	by	by	ADP
aji-145	156	10	going	go	VERB
aji-145	156	11	through	through	ADP
aji-145	156	12	their	their	PRON
aji-145	156	13	medical	medical	ADJ
aji-145	156	14	laboratory	laboratory	NOUN
aji-145	156	15	records	record	NOUN
aji-145	156	16	.	.	PUNCT
aji-145	157	1	the	the	DET
aji-145	157	2	outcomes	outcome	NOUN
aji-145	157	3	of	of	ADP
aji-145	157	4	the	the	DET
aji-145	157	5	laboratory	laboratory	NOUN
aji-145	157	6	tests	test	NOUN
aji-145	157	7	of	of	ADP
aji-145	157	8	hbv	hbv	NOUN
aji-145	157	9	and	and	CCONJ
aji-145	157	10	hcv	hcv	NOUN
aji-145	157	11	infections	infection	NOUN
aji-145	157	12	and	and	CCONJ
aji-145	157	13	relevant	relevant	ADJ
aji-145	157	14	socio	socio	NOUN
aji-145	157	15	-	-	ADJ
aji-145	157	16	demographic	demographic	ADJ
aji-145	157	17	data	datum	NOUN
aji-145	157	18	about	about	ADP
aji-145	157	19	the	the	DET
aji-145	157	20	ages	age	NOUN
aji-145	157	21	,	,	PUNCT
aji-145	157	22	genders	gender	NOUN
aji-145	157	23	and	and	CCONJ
aji-145	157	24	areas	area	NOUN
aji-145	157	25	of	of	ADP
aji-145	157	26	residence	residence	NOUN
aji-145	157	27	were	be	AUX
aji-145	157	28	extracted	extract	VERB
aji-145	157	29	,	,	PUNCT
aji-145	157	30	coded	code	VERB
aji-145	157	31	and	and	CCONJ
aji-145	157	32	anonymously	anonymously	ADV
aji-145	157	33	analyzed	analyze	VERB
aji-145	157	34	.	.	PUNCT
aji-145	158	1	specimen	speciman	NOUN
aji-145	158	2	collection	collection	NOUN
aji-145	158	3	and	and	CCONJ
aji-145	158	4	assay	assay	VERB
aji-145	158	5	:	:	PUNCT
aji-145	158	6	about	about	ADV
aji-145	158	7	3	3	NUM
aji-145	158	8	ml	ml	NOUN
aji-145	158	9	of	of	ADP
aji-145	158	10	venous	venous	ADJ
aji-145	158	11	blood	blood	NOUN
aji-145	158	12	was	be	AUX
aji-145	158	13	collected	collect	VERB
aji-145	158	14	from	from	ADP
aji-145	158	15	each	each	DET
aji-145	158	16	study	study	NOUN
aji-145	158	17	participant	participant	NOUN
aji-145	158	18	,	,	PUNCT
aji-145	158	19	transferred	transfer	VERB
aji-145	158	20	to	to	ADP
aji-145	158	21	a	a	DET
aji-145	158	22	test	test	NOUN
aji-145	158	23	tube	tube	NOUN
aji-145	158	24	and	and	CCONJ
aji-145	158	25	allowed	allow	VERB
aji-145	158	26	to	to	PART
aji-145	158	27	stand	stand	VERB
aji-145	158	28	until	until	ADP
aji-145	158	29	clotted	clot	VERB
aji-145	158	30	the	the	DET
aji-145	158	31	serum	serum	NOUN
aji-145	158	32	was	be	AUX
aji-145	158	33	separated	separate	VERB
aji-145	158	34	from	from	ADP
aji-145	158	35	the	the	DET
aji-145	158	36	clotted	clot	VERB
aji-145	158	37	by	by	ADP
aji-145	158	38	centrifugation	centrifugation	NOUN
aji-145	158	39	at	at	ADP
aji-145	158	40	5000	5000	NUM
aji-145	158	41	revolutions	revolution	NOUN
aji-145	158	42	per	per	ADP
aji-145	158	43	minute	minute	NOUN
aji-145	158	44	for	for	ADP
aji-145	158	45	10	10	NUM
aji-145	158	46	min	min	NOUN
aji-145	158	47	and	and	CCONJ
aji-145	158	48	tested	test	VERB
aji-145	158	49	for	for	ADP
aji-145	158	50	hbsag	hbsag	NOUN
aji-145	158	51	and	and	CCONJ
aji-145	158	52	anti	anti	ADJ
aji-145	158	53	-	-	ADJ
aji-145	158	54	hcv	hcv	ADJ
aji-145	158	55	using	use	VERB
aji-145	158	56	a	a	DET
aji-145	158	57	one	one	NUM
aji-145	158	58	-	-	PUNCT
aji-145	158	59	step	step	NOUN
aji-145	158	60	hbsag	hbsag	NOUN
aji-145	158	61	test	test	NOUN
aji-145	158	62	strip	strip	NOUN
aji-145	158	63	(	(	PUNCT
aji-145	158	64	sd	sd	ADP
aji-145	158	65	bioline	bioline	NOUN
aji-145	158	66	)	)	PUNCT
aji-145	158	67	and	and	CCONJ
aji-145	158	68	a	a	DET
aji-145	158	69	one	one	NUM
aji-145	158	70	-	-	PUNCT
aji-145	158	71	step	step	NOUN
aji-145	158	72	hcv	hcv	PROPN
aji-145	158	73	test	test	NOUN
aji-145	158	74	strip	strip	NOUN
aji-145	158	75	(	(	PUNCT
aji-145	158	76	sd	sd	ADP
aji-145	158	77	bioline	bioline	NOUN
aji-145	158	78	)	)	PUNCT
aji-145	158	79	,	,	PUNCT
aji-145	158	80	respectively	respectively	ADV
aji-145	158	81	,	,	PUNCT
aji-145	158	82	following	follow	VERB
aji-145	158	83	the	the	DET
aji-145	158	84	manufacturer	manufacturer	NOUN
aji-145	158	85	instructions	instruction	NOUN
aji-145	158	86	.	.	PUNCT
aji-145	159	1	the	the	DET
aji-145	159	2	sensitivity	sensitivity	NOUN
aji-145	159	3	and	and	CCONJ
aji-145	159	4	specificity	specificity	NOUN
aji-145	159	5	of	of	ADP
aji-145	159	6	rapid	rapid	ADJ
aji-145	159	7	test	test	NOUN
aji-145	159	8	kits	kit	NOUN
aji-145	159	9	of	of	ADP
aji-145	159	10	hbsag	hbsag	PROPN
aji-145	159	11	and	and	CCONJ
aji-145	159	12	onestep	onestep	NOUN
aji-145	159	13	hcv	hcv	PROPN
aji-145	159	14	test	test	NOUN
aji-145	159	15	strips	strip	NOUN
aji-145	159	16	were	be	AUX
aji-145	159	17	99.1	99.1	NUM
aji-145	159	18	%	%	NOUN
aji-145	159	19	and	and	CCONJ
aji-145	159	20	99.6	99.6	NUM
aji-145	159	21	%	%	NOUN
aji-145	159	22	,	,	PUNCT
aji-145	159	23	respectively	respectively	ADV
aji-145	159	24	.	.	PUNCT
aji-145	160	1	2.4	2.4	NUM
aji-145	160	2	data	datum	NOUN
aji-145	160	3	analysis	analysis	NOUN
aji-145	160	4	data	datum	NOUN
aji-145	160	5	were	be	AUX
aji-145	160	6	analyzed	analyze	VERB
aji-145	160	7	with	with	ADP
aji-145	160	8	ibm	ibm	PROPN
aji-145	160	9	spss	spss	PROPN
aji-145	160	10	statistics	statistics	PROPN
aji-145	160	11	version	version	PROPN
aji-145	160	12	25	25	NUM
aji-145	160	13	.	.	PUNCT
aji-145	161	1	descriptive	descriptive	ADJ
aji-145	161	2	statistics	statistic	NOUN
aji-145	161	3	were	be	AUX
aji-145	161	4	employed	employ	VERB
aji-145	161	5	in	in	ADP
aji-145	161	6	presenting	present	VERB
aji-145	161	7	the	the	DET
aji-145	161	8	data	datum	NOUN
aji-145	161	9	were	be	AUX
aji-145	161	10	in	in	ADP
aji-145	161	11	counts	count	NOUN
aji-145	161	12	and	and	CCONJ
aji-145	161	13	percentages	percentage	NOUN
aji-145	161	14	.	.	PUNCT
aji-145	162	1	pearson	pearson	PROPN
aji-145	162	2	chi	chi	PROPN
aji-145	162	3	-	-	PUNCT
aji-145	162	4	square	square	PROPN
aji-145	162	5	test	test	NOUN
aji-145	162	6	were	be	AUX
aji-145	162	7	employed	employ	VERB
aji-145	162	8	to	to	PART
aji-145	162	9	ascertain	ascertain	VERB
aji-145	162	10	associations	association	NOUN
aji-145	162	11	between	between	ADP
aji-145	162	12	the	the	DET
aji-145	162	13	categorical	categorical	ADJ
aji-145	162	14	variables	variable	NOUN
aji-145	162	15	.	.	PUNCT
aji-145	163	1	3	3	X
aji-145	163	2	.	.	NOUN
aji-145	163	3	results	result	NOUN
aji-145	163	4	in	in	ADP
aji-145	163	5	this	this	DET
aji-145	163	6	retrospective	retrospective	ADJ
aji-145	163	7	cross	cross	ADJ
aji-145	163	8	-	-	ADJ
aji-145	163	9	sectional	sectional	ADJ
aji-145	163	10	study	study	NOUN
aji-145	163	11	,	,	PUNCT
aji-145	163	12	we	we	PRON
aji-145	163	13	reviewed	review	VERB
aji-145	163	14	the	the	DET
aji-145	163	15	laboratory	laboratory	NOUN
aji-145	163	16	records	record	NOUN
aji-145	163	17	of	of	ADP
aji-145	163	18	206	206	NUM
aji-145	163	19	persons	person	NOUN
aji-145	163	20	;	;	PUNCT
aji-145	163	21	123	123	NUM
aji-145	163	22	(	(	PUNCT
aji-145	163	23	59.7	59.7	NUM
aji-145	163	24	%	%	NOUN
aji-145	163	25	)	)	PUNCT
aji-145	163	26	males	male	NOUN
aji-145	163	27	and	and	CCONJ
aji-145	163	28	83	83	NUM
aji-145	163	29	(	(	PUNCT
aji-145	163	30	40.3	40.3	NUM
aji-145	163	31	%	%	NOUN
aji-145	163	32	)	)	PUNCT
aji-145	163	33	females	female	NOUN
aji-145	163	34	,	,	PUNCT
aji-145	163	35	attending	attend	VERB
aji-145	163	36	public	public	ADJ
aji-145	163	37	and	and	CCONJ
aji-145	163	38	private	private	ADJ
aji-145	163	39	healthcare	healthcare	NOUN
aji-145	163	40	facilities	facility	NOUN
aji-145	163	41	in	in	ADP
aji-145	163	42	port	port	NOUN
aji-145	163	43	harcourt	harcourt	PROPN
aji-145	163	44	who	who	PRON
aji-145	163	45	conducted	conduct	VERB
aji-145	163	46	serological	serological	ADJ
aji-145	163	47	investigations	investigation	NOUN
aji-145	163	48	of	of	ADP
aji-145	163	49	hepatitis	hepatitis	PROPN
aji-145	163	50	b	b	PROPN
aji-145	163	51	and	and	CCONJ
aji-145	163	52	hepatitis	hepatitis	PROPN
aji-145	163	53	c	c	PROPN
aji-145	163	54	viral	viral	ADJ
aji-145	163	55	infections	infection	NOUN
aji-145	163	56	at	at	ADP
aji-145	163	57	diagnostix	diagnostix	NOUN
aji-145	163	58	and	and	CCONJ
aji-145	163	59	scientifique	scientifique	PROPN
aji-145	163	60	laboratories	laboratory	NOUN
aji-145	163	61	,	,	PUNCT
aji-145	163	62	port	port	NOUN
aji-145	163	63	harcourt	harcourt	PROPN
aji-145	163	64	.	.	PUNCT
aji-145	164	1	the	the	DET
aji-145	164	2	mean	mean	ADJ
aji-145	164	3	age	age	NOUN
aji-145	164	4	in	in	ADP
aji-145	164	5	years	year	NOUN
aji-145	164	6	was	be	AUX
aji-145	164	7	37.04±	37.04±	NUM
aji-145	164	8	12.06	12.06	NUM
aji-145	164	9	the	the	DET
aji-145	164	10	median	median	ADJ
aji-145	164	11	age	age	NOUN
aji-145	164	12	:	:	PUNCT
aji-145	164	13	36	36	NUM
aji-145	164	14	,	,	PUNCT
aji-145	164	15	mode	mode	NOUN
aji-145	164	16	:	:	PUNCT
aji-145	164	17	33	33	NUM
aji-145	164	18	,	,	PUNCT
aji-145	164	19	while	while	SCONJ
aji-145	164	20	the	the	DET
aji-145	164	21	minimum	minimum	ADJ
aji-145	164	22	and	and	CCONJ
aji-145	164	23	maximum	maximum	ADJ
aji-145	164	24	ages	age	NOUN
aji-145	164	25	were	be	AUX
aji-145	164	26	12	12	NUM
aji-145	164	27	and	and	CCONJ
aji-145	164	28	69	69	NUM
aji-145	164	29	years	year	NOUN
aji-145	164	30	,	,	PUNCT
aji-145	164	31	respectively	respectively	ADV
aji-145	164	32	(	(	PUNCT
aji-145	164	33	fig	fig	NOUN
aji-145	164	34	.	.	NOUN
aji-145	164	35	1	1	NUM
aji-145	164	36	)	)	PUNCT
aji-145	164	37	.	.	PUNCT
aji-145	165	1	3.1	3.1	NUM
aji-145	165	2	seroprevalence	seroprevalence	NOUN
aji-145	165	3	of	of	ADP
aji-145	165	4	hepatitis	hepatitis	PROPN
aji-145	165	5	b	b	PROPN
aji-145	165	6	and	and	CCONJ
aji-145	165	7	hepatitis	hepatitis	PROPN
aji-145	165	8	c	c	PROPN
aji-145	165	9	viral	viral	ADJ
aji-145	165	10	infections	infection	NOUN
aji-145	165	11	in	in	ADP
aji-145	165	12	port	port	NOUN
aji-145	165	13	harcourt	harcourt	PROPN
aji-145	165	14	,	,	PUNCT
aji-145	165	15	nigeria	nigeria	PROPN
aji-145	165	16	the	the	DET
aji-145	165	17	seroprevalence	seroprevalence	NOUN
aji-145	165	18	of	of	ADP
aji-145	165	19	hepatitis	hepatitis	PROPN
aji-145	165	20	b	b	PROPN
aji-145	165	21	in	in	ADP
aji-145	165	22	the	the	DET
aji-145	165	23	study	study	NOUN
aji-145	165	24	area	area	NOUN
aji-145	165	25	was	be	AUX
aji-145	165	26	found	find	VERB
aji-145	165	27	to	to	PART
aji-145	165	28	be	be	AUX
aji-145	165	29	5.8	5.8	NUM
aji-145	165	30	%	%	NOUN
aji-145	165	31	,	,	PUNCT
aji-145	165	32	while	while	SCONJ
aji-145	165	33	that	that	PRON
aji-145	165	34	for	for	ADP
aji-145	165	35	hepatitis	hepatitis	PROPN
aji-145	165	36	c	c	PROPN
aji-145	165	37	was	be	AUX
aji-145	165	38	0.5	0.5	NUM
aji-145	165	39	%	%	NOUN
aji-145	165	40	.	.	PUNCT
aji-145	166	1	the	the	DET
aji-145	166	2	males	male	NOUN
aji-145	166	3	had	have	VERB
aji-145	166	4	a	a	DET
aji-145	166	5	seroprevalence	seroprevalence	NOUN
aji-145	166	6	of	of	ADP
aji-145	166	7	7.3	7.3	NUM
aji-145	166	8	%	%	NOUN
aji-145	166	9	and	and	CCONJ
aji-145	166	10	females	female	NOUN
aji-145	166	11	3.6	3.6	NUM
aji-145	166	12	%	%	NOUN
aji-145	166	13	.	.	PUNCT
aji-145	167	1	among	among	ADP
aji-145	167	2	the	the	DET
aji-145	167	3	age	age	NOUN
aji-145	167	4	groups	group	NOUN
aji-145	167	5	,	,	PUNCT
aji-145	167	6	the	the	DET
aji-145	167	7	highest	high	ADJ
aji-145	167	8	prevalence	prevalence	NOUN
aji-145	167	9	was	be	AUX
aji-145	167	10	found	find	VERB
aji-145	167	11	in	in	ADP
aji-145	167	12	the	the	DET
aji-145	167	13	31	31	NUM
aji-145	167	14	-	-	SYM
aji-145	167	15	40	40	NUM
aji-145	167	16	years	year	NOUN
aji-145	167	17	age	age	NOUN
aji-145	167	18	bracket	bracket	NOUN
aji-145	167	19	at	at	ADP
aji-145	167	20	10.6	10.6	NUM
aji-145	167	21	%	%	NOUN
aji-145	167	22	,	,	PUNCT
aji-145	167	23	followed	follow	VERB
aji-145	167	24	by	by	ADP
aji-145	167	25	11	11	NUM
aji-145	167	26	-	-	SYM
aji-145	167	27	20	20	NUM
aji-145	167	28	years	year	NOUN
aji-145	167	29	(	(	PUNCT
aji-145	167	30	59	59	NUM
aji-145	167	31	%	%	NOUN
aji-145	167	32	)	)	PUNCT
aji-145	167	33	,	,	PUNCT
aji-145	167	34	21	21	NUM
aji-145	167	35	-	-	SYM
aji-145	167	36	30	30	NUM
aji-145	167	37	years	year	NOUN
aji-145	167	38	,	,	PUNCT
aji-145	167	39	(	(	PUNCT
aji-145	167	40	5.0	5.0	NUM
aji-145	167	41	%	%	NOUN
aji-145	167	42	)	)	PUNCT
aji-145	167	43	and	and	CCONJ
aji-145	167	44	41	41	NUM
aji-145	167	45	-	-	SYM
aji-145	167	46	50	50	NUM
aji-145	167	47	%	%	NOUN
aji-145	167	48	(	(	PUNCT
aji-145	167	49	3.6	3.6	NUM
aji-145	167	50	%	%	NOUN
aji-145	167	51	)	)	PUNCT
aji-145	167	52	(	(	PUNCT
aji-145	167	53	table	table	NOUN
aji-145	167	54	1	1	NUM
aji-145	167	55	)	)	PUNCT
aji-145	167	56	.	.	PUNCT
aji-145	168	1	in	in	ADP
aji-145	168	2	the	the	DET
aji-145	168	3	residential	residential	ADJ
aji-145	168	4	areas	area	NOUN
aji-145	168	5	,	,	PUNCT
aji-145	168	6	the	the	DET
aji-145	168	7	highest	high	ADJ
aji-145	168	8	prevalence	prevalence	NOUN
aji-145	168	9	of	of	ADP
aji-145	168	10	7.0	7.0	NUM
aji-145	168	11	%	%	NOUN
aji-145	168	12	was	be	AUX
aji-145	168	13	observed	observe	VERB
aji-145	168	14	in	in	ADP
aji-145	168	15	mile	mile	PROPN
aji-145	168	16	ii	ii	PROPN
aji-145	168	17	diobu	diobu	NOUN
aji-145	168	18	,	,	PUNCT
aji-145	168	19	followed	follow	VERB
aji-145	168	20	by	by	ADP
aji-145	168	21	mile	mile	NOUN
aji-145	168	22	iii	iii	NUM
aji-145	168	23	diobu	diobu	NOUN
aji-145	168	24	(	(	PUNCT
aji-145	168	25	6.4	6.4	NUM
aji-145	168	26	%	%	NOUN
aji-145	168	27	)	)	PUNCT
aji-145	168	28	,	,	PUNCT
aji-145	168	29	mile	mile	NOUN
aji-145	168	30	i	i	PRON
aji-145	168	31	diobu	diobu	VERB
aji-145	168	32	(	(	PUNCT
aji-145	168	33	5.8	5.8	NUM
aji-145	168	34	%	%	NOUN
aji-145	168	35	)	)	PUNCT
aji-145	168	36	and	and	CCONJ
aji-145	168	37	adjoining	adjoining	ADJ
aji-145	168	38	communities	community	NOUN
aji-145	168	39	(	(	PUNCT
aji-145	168	40	4.0	4.0	NUM
aji-145	168	41	%	%	NOUN
aji-145	168	42	)	)	PUNCT
aji-145	168	43	(	(	PUNCT
aji-145	168	44	table	table	NOUN
aji-145	168	45	1	1	NUM
aji-145	168	46	)	)	PUNCT
aji-145	168	47	.	.	PUNCT
aji-145	169	1	3.2	3.2	NUM
aji-145	169	2	seroprevalence	seroprevalence	NOUN
aji-145	169	3	of	of	ADP
aji-145	169	4	hepatitis	hepatitis	PROPN
aji-145	169	5	c	c	PROPN
aji-145	169	6	viral	viral	ADJ
aji-145	169	7	infections	infection	NOUN
aji-145	169	8	the	the	DET
aji-145	169	9	seroprevalence	seroprevalence	NOUN
aji-145	169	10	of	of	ADP
aji-145	169	11	hepatitis	hepatitis	PROPN
aji-145	169	12	c	c	PROPN
aji-145	169	13	virus	virus	NOUN
aji-145	169	14	infection	infection	NOUN
aji-145	169	15	as	as	SCONJ
aji-145	169	16	determined	determine	VERB
aji-145	169	17	in	in	ADP
aji-145	169	18	the	the	DET
aji-145	169	19	study	study	NOUN
aji-145	169	20	area	area	NOUN
aji-145	169	21	was	be	AUX
aji-145	169	22	0.5	0.5	NUM
aji-145	169	23	%	%	NOUN
aji-145	169	24	as	as	ADP
aji-145	169	25	only	only	ADV
aji-145	169	26	one	one	NUM
aji-145	169	27	of	of	ADP
aji-145	169	28	the	the	DET
aji-145	169	29	206	206	NUM
aji-145	169	30	tests	test	NOUN
aji-145	169	31	recorded	record	VERB
aji-145	169	32	positive	positive	ADJ
aji-145	169	33	.	.	PUNCT
aji-145	170	1	the	the	DET
aji-145	170	2	prevalence	prevalence	NOUN
aji-145	170	3	for	for	ADP
aji-145	170	4	males	male	NOUN
aji-145	170	5	was	be	AUX
aji-145	170	6	0.8	0.8	NUM
aji-145	170	7	%	%	NOUN
aji-145	170	8	,	,	PUNCT
aji-145	170	9	while	while	SCONJ
aji-145	170	10	females	female	NOUN
aji-145	170	11	.	.	PUNCT
aji-145	171	1	was	be	AUX
aji-145	171	2	0	0	NUM
aji-145	171	3	%	%	NOUN
aji-145	171	4	.	.	PUNCT
aji-145	172	1	the	the	DET
aji-145	172	2	31	31	NUM
aji-145	172	3	-	-	SYM
aji-145	172	4	40	40	NUM
aji-145	172	5	age	age	NOUN
aji-145	172	6	group	group	NOUN
aji-145	172	7	had	have	VERB
aji-145	172	8	a	a	DET
aji-145	172	9	prevalence	prevalence	NOUN
aji-145	172	10	had	have	VERB
aji-145	172	11	a	a	DET
aji-145	172	12	prevalence	prevalence	NOUN
aji-145	172	13	of	of	ADP
aji-145	172	14	1.9	1.9	NUM
aji-145	172	15	%	%	NOUN
aji-145	172	16	while	while	SCONJ
aji-145	172	17	the	the	DET
aji-145	172	18	rest	rest	NOUN
aji-145	172	19	had	have	VERB
aji-145	172	20	zero	zero	NUM
aji-145	172	21	prevalence	prevalence	NOUN
aji-145	172	22	(	(	PUNCT
aji-145	172	23	table	table	NOUN
aji-145	172	24	2	2	NUM
aji-145	172	25	)	)	PUNCT
aji-145	172	26	.	.	PUNCT
aji-145	173	1	3.3	3.3	NUM
aji-145	173	2	statistical	statistical	ADJ
aji-145	173	3	analysis	analysis	NOUN
aji-145	173	4	pearson	pearson	PROPN
aji-145	173	5	’s	’s	PART
aji-145	173	6	chi	chi	ADJ
aji-145	173	7	-	-	PUNCT
aji-145	173	8	square	square	ADJ
aji-145	173	9	test	test	NOUN
aji-145	173	10	of	of	ADP
aji-145	173	11	independence	independence	NOUN
aji-145	173	12	and	and	CCONJ
aji-145	173	13	fisher	fisher	PROPN
aji-145	173	14	’s	’s	PART
aji-145	173	15	exact	exact	ADJ
aji-145	173	16	test	test	NOUN
aji-145	173	17	were	be	AUX
aji-145	173	18	performed	perform	VERB
aji-145	173	19	to	to	PART
aji-145	173	20	evaluate	evaluate	VERB
aji-145	173	21	https://en.wikipedia.org/wiki/old_gra,_port_harcourt	https://en.wikipedia.org/wiki/old_gra,_port_harcourt	PROPN
aji-145	173	22	ndukwu	ndukwu	NOUN
aji-145	173	23	and	and	CCONJ
aji-145	173	24	chinedu	chinedu	NOUN
aji-145	173	25	-	-	PUNCT
aji-145	173	26	madu	madu	NOUN
aji-145	173	27	;	;	PUNCT
aji-145	173	28	asian	asian	PROPN
aji-145	173	29	j.	j.	PROPN
aji-145	173	30	immunol	immunol	PROPN
aji-145	173	31	.	.	PROPN
aji-145	173	32	,	,	PUNCT
aji-145	173	33	vol	vol	NOUN
aji-145	173	34	.	.	PROPN
aji-145	174	1	7	7	NUM
aji-145	174	2	,	,	PUNCT
aji-145	174	3	no	no	INTJ
aji-145	174	4	.	.	NOUN
aji-145	174	5	1	1	NUM
aji-145	174	6	,	,	PUNCT
aji-145	174	7	pp	pp	ADJ
aji-145	174	8	.	.	PUNCT
aji-145	175	1	209	209	NUM
aji-145	175	2	-	-	SYM
aji-145	175	3	216	216	NUM
aji-145	175	4	,	,	PUNCT
aji-145	175	5	2024	2024	NUM
aji-145	175	6	;	;	PUNCT
aji-145	175	7	article	article	NOUN
aji-145	175	8	no.aji.125624	no.aji.125624	VERB
aji-145	175	9	212	212	NUM
aji-145	175	10	the	the	DET
aji-145	175	11	relationship	relationship	NOUN
aji-145	175	12	between	between	ADP
aji-145	175	13	the	the	DET
aji-145	175	14	residence	residence	NOUN
aji-145	175	15	,	,	PUNCT
aji-145	175	16	age	age	NOUN
aji-145	175	17	and	and	CCONJ
aji-145	175	18	gender	gender	NOUN
aji-145	175	19	(	(	PUNCT
aji-145	175	20	independent	independent	ADJ
aji-145	175	21	variables	variable	NOUN
aji-145	175	22	)	)	PUNCT
aji-145	175	23	and	and	CCONJ
aji-145	175	24	results	result	NOUN
aji-145	175	25	of	of	ADP
aji-145	175	26	hbv	hbv	NOUN
aji-145	175	27	and	and	CCONJ
aji-145	175	28	hcv	hcv	PROPN
aji-145	175	29	test	test	NOUN
aji-145	175	30	results	result	NOUN
aji-145	175	31	(	(	PUNCT
aji-145	175	32	dependent	dependent	ADJ
aji-145	175	33	variable	variable	NOUN
aji-145	175	34	)	)	PUNCT
aji-145	175	35	.	.	PUNCT
aji-145	176	1	the	the	DET
aji-145	176	2	association	association	NOUN
aji-145	176	3	between	between	ADP
aji-145	176	4	these	these	DET
aji-145	176	5	variables	variable	NOUN
aji-145	176	6	were	be	AUX
aji-145	176	7	found	find	VERB
aji-145	176	8	not	not	PART
aji-145	176	9	be	be	AUX
aji-145	176	10	significant	significant	ADJ
aji-145	176	11	,	,	PUNCT
aji-145	176	12	given	give	VERB
aji-145	176	13	that	that	SCONJ
aji-145	176	14	the	the	DET
aji-145	176	15	p	p	PROPN
aji-145	176	16	values	value	NOUN
aji-145	176	17	were	be	AUX
aji-145	176	18	not	not	PART
aji-145	176	19	less	less	ADJ
aji-145	176	20	than	than	ADP
aji-145	176	21	0.05	0.05	NUM
aji-145	176	22	,	,	PUNCT
aji-145	176	23	we	we	PRON
aji-145	176	24	therefore	therefore	ADV
aji-145	176	25	failed	fail	VERB
aji-145	176	26	to	to	PART
aji-145	176	27	reject	reject	VERB
aji-145	176	28	the	the	DET
aji-145	176	29	null	null	ADJ
aji-145	176	30	hypothesis	hypothesis	NOUN
aji-145	176	31	which	which	PRON
aji-145	176	32	states	state	VERB
aji-145	176	33	that	that	SCONJ
aji-145	176	34	the	the	DET
aji-145	176	35	variables	variable	NOUN
aji-145	176	36	are	be	AUX
aji-145	176	37	independent	independent	ADJ
aji-145	176	38	.	.	PUNCT
aji-145	177	1	in	in	ADP
aji-145	177	2	other	other	ADJ
aji-145	177	3	words	word	NOUN
aji-145	177	4	,	,	PUNCT
aji-145	177	5	there	there	PRON
aji-145	177	6	was	be	VERB
aji-145	177	7	no	no	DET
aji-145	177	8	sufficient	sufficient	ADJ
aji-145	177	9	evidence	evidence	NOUN
aji-145	177	10	to	to	PART
aji-145	177	11	conclude	conclude	VERB
aji-145	177	12	that	that	SCONJ
aji-145	177	13	a	a	DET
aji-145	177	14	significant	significant	ADJ
aji-145	177	15	association	association	NOUN
aji-145	177	16	exists	exist	VERB
aji-145	177	17	between	between	ADP
aji-145	177	18	the	the	DET
aji-145	177	19	variable	variable	NOUN
aji-145	177	20	and	and	CCONJ
aji-145	177	21	the	the	DET
aji-145	177	22	test	test	NOUN
aji-145	177	23	results	result	NOUN
aji-145	177	24	obtained	obtain	VERB
aji-145	177	25	for	for	ADP
aji-145	177	26	the	the	DET
aji-145	177	27	hepatitis	hepatitis	PROPN
aji-145	177	28	b	b	PROPN
aji-145	177	29	and	and	CCONJ
aji-145	177	30	hepatitis	hepatitis	PROPN
aji-145	177	31	c	c	NOUN
aji-145	177	32	screening	screen	VERB
aji-145	177	33	.	.	PUNCT
aji-145	178	1	fig	fig	NOUN
aji-145	178	2	.	.	PUNCT
aji-145	179	1	1	1	X
aji-145	179	2	.	.	X
aji-145	179	3	frequency	frequency	NOUN
aji-145	179	4	distributions	distribution	NOUN
aji-145	179	5	of	of	ADP
aji-145	179	6	the	the	DET
aji-145	179	7	hbv	hbv	NOUN
aji-145	179	8	and	and	CCONJ
aji-145	179	9	hcv	hcv	NOUN
aji-145	179	10	specimens	specimen	NOUN
aji-145	179	11	by	by	ADP
aji-145	179	12	age	age	NOUN
aji-145	179	13	table	table	NOUN
aji-145	179	14	1	1	NUM
aji-145	179	15	.	.	X
aji-145	180	1	seroprevalence	seroprevalence	NOUN
aji-145	180	2	of	of	ADP
aji-145	180	3	hepatitis	hepatitis	PROPN
aji-145	180	4	b	b	ADP
aji-145	180	5	viral	viral	ADJ
aji-145	180	6	infection	infection	NOUN
aji-145	180	7	characteristics	characteristic	NOUN
aji-145	180	8	number	number	NOUN
aji-145	180	9	tested	test	VERB
aji-145	180	10	positive	positive	ADJ
aji-145	180	11	tests	test	NOUN
aji-145	180	12	prevalence	prevalence	NOUN
aji-145	180	13	%	%	NOUN
aji-145	180	14	age	age	NOUN
aji-145	180	15	groups	group	NOUN
aji-145	180	16	11	11	NUM
aji-145	180	17	-	-	SYM
aji-145	180	18	20	20	NUM
aji-145	180	19	16	16	NUM
aji-145	180	20	1	1	NUM
aji-145	180	21	5.9	5.9	NUM
aji-145	180	22	21	21	NUM
aji-145	180	23	-	-	SYM
aji-145	180	24	30	30	NUM
aji-145	180	25	38	38	NUM
aji-145	180	26	2	2	NUM
aji-145	180	27	5.0	5.0	NUM
aji-145	180	28	31	31	NUM
aji-145	180	29	-	-	SYM
aji-145	180	30	40	40	NUM
aji-145	180	31	59	59	NUM
aji-145	180	32	7	7	NUM
aji-145	180	33	10.6	10.6	NUM
aji-145	180	34	41	41	NUM
aji-145	180	35	-	-	SYM
aji-145	180	36	50	50	NUM
aji-145	181	1	53	53	NUM
aji-145	181	2	2	2	NUM
aji-145	181	3	3.6	3.6	NUM
aji-145	181	4	51	51	NUM
aji-145	181	5	-	-	SYM
aji-145	181	6	60	60	NUM
aji-145	181	7	17	17	NUM
aji-145	181	8	0	0	NUM
aji-145	181	9	0.0	0.0	NUM
aji-145	181	10	61	61	NUM
aji-145	181	11	-	-	SYM
aji-145	181	12	70	70	NUM
aji-145	181	13	11	11	NUM
aji-145	181	14	0	0	NUM
aji-145	181	15	0.0	0.0	NUM
aji-145	181	16	total	total	NOUN
aji-145	181	17	206	206	NUM
aji-145	181	18	12	12	NUM
aji-145	181	19	5.8	5.8	NUM
aji-145	181	20	gender	gender	NOUN
aji-145	181	21	males	male	NOUN
aji-145	181	22	123	123	NUM
aji-145	181	23	9	9	NUM
aji-145	181	24	7.3	7.3	NUM
aji-145	181	25	females	female	NOUN
aji-145	181	26	83	83	NUM
aji-145	181	27	3	3	NUM
aji-145	181	28	3.6	3.6	NUM
aji-145	181	29	females	female	NOUN
aji-145	181	30	206	206	NUM
aji-145	181	31	12	12	NUM
aji-145	181	32	5.8	5.8	NUM
aji-145	181	33	total	total	NOUN
aji-145	181	34	206	206	NUM
aji-145	181	35	12	12	NUM
aji-145	181	36	5.8	5.8	NUM
aji-145	181	37	residence	residence	NOUN
aji-145	181	38	mile	mile	NOUN
aji-145	181	39	i	i	PRON
aji-145	181	40	diobu	diobu	VERB
aji-145	181	41	49	49	NUM
aji-145	181	42	3	3	NUM
aji-145	181	43	5.8	5.8	NUM
aji-145	181	44	mile	mile	NOUN
aji-145	181	45	ii	ii	PROPN
aji-145	181	46	diobu	diobu	VERB
aji-145	181	47	53	53	NUM
aji-145	181	48	4	4	NUM
aji-145	181	49	7.0	7.0	NUM
aji-145	181	50	mile	mile	NOUN
aji-145	181	51	iii	iii	NOUN
aji-145	181	52	diobu	diobu	NOUN
aji-145	181	53	44	44	NUM
aji-145	181	54	3	3	NUM
aji-145	181	55	6.4	6.4	NUM
aji-145	181	56	adjoining	adjoining	ADJ
aji-145	181	57	communities	community	NOUN
aji-145	181	58	48	48	NUM
aji-145	181	59	2	2	NUM
aji-145	181	60	4.0	4.0	NUM
aji-145	181	61	total	total	NOUN
aji-145	181	62	206	206	NUM
aji-145	181	63	12	12	NUM
aji-145	181	64	5.8	5.8	NUM
aji-145	181	65	ndukwu	ndukwu	NOUN
aji-145	181	66	and	and	CCONJ
aji-145	181	67	chinedu	chinedu	NOUN
aji-145	181	68	-	-	PUNCT
aji-145	181	69	madu	madu	NOUN
aji-145	181	70	;	;	PUNCT
aji-145	181	71	asian	asian	PROPN
aji-145	181	72	j.	j.	PROPN
aji-145	181	73	immunol	immunol	PROPN
aji-145	181	74	.	.	PROPN
aji-145	181	75	,	,	PUNCT
aji-145	181	76	vol	vol	NOUN
aji-145	181	77	.	.	PROPN
aji-145	182	1	7	7	NUM
aji-145	182	2	,	,	PUNCT
aji-145	182	3	no	no	INTJ
aji-145	182	4	.	.	NOUN
aji-145	182	5	1	1	NUM
aji-145	182	6	,	,	PUNCT
aji-145	182	7	pp	pp	ADJ
aji-145	182	8	.	.	PUNCT
aji-145	183	1	209	209	NUM
aji-145	183	2	-	-	SYM
aji-145	183	3	216	216	NUM
aji-145	183	4	,	,	PUNCT
aji-145	183	5	2024	2024	NUM
aji-145	183	6	;	;	PUNCT
aji-145	183	7	article	article	NOUN
aji-145	183	8	no.aji.125624	no.aji.125624	VERB
aji-145	183	9	213	213	NUM
aji-145	183	10	table	table	NOUN
aji-145	183	11	2	2	NUM
aji-145	183	12	.	.	X
aji-145	184	1	seroprevalence	seroprevalence	NOUN
aji-145	184	2	of	of	ADP
aji-145	184	3	hepatitis	hepatitis	PROPN
aji-145	184	4	c	c	PROPN
aji-145	184	5	viral	viral	ADJ
aji-145	184	6	infections	infection	NOUN
aji-145	184	7	in	in	ADP
aji-145	184	8	port	port	NOUN
aji-145	184	9	harcourt	harcourt	PROPN
aji-145	184	10	,	,	PUNCT
aji-145	184	11	nigeria	nigeria	PROPN
aji-145	184	12	characteristics	characteristic	NOUN
aji-145	184	13	number	number	NOUN
aji-145	184	14	tested	test	VERB
aji-145	184	15	positive	positive	ADJ
aji-145	184	16	tests	test	NOUN
aji-145	184	17	prevalence	prevalence	NOUN
aji-145	184	18	age	age	NOUN
aji-145	184	19	groups	group	NOUN
aji-145	184	20	11	11	NUM
aji-145	184	21	-	-	SYM
aji-145	184	22	20	20	NUM
aji-145	185	1	16	16	NUM
aji-145	185	2	0	0	NUM
aji-145	185	3	0.0	0.0	NUM
aji-145	185	4	21	21	NUM
aji-145	185	5	-	-	SYM
aji-145	185	6	30	30	NUM
aji-145	185	7	38	38	NUM
aji-145	185	8	0	0	NUM
aji-145	185	9	0.0	0.0	NUM
aji-145	185	10	31	31	NUM
aji-145	185	11	-	-	SYM
aji-145	185	12	40	40	NUM
aji-145	185	13	59	59	NUM
aji-145	185	14	1	1	NUM
aji-145	185	15	1.5	1.5	NUM
aji-145	185	16	41	41	NUM
aji-145	185	17	-	-	SYM
aji-145	185	18	50	50	NUM
aji-145	186	1	53	53	NUM
aji-145	186	2	0	0	NUM
aji-145	186	3	0.0	0.0	NUM
aji-145	186	4	51	51	NUM
aji-145	186	5	-	-	SYM
aji-145	186	6	60	60	NUM
aji-145	186	7	17	17	NUM
aji-145	186	8	0	0	NUM
aji-145	186	9	0.0	0.0	NUM
aji-145	186	10	61	61	NUM
aji-145	186	11	-	-	SYM
aji-145	186	12	70	70	NUM
aji-145	186	13	11	11	NUM
aji-145	186	14	0	0	NUM
aji-145	186	15	0.0	0.0	NUM
aji-145	186	16	total	total	NOUN
aji-145	186	17	206	206	NUM
aji-145	186	18	1	1	NUM
aji-145	186	19	0.5	0.5	NUM
aji-145	186	20	gender	gender	NOUN
aji-145	186	21	males	male	NOUN
aji-145	186	22	123	123	NUM
aji-145	186	23	1	1	NUM
aji-145	186	24	0.8	0.8	NUM
aji-145	186	25	females	female	NOUN
aji-145	186	26	83	83	NUM
aji-145	186	27	0	0	NUM
aji-145	186	28	0.0	0.0	NUM
aji-145	186	29	total	total	NOUN
aji-145	186	30	206	206	NUM
aji-145	186	31	1	1	NUM
aji-145	186	32	0.5	0.5	NUM
aji-145	186	33	residence	residence	NOUN
aji-145	186	34	mile	mile	NOUN
aji-145	186	35	i	i	PRON
aji-145	186	36	diobu	diobu	VERB
aji-145	186	37	49	49	NUM
aji-145	186	38	1	1	NUM
aji-145	186	39	1.9	1.9	NUM
aji-145	186	40	mile	mile	NOUN
aji-145	186	41	ii	ii	NOUN
aji-145	186	42	diobu	diobu	VERB
aji-145	186	43	53	53	NUM
aji-145	186	44	0	0	NUM
aji-145	186	45	0.0	0.0	NUM
aji-145	186	46	mile	mile	NOUN
aji-145	186	47	iii	iii	NOUN
aji-145	186	48	diobu	diobu	NOUN
aji-145	186	49	44	44	NUM
aji-145	186	50	0	0	NUM
aji-145	186	51	0.0	0.0	NUM
aji-145	186	52	adjoining	adjoining	ADJ
aji-145	186	53	communities	community	NOUN
aji-145	186	54	48	48	NUM
aji-145	186	55	0	0	NUM
aji-145	186	56	0.0	0.0	NUM
aji-145	186	57	total	total	NOUN
aji-145	186	58	206	206	NUM
aji-145	186	59	1	1	NUM
aji-145	186	60	0.5	0.5	NUM
aji-145	186	61	4	4	NUM
aji-145	186	62	.	.	PUNCT
aji-145	186	63	discussion	discussion	NOUN
aji-145	186	64	the	the	DET
aji-145	186	65	findings	finding	NOUN
aji-145	186	66	in	in	ADP
aji-145	186	67	this	this	DET
aji-145	186	68	study	study	NOUN
aji-145	186	69	indicate	indicate	VERB
aji-145	186	70	an	an	DET
aji-145	186	71	intermediate	intermediate	ADJ
aji-145	186	72	prevalence	prevalence	NOUN
aji-145	186	73	for	for	ADP
aji-145	186	74	hepatitis	hepatitis	PROPN
aji-145	186	75	b	b	PROPN
aji-145	186	76	and	and	CCONJ
aji-145	186	77	low	low	ADJ
aji-145	186	78	prevalence	prevalence	NOUN
aji-145	186	79	for	for	ADP
aji-145	186	80	hepatitis	hepatitis	PROPN
aji-145	186	81	c.	c.	PROPN
aji-145	186	82	majority	majority	NOUN
aji-145	186	83	of	of	ADP
aji-145	186	84	the	the	DET
aji-145	186	85	people	people	NOUN
aji-145	186	86	screened	screen	VERB
aji-145	186	87	were	be	AUX
aji-145	186	88	those	those	PRON
aji-145	186	89	who	who	PRON
aji-145	186	90	wanted	want	VERB
aji-145	186	91	medical	medical	ADJ
aji-145	186	92	tests	test	NOUN
aji-145	186	93	to	to	PART
aji-145	186	94	ascertain	ascertain	VERB
aji-145	186	95	their	their	PRON
aji-145	186	96	health	health	NOUN
aji-145	186	97	status	status	NOUN
aji-145	186	98	,	,	PUNCT
aji-145	186	99	while	while	SCONJ
aji-145	186	100	a	a	DET
aji-145	186	101	few	few	ADJ
aji-145	186	102	were	be	AUX
aji-145	186	103	referred	refer	VERB
aji-145	186	104	based	base	VERB
aji-145	186	105	on	on	ADP
aji-145	186	106	presumptive	presumptive	ADJ
aji-145	186	107	diagnosis	diagnosis	NOUN
aji-145	186	108	for	for	ADP
aji-145	186	109	viral	viral	ADJ
aji-145	186	110	hepatitis	hepatitis	NOUN
aji-145	186	111	.	.	PUNCT
aji-145	187	1	majority	majority	NOUN
aji-145	187	2	of	of	ADP
aji-145	187	3	the	the	PRON
aji-145	187	4	were	be	AUX
aji-145	187	5	collected	collect	VERB
aji-145	187	6	from	from	ADP
aji-145	187	7	males	male	NOUN
aji-145	187	8	(	(	PUNCT
aji-145	187	9	59.7	59.7	NUM
aji-145	187	10	%	%	NOUN
aji-145	187	11	)	)	PUNCT
aji-145	187	12	,	,	PUNCT
aji-145	187	13	who	who	PRON
aji-145	187	14	also	also	ADV
aji-145	187	15	recorded	record	VERB
aji-145	187	16	a	a	DET
aji-145	187	17	higher	high	ADJ
aji-145	187	18	prevalence	prevalence	NOUN
aji-145	187	19	of	of	ADP
aji-145	187	20	7.3	7.3	NUM
aji-145	187	21	%	%	NOUN
aji-145	187	22	than	than	ADP
aji-145	187	23	females	female	NOUN
aji-145	187	24	(	(	PUNCT
aji-145	187	25	3.6	3.6	NUM
aji-145	187	26	%	%	NOUN
aji-145	187	27	)	)	PUNCT
aji-145	187	28	.	.	PUNCT
aji-145	188	1	the	the	DET
aji-145	188	2	proportion	proportion	NOUN
aji-145	188	3	of	of	ADP
aji-145	188	4	males	male	NOUN
aji-145	188	5	to	to	ADP
aji-145	188	6	females	female	NOUN
aji-145	188	7	was	be	AUX
aji-145	188	8	similar	similar	ADJ
aji-145	188	9	to	to	ADP
aji-145	188	10	that	that	PRON
aji-145	188	11	of	of	ADP
aji-145	188	12	a	a	DET
aji-145	188	13	study	study	NOUN
aji-145	188	14	in	in	ADP
aji-145	188	15	northern	northern	PROPN
aji-145	188	16	nigeria	nigeria	PROPN
aji-145	188	17	with	with	ADP
aji-145	188	18	60.4	60.4	NUM
aji-145	188	19	%	%	NOUN
aji-145	188	20	males	male	NOUN
aji-145	188	21	and	and	CCONJ
aji-145	188	22	39.4%%	39.4%%	NUM
aji-145	189	1	[	[	X
aji-145	189	2	11	11	NUM
aji-145	189	3	]	]	PUNCT
aji-145	189	4	.	.	PUNCT
aji-145	190	1	the	the	DET
aji-145	190	2	prevalence	prevalence	NOUN
aji-145	190	3	of	of	ADP
aji-145	190	4	5.8	5.8	NUM
aji-145	190	5	%	%	NOUN
aji-145	190	6	obtained	obtain	VERB
aji-145	190	7	here	here	ADV
aji-145	190	8	for	for	ADP
aji-145	190	9	hepatitis	hepatitis	PROPN
aji-145	190	10	b	b	PROPN
aji-145	190	11	infection	infection	NOUN
aji-145	190	12	was	be	AUX
aji-145	190	13	higher	high	ADJ
aji-145	190	14	than	than	ADP
aji-145	190	15	the	the	DET
aji-145	190	16	1.2	1.2	NUM
aji-145	190	17	%	%	NOUN
aji-145	190	18	prevalence	prevalence	NOUN
aji-145	190	19	among	among	ADP
aji-145	190	20	members	member	NOUN
aji-145	190	21	of	of	ADP
aji-145	190	22	a	a	DET
aji-145	190	23	university	university	NOUN
aji-145	190	24	community	community	NOUN
aji-145	190	25	in	in	ADP
aji-145	190	26	port	port	NOUN
aji-145	190	27	harcourt	harcourt	PROPN
aji-145	190	28	[	[	X
aji-145	190	29	12	12	NUM
aji-145	190	30	]	]	PUNCT
aji-145	190	31	,	,	PUNCT
aji-145	190	32	it	it	PRON
aji-145	190	33	however	however	ADV
aji-145	190	34	aligned	align	VERB
aji-145	190	35	closely	closely	ADV
aji-145	190	36	with	with	ADP
aji-145	190	37	the	the	DET
aji-145	190	38	prevalence	prevalence	NOUN
aji-145	190	39	of	of	ADP
aji-145	190	40	6.2	6.2	NUM
aji-145	190	41	%	%	NOUN
aji-145	190	42	reported	report	VERB
aji-145	190	43	in	in	ADP
aji-145	190	44	a	a	DET
aji-145	190	45	study	study	NOUN
aji-145	190	46	among	among	ADP
aji-145	190	47	abattoir	abattoir	NOUN
aji-145	190	48	workers	worker	NOUN
aji-145	190	49	in	in	ADP
aji-145	190	50	port	port	NOUN
aji-145	190	51	harcourt	harcourt	PROPN
aji-145	190	52	[	[	X
aji-145	190	53	13	13	NUM
aji-145	190	54	]	]	PUNCT
aji-145	190	55	.	.	PUNCT
aji-145	191	1	the	the	DET
aji-145	191	2	discrepancy	discrepancy	NOUN
aji-145	191	3	between	between	ADP
aji-145	191	4	this	this	PRON
aji-145	191	5	and	and	CCONJ
aji-145	191	6	the	the	DET
aji-145	191	7	result	result	NOUN
aji-145	191	8	from	from	ADP
aji-145	191	9	the	the	DET
aji-145	191	10	university	university	NOUN
aji-145	191	11	may	may	AUX
aji-145	191	12	be	be	AUX
aji-145	191	13	due	due	ADJ
aji-145	191	14	to	to	ADP
aji-145	191	15	the	the	DET
aji-145	191	16	nature	nature	NOUN
aji-145	191	17	of	of	ADP
aji-145	191	18	the	the	DET
aji-145	191	19	population	population	NOUN
aji-145	191	20	.	.	PUNCT
aji-145	192	1	the	the	DET
aji-145	192	2	university	university	NOUN
aji-145	192	3	community	community	NOUN
aji-145	192	4	is	be	AUX
aji-145	192	5	populated	populate	VERB
aji-145	192	6	by	by	ADP
aji-145	192	7	persons	person	NOUN
aji-145	192	8	with	with	ADP
aji-145	192	9	good	good	ADJ
aji-145	192	10	knowledge	knowledge	NOUN
aji-145	192	11	of	of	ADP
aji-145	192	12	the	the	DET
aji-145	192	13	infections	infection	NOUN
aji-145	192	14	and	and	CCONJ
aji-145	192	15	the	the	DET
aji-145	192	16	preventive	preventive	ADJ
aji-145	192	17	measures	measure	NOUN
aji-145	192	18	,	,	PUNCT
aji-145	192	19	above	above	ADP
aji-145	192	20	what	what	PRON
aji-145	192	21	is	be	AUX
aji-145	192	22	obtainable	obtainable	ADJ
aji-145	192	23	in	in	ADP
aji-145	192	24	the	the	DET
aji-145	192	25	general	general	ADJ
aji-145	192	26	population	population	NOUN
aji-145	192	27	.	.	PUNCT
aji-145	193	1	the	the	DET
aji-145	193	2	prevalence	prevalence	NOUN
aji-145	193	3	of	of	ADP
aji-145	193	4	0.5	0.5	NUM
aji-145	193	5	%	%	NOUN
aji-145	193	6	observed	observe	VERB
aji-145	193	7	here	here	ADV
aji-145	193	8	however	however	ADV
aji-145	193	9	aligned	align	VERB
aji-145	193	10	very	very	ADV
aji-145	193	11	closely	closely	ADV
aji-145	193	12	with	with	ADP
aji-145	193	13	the	the	DET
aji-145	193	14	0.6	0.6	NUM
aji-145	193	15	%	%	NOUN
aji-145	193	16	prevalence	prevalence	NOUN
aji-145	193	17	in	in	ADP
aji-145	193	18	the	the	DET
aji-145	193	19	university	university	NOUN
aji-145	193	20	community	community	NOUN
aji-145	193	21	[	[	X
aji-145	193	22	12	12	NUM
aji-145	193	23	]	]	PUNCT
aji-145	193	24	.	.	PUNCT
aji-145	194	1	the	the	DET
aji-145	194	2	prevalence	prevalence	NOUN
aji-145	194	3	for	for	ADP
aji-145	194	4	both	both	DET
aji-145	194	5	hepatitis	hepatitis	PROPN
aji-145	194	6	b	b	PROPN
aji-145	194	7	and	and	CCONJ
aji-145	194	8	c	c	PROPN
aji-145	194	9	were	be	AUX
aji-145	194	10	lower	low	ADJ
aji-145	194	11	than	than	ADP
aji-145	194	12	the	the	DET
aji-145	194	13	prevalences	prevalence	NOUN
aji-145	194	14	of	of	ADP
aji-145	194	15	12.6	12.6	NUM
aji-145	194	16	%	%	NOUN
aji-145	194	17	and	and	CCONJ
aji-145	194	18	15.2	15.2	NUM
aji-145	194	19	%	%	NOUN
aji-145	194	20	for	for	ADP
aji-145	194	21	hbv	hbv	NOUN
aji-145	194	22	and	and	CCONJ
aji-145	194	23	hcv	hcv	NOUN
aji-145	194	24	respectively	respectively	ADV
aji-145	194	25	in	in	ADP
aji-145	194	26	a	a	DET
aji-145	194	27	study	study	NOUN
aji-145	194	28	in	in	ADP
aji-145	194	29	northern	northern	PROPN
aji-145	194	30	nigeria	nigeria	PROPN
aji-145	194	31	for	for	ADP
aji-145	194	32	persons	person	NOUN
aji-145	194	33	investigated	investigate	VERB
aji-145	194	34	due	due	ADP
aji-145	194	35	to	to	ADP
aji-145	194	36	ill	ill	ADJ
aji-145	194	37	-	-	PUNCT
aji-145	194	38	health	health	NOUN
aji-145	194	39	;	;	PUNCT
aji-145	194	40	but	but	CCONJ
aji-145	194	41	aligned	align	VERB
aji-145	194	42	with	with	ADP
aji-145	194	43	6.6	6.6	NUM
aji-145	194	44	%	%	NOUN
aji-145	194	45	for	for	ADP
aji-145	194	46	hbv	hbv	NOUN
aji-145	194	47	among	among	ADP
aji-145	194	48	healthcare	healthcare	NOUN
aji-145	194	49	workers	worker	NOUN
aji-145	194	50	in	in	ADP
aji-145	194	51	the	the	DET
aji-145	194	52	same	same	ADJ
aji-145	194	53	study	study	NOUN
aji-145	194	54	,	,	PUNCT
aji-145	194	55	but	but	CCONJ
aji-145	194	56	lower	low	ADJ
aji-145	194	57	than	than	ADP
aji-145	194	58	6.5	6.5	NUM
aji-145	194	59	%	%	NOUN
aji-145	194	60	for	for	ADP
aji-145	194	61	hcv	hcv	NOUN
aji-145	194	62	among	among	ADP
aji-145	194	63	the	the	DET
aji-145	194	64	healthcare	healthcare	NOUN
aji-145	194	65	workers	worker	NOUN
aji-145	194	66	[	[	X
aji-145	194	67	11	11	NUM
aji-145	194	68	]	]	PUNCT
aji-145	194	69	.	.	PUNCT
aji-145	195	1	another	another	DET
aji-145	195	2	study	study	NOUN
aji-145	195	3	in	in	ADP
aji-145	195	4	northern	northern	PROPN
aji-145	195	5	nigeria	nigeria	PROPN
aji-145	195	6	reported	report	VERB
aji-145	195	7	a	a	DET
aji-145	195	8	seroprevalence	seroprevalence	NOUN
aji-145	195	9	of	of	ADP
aji-145	195	10	hbv	hbv	NOUN
aji-145	195	11	infection	infection	NOUN
aji-145	195	12	of	of	ADP
aji-145	195	13	14.0	14.0	NUM
aji-145	195	14	%	%	NOUN
aji-145	195	15	and	and	CCONJ
aji-145	195	16	hcv	hcv	NOUN
aji-145	195	17	infection	infection	NOUN
aji-145	195	18	(	(	PUNCT
aji-145	195	19	10.4	10.4	NUM
aji-145	195	20	%	%	NOUN
aji-145	195	21	)	)	PUNCT
aji-145	196	1	[	[	X
aji-145	196	2	14	14	NUM
aji-145	196	3	]	]	X
aji-145	196	4	;	;	PUNCT
aji-145	196	5	these	these	PRON
aji-145	196	6	were	be	AUX
aji-145	196	7	higher	high	ADJ
aji-145	196	8	than	than	ADP
aji-145	196	9	the	the	DET
aji-145	196	10	outcomes	outcome	NOUN
aji-145	196	11	of	of	ADP
aji-145	196	12	this	this	DET
aji-145	196	13	study	study	NOUN
aji-145	196	14	.	.	PUNCT
aji-145	197	1	the	the	DET
aji-145	197	2	lower	low	ADJ
aji-145	197	3	prevalence	prevalence	NOUN
aji-145	197	4	in	in	ADP
aji-145	197	5	this	this	DET
aji-145	197	6	study	study	NOUN
aji-145	197	7	may	may	AUX
aji-145	197	8	be	be	AUX
aji-145	197	9	attributed	attribute	VERB
aji-145	197	10	to	to	ADP
aji-145	197	11	a	a	DET
aji-145	197	12	variety	variety	NOUN
aji-145	197	13	of	of	ADP
aji-145	197	14	factors	factor	NOUN
aji-145	197	15	such	such	ADJ
aji-145	197	16	as	as	ADP
aji-145	197	17	geographical	geographical	ADJ
aji-145	197	18	and	and	CCONJ
aji-145	197	19	cultural	cultural	ADJ
aji-145	197	20	factors	factor	NOUN
aji-145	197	21	,	,	PUNCT
aji-145	197	22	level	level	NOUN
aji-145	197	23	of	of	ADP
aji-145	197	24	awareness	awareness	NOUN
aji-145	197	25	and	and	CCONJ
aji-145	197	26	compliance	compliance	NOUN
aji-145	197	27	with	with	ADP
aji-145	197	28	preventive	preventive	ADJ
aji-145	197	29	measures	measure	NOUN
aji-145	197	30	among	among	ADP
aji-145	197	31	others	other	NOUN
aji-145	197	32	.	.	PUNCT
aji-145	198	1	it	it	PRON
aji-145	198	2	may	may	AUX
aji-145	198	3	also	also	ADV
aji-145	198	4	be	be	AUX
aji-145	198	5	as	as	ADP
aji-145	198	6	a	a	DET
aji-145	198	7	result	result	NOUN
aji-145	198	8	of	of	ADP
aji-145	198	9	reported	report	VERB
aji-145	198	10	decline	decline	NOUN
aji-145	198	11	in	in	ADP
aji-145	198	12	the	the	DET
aji-145	198	13	prevalence	prevalence	NOUN
aji-145	198	14	of	of	ADP
aji-145	198	15	hbv	hbv	NOUN
aji-145	198	16	infection	infection	NOUN
aji-145	198	17	[	[	X
aji-145	198	18	15	15	NUM
aji-145	198	19	]	]	PUNCT
aji-145	198	20	.	.	PUNCT
aji-145	199	1	the	the	DET
aji-145	199	2	prevalence	prevalence	NOUN
aji-145	199	3	of	of	ADP
aji-145	199	4	5.8	5.8	NUM
aji-145	199	5	%	%	NOUN
aji-145	199	6	is	be	AUX
aji-145	199	7	the	the	DET
aji-145	199	8	same	same	ADJ
aji-145	199	9	as	as	ADP
aji-145	199	10	the	the	DET
aji-145	199	11	pooled	pool	VERB
aji-145	199	12	global	global	ADJ
aji-145	199	13	prevalence	prevalence	NOUN
aji-145	199	14	of	of	ADP
aji-145	199	15	5.8	5.8	NUM
aji-145	199	16	%	%	NOUN
aji-145	199	17	,	,	PUNCT
aji-145	199	18	less	less	ADJ
aji-145	199	19	than	than	ADP
aji-145	199	20	the	the	DET
aji-145	199	21	prevalence	prevalence	NOUN
aji-145	199	22	of	of	ADP
aji-145	199	23	7.8	7.8	NUM
aji-145	199	24	%	%	NOUN
aji-145	199	25	for	for	ADP
aji-145	199	26	the	the	DET
aji-145	199	27	who	who	PRON
aji-145	199	28	african	african	ADJ
aji-145	199	29	region	region	NOUN
aji-145	199	30	which	which	PRON
aji-145	199	31	bears	bear	VERB
aji-145	199	32	the	the	DET
aji-145	199	33	largest	large	ADJ
aji-145	199	34	burden	burden	NOUN
aji-145	199	35	of	of	ADP
aji-145	199	36	global	global	ADJ
aji-145	199	37	prevalence	prevalence	NOUN
aji-145	199	38	for	for	ADP
aji-145	199	39	hbv	hbv	NOUN
aji-145	199	40	infection	infection	NOUN
aji-145	199	41	[	[	X
aji-145	199	42	16	16	NUM
aji-145	199	43	]	]	PUNCT
aji-145	199	44	.	.	PUNCT
aji-145	200	1	in	in	ADP
aji-145	200	2	the	the	DET
aji-145	200	3	same	same	ADJ
aji-145	200	4	northern	northern	ADJ
aji-145	200	5	nigerian	nigerian	ADJ
aji-145	200	6	study	study	NOUN
aji-145	200	7	,	,	PUNCT
aji-145	200	8	hbv	hbv	NOUN
aji-145	200	9	seroprevalence	seroprevalence	NOUN
aji-145	200	10	of	of	ADP
aji-145	200	11	9.1	9.1	NUM
aji-145	200	12	%	%	NOUN
aji-145	200	13	for	for	ADP
aji-145	200	14	males	male	NOUN
aji-145	200	15	was	be	AUX
aji-145	200	16	higher	high	ADJ
aji-145	200	17	than	than	ADP
aji-145	200	18	that	that	PRON
aji-145	200	19	for	for	ADP
aji-145	200	20	females	female	NOUN
aji-145	200	21	(	(	PUNCT
aji-145	200	22	4.9	4.9	NUM
aji-145	200	23	%	%	NOUN
aji-145	200	24	)	)	PUNCT
aji-145	200	25	,	,	PUNCT
aji-145	200	26	which	which	PRON
aji-145	200	27	was	be	AUX
aji-145	200	28	similar	similar	ADJ
aji-145	200	29	to	to	ADP
aji-145	200	30	the	the	DET
aji-145	200	31	results	result	NOUN
aji-145	200	32	in	in	ADP
aji-145	200	33	this	this	DET
aji-145	200	34	study	study	NOUN
aji-145	200	35	;	;	PUNCT
aji-145	200	36	conversely	conversely	ADV
aji-145	200	37	,	,	PUNCT
aji-145	200	38	the	the	DET
aji-145	200	39	hcv	hcv	NOUN
aji-145	200	40	seroprevalence	seroprevalence	NOUN
aji-145	200	41	for	for	ADP
aji-145	200	42	females	female	NOUN
aji-145	200	43	(	(	PUNCT
aji-145	200	44	6.2	6.2	NUM
aji-145	200	45	%	%	NOUN
aji-145	200	46	)	)	PUNCT
aji-145	200	47	was	be	AUX
aji-145	200	48	higher	high	ADJ
aji-145	200	49	than	than	ADP
aji-145	200	50	that	that	PRON
aji-145	200	51	for	for	ADP
aji-145	200	52	males	male	NOUN
aji-145	200	53	(	(	PUNCT
aji-145	200	54	4.2	4.2	NUM
aji-145	200	55	%	%	NOUN
aji-145	200	56	)	)	PUNCT
aji-145	201	1	[	[	X
aji-145	201	2	14	14	NUM
aji-145	201	3	]	]	PUNCT
aji-145	201	4	.	.	PUNCT
aji-145	202	1	the	the	DET
aji-145	202	2	hbv	hbv	PROPN
aji-145	202	3	ndukwu	ndukwu	PROPN
aji-145	202	4	and	and	CCONJ
aji-145	202	5	chinedu	chinedu	NOUN
aji-145	202	6	-	-	PUNCT
aji-145	202	7	madu	madu	NOUN
aji-145	202	8	;	;	PUNCT
aji-145	202	9	asian	asian	PROPN
aji-145	202	10	j.	j.	PROPN
aji-145	202	11	immunol	immunol	PROPN
aji-145	202	12	.	.	PROPN
aji-145	202	13	,	,	PUNCT
aji-145	202	14	vol	vol	NOUN
aji-145	202	15	.	.	PROPN
aji-145	202	16	7	7	NUM
aji-145	202	17	,	,	PUNCT
aji-145	202	18	no	no	INTJ
aji-145	202	19	.	.	NOUN
aji-145	202	20	1	1	NUM
aji-145	202	21	,	,	PUNCT
aji-145	202	22	pp	pp	ADJ
aji-145	202	23	.	.	PUNCT
aji-145	203	1	209	209	NUM
aji-145	203	2	-	-	SYM
aji-145	203	3	216	216	NUM
aji-145	203	4	,	,	PUNCT
aji-145	203	5	2024	2024	NUM
aji-145	203	6	;	;	PUNCT
aji-145	203	7	article	article	NOUN
aji-145	203	8	no.aji.125624	no.aji.125624	VERB
aji-145	203	9	214	214	NUM
aji-145	203	10	prevalence	prevalence	NOUN
aji-145	203	11	for	for	ADP
aji-145	203	12	the	the	DET
aji-145	203	13	young	young	ADJ
aji-145	203	14	adults	adult	NOUN
aji-145	203	15	age	age	NOUN
aji-145	203	16	group	group	NOUN
aji-145	203	17	(	(	PUNCT
aji-145	203	18	10.2	10.2	NUM
aji-145	203	19	%	%	NOUN
aji-145	203	20	)	)	PUNCT
aji-145	203	21	,	,	PUNCT
aji-145	203	22	was	be	AUX
aji-145	203	23	the	the	DET
aji-145	203	24	highest	high	ADJ
aji-145	203	25	among	among	ADP
aji-145	203	26	age	age	NOUN
aji-145	203	27	groups	group	NOUN
aji-145	203	28	,	,	PUNCT
aji-145	203	29	while	while	SCONJ
aji-145	203	30	the	the	DET
aji-145	203	31	highest	high	ADJ
aji-145	203	32	prevalence	prevalence	NOUN
aji-145	203	33	for	for	ADP
aji-145	203	34	hcv	hcv	NOUN
aji-145	203	35	was	be	AUX
aji-145	203	36	6.2	6.2	NUM
aji-145	203	37	%	%	NOUN
aji-145	203	38	observed	observe	VERB
aji-145	203	39	with	with	ADP
aji-145	203	40	the	the	DET
aji-145	203	41	middle	middle	ADJ
aji-145	203	42	-	-	PUNCT
aji-145	203	43	aged	aged	ADJ
aji-145	203	44	group	group	NOUN
aji-145	203	45	[	[	X
aji-145	203	46	14	14	NUM
aji-145	203	47	]	]	PUNCT
aji-145	203	48	.	.	PUNCT
aji-145	204	1	these	these	DET
aji-145	204	2	results	result	NOUN
aji-145	204	3	for	for	ADP
aji-145	204	4	hbv	hbv	NOUN
aji-145	204	5	had	have	VERB
aji-145	204	6	close	close	ADJ
aji-145	204	7	semblance	semblance	NOUN
aji-145	204	8	with	with	ADP
aji-145	204	9	the	the	DET
aji-145	204	10	findings	finding	NOUN
aji-145	204	11	of	of	ADP
aji-145	204	12	this	this	DET
aji-145	204	13	study	study	NOUN
aji-145	204	14	where	where	SCONJ
aji-145	204	15	the	the	DET
aji-145	204	16	males	male	NOUN
aji-145	204	17	had	have	VERB
aji-145	204	18	a	a	DET
aji-145	204	19	higher	high	ADJ
aji-145	204	20	prevalence	prevalence	NOUN
aji-145	204	21	than	than	ADP
aji-145	204	22	females	female	NOUN
aji-145	204	23	,	,	PUNCT
aji-145	204	24	and	and	CCONJ
aji-145	204	25	the	the	DET
aji-145	204	26	highest	high	ADJ
aji-145	204	27	prevalence	prevalence	NOUN
aji-145	204	28	was	be	AUX
aji-145	204	29	found	find	VERB
aji-145	204	30	the	the	DET
aji-145	204	31	30	30	NUM
aji-145	204	32	-	-	SYM
aji-145	204	33	40	40	NUM
aji-145	204	34	age	age	NOUN
aji-145	204	35	group	group	NOUN
aji-145	204	36	.	.	PUNCT
aji-145	205	1	the	the	DET
aji-145	205	2	results	result	NOUN
aji-145	205	3	hcv	hcv	PROPN
aji-145	205	4	were	be	AUX
aji-145	205	5	however	however	ADV
aji-145	205	6	different	different	ADJ
aji-145	205	7	from	from	ADP
aji-145	205	8	the	the	DET
aji-145	205	9	findings	finding	NOUN
aji-145	205	10	here	here	ADV
aji-145	205	11	,	,	PUNCT
aji-145	205	12	the	the	DET
aji-145	205	13	only	only	ADJ
aji-145	205	14	positive	positive	ADJ
aji-145	205	15	hcv	hcv	NOUN
aji-145	205	16	result	result	NOUN
aji-145	205	17	was	be	AUX
aji-145	205	18	from	from	ADP
aji-145	205	19	a	a	DET
aji-145	205	20	male	male	NOUN
aji-145	205	21	within	within	ADP
aji-145	205	22	the	the	DET
aji-145	205	23	30–40	30–40	NUM
aji-145	205	24	-	-	PUNCT
aji-145	205	25	year	year	NOUN
aji-145	205	26	group	group	NOUN
aji-145	205	27	.	.	PUNCT
aji-145	206	1	the	the	DET
aji-145	206	2	incidence	incidence	NOUN
aji-145	206	3	of	of	ADP
aji-145	206	4	hcv	hcv	ADJ
aji-145	206	5	infection	infection	NOUN
aji-145	206	6	is	be	AUX
aji-145	206	7	reported	report	VERB
aji-145	206	8	by	by	ADP
aji-145	206	9	several	several	ADJ
aji-145	206	10	studies	study	NOUN
aji-145	206	11	to	to	PART
aji-145	206	12	be	be	AUX
aji-145	206	13	driven	drive	VERB
aji-145	206	14	by	by	ADP
aji-145	206	15	intravenous	intravenous	ADJ
aji-145	206	16	drug	drug	NOUN
aji-145	206	17	use	use	NOUN
aji-145	206	18	,	,	PUNCT
aji-145	206	19	men	man	NOUN
aji-145	206	20	having	have	VERB
aji-145	206	21	sex	sex	NOUN
aji-145	206	22	with	with	ADP
aji-145	206	23	men	man	NOUN
aji-145	206	24	among	among	ADP
aji-145	206	25	other	other	ADJ
aji-145	206	26	factors	factor	NOUN
aji-145	206	27	with	with	ADP
aji-145	206	28	the	the	DET
aji-145	206	29	prevalence	prevalence	NOUN
aji-145	206	30	found	find	VERB
aji-145	206	31	in	in	ADP
aji-145	206	32	eastern	eastern	PROPN
aji-145	206	33	mediterranean	mediterranean	PROPN
aji-145	206	34	region	region	PROPN
aji-145	206	35	,	,	PUNCT
aji-145	206	36	south	south	PROPN
aji-145	206	37	-	-	PUNCT
aji-145	206	38	east	east	PROPN
aji-145	206	39	asia	asia	PROPN
aji-145	206	40	region	region	PROPN
aji-145	206	41	and	and	CCONJ
aji-145	206	42	european	european	ADJ
aji-145	206	43	region	region	NOUN
aji-145	207	1	[	[	X
aji-145	207	2	5,17,18,19,20	5,17,18,19,20	NUM
aji-145	207	3	]	]	PUNCT
aji-145	207	4	.	.	PUNCT
aji-145	208	1	these	these	PRON
aji-145	208	2	may	may	AUX
aji-145	208	3	therefore	therefore	ADV
aji-145	208	4	not	not	PART
aji-145	208	5	the	the	DET
aji-145	208	6	critical	critical	ADJ
aji-145	208	7	factors	factor	NOUN
aji-145	208	8	in	in	ADP
aji-145	208	9	port	port	NOUN
aji-145	208	10	harcourt	harcourt	PROPN
aji-145	208	11	and	and	CCONJ
aji-145	208	12	the	the	DET
aji-145	208	13	country	country	NOUN
aji-145	208	14	as	as	SCONJ
aji-145	208	15	shown	show	VERB
aji-145	208	16	with	with	ADP
aji-145	208	17	low	low	ADJ
aji-145	208	18	prevalence	prevalence	NOUN
aji-145	208	19	rates	rate	NOUN
aji-145	208	20	for	for	ADP
aji-145	208	21	hcv	hcv	NOUN
aji-145	208	22	infection	infection	NOUN
aji-145	208	23	.	.	PUNCT
aji-145	209	1	the	the	DET
aji-145	209	2	limitations	limitation	NOUN
aji-145	209	3	of	of	ADP
aji-145	209	4	the	the	DET
aji-145	209	5	study	study	NOUN
aji-145	209	6	like	like	ADP
aji-145	209	7	in	in	ADP
aji-145	209	8	retrospective	retrospective	ADJ
aji-145	209	9	studies	study	NOUN
aji-145	209	10	,	,	PUNCT
aji-145	209	11	is	be	AUX
aji-145	209	12	based	base	VERB
aji-145	209	13	on	on	ADP
aji-145	209	14	secondary	secondary	ADJ
aji-145	209	15	records	record	NOUN
aji-145	209	16	.	.	PUNCT
aji-145	210	1	the	the	DET
aji-145	210	2	samples	sample	NOUN
aji-145	210	3	were	be	AUX
aji-145	210	4	collected	collect	VERB
aji-145	210	5	and	and	CCONJ
aji-145	210	6	analyzed	analyze	VERB
aji-145	210	7	without	without	ADP
aji-145	210	8	consideration	consideration	NOUN
aji-145	210	9	for	for	ADP
aji-145	210	10	the	the	DET
aji-145	210	11	study	study	NOUN
aji-145	210	12	.	.	PUNCT
aji-145	211	1	the	the	DET
aji-145	211	2	sociodemographic	sociodemographic	ADJ
aji-145	211	3	data	datum	NOUN
aji-145	211	4	are	be	AUX
aji-145	211	5	limited	limit	VERB
aji-145	211	6	to	to	ADP
aji-145	211	7	those	those	PRON
aji-145	211	8	required	require	VERB
aji-145	211	9	for	for	ADP
aji-145	211	10	in	in	ADP
aji-145	211	11	the	the	DET
aji-145	211	12	laboratory	laboratory	NOUN
aji-145	211	13	records	record	NOUN
aji-145	211	14	,	,	PUNCT
aji-145	211	15	and	and	CCONJ
aji-145	211	16	there	there	PRON
aji-145	211	17	is	be	VERB
aji-145	211	18	no	no	DET
aji-145	211	19	personal	personal	ADJ
aji-145	211	20	interaction	interaction	NOUN
aji-145	211	21	with	with	ADP
aji-145	211	22	the	the	DET
aji-145	211	23	participants	participant	NOUN
aji-145	211	24	.	.	PUNCT
aji-145	212	1	some	some	DET
aji-145	212	2	information	information	NOUN
aji-145	212	3	that	that	PRON
aji-145	212	4	may	may	AUX
aji-145	212	5	enrich	enrich	VERB
aji-145	212	6	the	the	DET
aji-145	212	7	study	study	NOUN
aji-145	212	8	are	be	AUX
aji-145	212	9	therefore	therefore	ADV
aji-145	212	10	not	not	PART
aji-145	212	11	captured	capture	VERB
aji-145	212	12	.	.	PUNCT
aji-145	213	1	tests	test	NOUN
aji-145	213	2	carried	carry	VERB
aji-145	213	3	out	out	ADP
aji-145	213	4	are	be	AUX
aji-145	213	5	limited	limit	VERB
aji-145	213	6	to	to	ADP
aji-145	213	7	hbsag	hbsag	NOUN
aji-145	213	8	and	and	CCONJ
aji-145	213	9	anti	anti	ADJ
aji-145	213	10	-	-	ADJ
aji-145	213	11	hcv	hcv	ADJ
aji-145	213	12	;	;	PUNCT
aji-145	213	13	without	without	ADP
aji-145	213	14	additional	additional	ADJ
aji-145	213	15	analysis	analysis	NOUN
aji-145	213	16	like	like	ADP
aji-145	213	17	elisa	elisa	NOUN
aji-145	213	18	and	and	CCONJ
aji-145	213	19	the	the	DET
aji-145	213	20	molecular	molecular	ADJ
aji-145	213	21	analysis	analysis	NOUN
aji-145	213	22	.	.	PUNCT
aji-145	214	1	future	future	ADJ
aji-145	214	2	studies	study	NOUN
aji-145	214	3	may	may	AUX
aji-145	214	4	be	be	AUX
aji-145	214	5	designed	design	VERB
aji-145	214	6	to	to	PART
aji-145	214	7	overcome	overcome	VERB
aji-145	214	8	these	these	DET
aji-145	214	9	limitations	limitation	NOUN
aji-145	214	10	.	.	PUNCT
aji-145	215	1	5	5	X
aji-145	215	2	.	.	X
aji-145	215	3	conclusion	conclusion	VERB
aji-145	215	4	the	the	DET
aji-145	215	5	prevalence	prevalence	NOUN
aji-145	215	6	of	of	ADP
aji-145	215	7	5.8	5.8	NUM
aji-145	215	8	%	%	NOUN
aji-145	215	9	for	for	ADP
aji-145	215	10	hbv	hbv	NOUN
aji-145	215	11	in	in	ADP
aji-145	215	12	this	this	DET
aji-145	215	13	study	study	NOUN
aji-145	215	14	,	,	PUNCT
aji-145	215	15	represents	represent	VERB
aji-145	215	16	an	an	DET
aji-145	215	17	intermediate	intermediate	ADJ
aji-145	215	18	level	level	NOUN
aji-145	215	19	of	of	ADP
aji-145	215	20	transmission	transmission	NOUN
aji-145	215	21	(	(	PUNCT
aji-145	215	22	2–8	2–8	NUM
aji-145	215	23	%	%	NOUN
aji-145	215	24	)	)	PUNCT
aji-145	215	25	on	on	ADP
aji-145	215	26	the	the	PRON
aji-145	215	27	who	who	PRON
aji-145	215	28	criteria	criterion	NOUN
aji-145	215	29	of	of	ADP
aji-145	215	30	endemicity	endemicity	NOUN
aji-145	215	31	,	,	PUNCT
aji-145	215	32	while	while	SCONJ
aji-145	215	33	the	the	DET
aji-145	215	34	0.5	0.5	NUM
aji-145	215	35	%	%	NOUN
aji-145	215	36	for	for	ADP
aji-145	215	37	hcv	hcv	PROPN
aji-145	215	38	is	be	AUX
aji-145	215	39	a	a	DET
aji-145	215	40	low	low	ADJ
aji-145	215	41	level	level	NOUN
aji-145	215	42	of	of	ADP
aji-145	215	43	transmission	transmission	NOUN
aji-145	215	44	.	.	PUNCT
aji-145	216	1	the	the	DET
aji-145	216	2	morbidity	morbidity	NOUN
aji-145	216	3	and	and	CCONJ
aji-145	216	4	mortality	mortality	NOUN
aji-145	216	5	associated	associate	VERB
aji-145	216	6	the	the	DET
aji-145	216	7	viral	viral	ADJ
aji-145	216	8	hepatitis	hepatitis	NOUN
aji-145	216	9	can	can	AUX
aji-145	216	10	be	be	AUX
aji-145	216	11	avoided	avoid	VERB
aji-145	216	12	if	if	SCONJ
aji-145	216	13	efforts	effort	NOUN
aji-145	216	14	are	be	AUX
aji-145	216	15	made	make	VERB
aji-145	216	16	to	to	PART
aji-145	216	17	curtail	curtail	VERB
aji-145	216	18	the	the	DET
aji-145	216	19	viral	viral	ADJ
aji-145	216	20	infections	infection	NOUN
aji-145	216	21	.	.	PUNCT
aji-145	217	1	this	this	PRON
aji-145	217	2	can	can	AUX
aji-145	217	3	be	be	AUX
aji-145	217	4	done	do	VERB
aji-145	217	5	by	by	ADP
aji-145	217	6	creating	create	VERB
aji-145	217	7	greater	great	ADJ
aji-145	217	8	awareness	awareness	NOUN
aji-145	217	9	among	among	ADP
aji-145	217	10	the	the	DET
aji-145	217	11	all	all	DET
aji-145	217	12	strata	strata	NOUN
aji-145	217	13	of	of	ADP
aji-145	217	14	the	the	DET
aji-145	217	15	populations	population	NOUN
aji-145	217	16	on	on	ADP
aji-145	217	17	preventive	preventive	ADJ
aji-145	217	18	measures	measure	NOUN
aji-145	217	19	.	.	PUNCT
aji-145	218	1	vaccination	vaccination	NOUN
aji-145	218	2	against	against	ADP
aji-145	218	3	hbv	hbv	NOUN
aji-145	218	4	is	be	AUX
aji-145	218	5	an	an	DET
aji-145	218	6	important	important	ADJ
aji-145	218	7	tool	tool	NOUN
aji-145	218	8	in	in	ADP
aji-145	218	9	the	the	DET
aji-145	218	10	fight	fight	NOUN
aji-145	218	11	against	against	ADP
aji-145	218	12	the	the	DET
aji-145	218	13	menace	menace	NOUN
aji-145	218	14	of	of	ADP
aji-145	218	15	the	the	DET
aji-145	218	16	virus	virus	NOUN
aji-145	218	17	and	and	CCONJ
aji-145	218	18	should	should	AUX
aji-145	218	19	be	be	AUX
aji-145	218	20	made	make	VERB
aji-145	218	21	available	available	ADJ
aji-145	218	22	to	to	ADP
aji-145	218	23	everyone	everyone	PRON
aji-145	218	24	.	.	PUNCT
aji-145	219	1	young	young	ADJ
aji-145	219	2	people	people	NOUN
aji-145	219	3	forty	forty	NUM
aji-145	219	4	years	year	NOUN
aji-145	219	5	and	and	CCONJ
aji-145	219	6	below	below	ADV
aji-145	219	7	are	be	AUX
aji-145	219	8	at	at	ADP
aji-145	219	9	the	the	DET
aji-145	219	10	greatest	great	ADJ
aji-145	219	11	risk	risk	NOUN
aji-145	219	12	of	of	ADP
aji-145	219	13	being	be	AUX
aji-145	219	14	infected	infect	VERB
aji-145	219	15	with	with	ADP
aji-145	219	16	viral	viral	ADJ
aji-145	219	17	hepatitis	hepatitis	NOUN
aji-145	219	18	.	.	PUNCT
aji-145	220	1	it	it	PRON
aji-145	220	2	is	be	AUX
aji-145	220	3	therefore	therefore	ADV
aji-145	220	4	advocated	advocate	VERB
aji-145	220	5	that	that	SCONJ
aji-145	220	6	social	social	ADJ
aji-145	220	7	media	medium	NOUN
aji-145	220	8	and	and	CCONJ
aji-145	220	9	other	other	ADJ
aji-145	220	10	modern	modern	ADJ
aji-145	220	11	means	mean	NOUN
aji-145	220	12	of	of	ADP
aji-145	220	13	communication	communication	NOUN
aji-145	220	14	should	should	AUX
aji-145	220	15	be	be	AUX
aji-145	220	16	utilized	utilize	VERB
aji-145	220	17	in	in	ADP
aji-145	220	18	passing	pass	VERB
aji-145	220	19	the	the	DET
aji-145	220	20	message	message	NOUN
aji-145	220	21	on	on	ADP
aji-145	220	22	prevention	prevention	NOUN
aji-145	220	23	and	and	CCONJ
aji-145	220	24	control	control	NOUN
aji-145	220	25	of	of	ADP
aji-145	220	26	the	the	DET
aji-145	220	27	infections	infection	NOUN
aji-145	220	28	.	.	PUNCT
aji-145	221	1	consent	consent	NOUN
aji-145	221	2	it	it	PRON
aji-145	221	3	is	be	AUX
aji-145	221	4	not	not	PART
aji-145	221	5	applicable	applicable	ADJ
aji-145	221	6	.	.	PUNCT
aji-145	222	1	ethical	ethical	ADJ
aji-145	222	2	approval	approval	NOUN
aji-145	222	3	the	the	DET
aji-145	222	4	study	study	NOUN
aji-145	222	5	was	be	AUX
aji-145	222	6	reviewed	review	VERB
aji-145	222	7	and	and	CCONJ
aji-145	222	8	approved	approve	VERB
aji-145	222	9	by	by	ADP
aji-145	222	10	ethical	ethical	ADJ
aji-145	222	11	review	review	PROPN
aji-145	222	12	committee	committee	NOUN
aji-145	222	13	of	of	ADP
aji-145	222	14	the	the	DET
aji-145	222	15	faculty	faculty	NOUN
aji-145	222	16	of	of	ADP
aji-145	222	17	medical	medical	ADJ
aji-145	222	18	laboratory	laboratory	NOUN
aji-145	222	19	science	science	NOUN
aji-145	222	20	,	,	PUNCT
aji-145	222	21	federal	federal	ADJ
aji-145	222	22	university	university	NOUN
aji-145	222	23	otuoke	otuoke	NOUN
aji-145	222	24	,	,	PUNCT
aji-145	222	25	nigeria	nigeria	PROPN
aji-145	222	26	.	.	PUNCT
aji-145	223	1	relevant	relevant	ADJ
aji-145	223	2	approvals	approval	NOUN
aji-145	223	3	were	be	AUX
aji-145	223	4	sought	seek	VERB
aji-145	223	5	and	and	CCONJ
aji-145	223	6	obtained	obtain	VERB
aji-145	223	7	from	from	ADP
aji-145	223	8	the	the	DET
aji-145	223	9	management	management	NOUN
aji-145	223	10	of	of	ADP
aji-145	223	11	diagnostix	diagnostix	NOUN
aji-145	223	12	and	and	CCONJ
aji-145	223	13	scientific	scientific	ADJ
aji-145	223	14	laboratories	laboratory	NOUN
aji-145	223	15	.	.	PUNCT
aji-145	224	1	disclaimer	disclaimer	NOUN
aji-145	224	2	(	(	PUNCT
aji-145	224	3	artificial	artificial	ADJ
aji-145	224	4	intelligence	intelligence	NOUN
aji-145	224	5	)	)	PUNCT
aji-145	224	6	author(s	author(s	NOUN
aji-145	224	7	)	)	PUNCT
aji-145	224	8	hereby	hereby	ADV
aji-145	224	9	declare	declare	VERB
aji-145	224	10	that	that	SCONJ
aji-145	224	11	no	no	DET
aji-145	224	12	generative	generative	NOUN
aji-145	224	13	ai	ai	VERB
aji-145	224	14	technologies	technology	NOUN
aji-145	224	15	such	such	ADJ
aji-145	224	16	as	as	ADP
aji-145	224	17	large	large	ADJ
aji-145	224	18	language	language	NOUN
aji-145	224	19	models	model	NOUN
aji-145	224	20	(	(	PUNCT
aji-145	224	21	chatgpt	chatgpt	NOUN
aji-145	224	22	,	,	PUNCT
aji-145	224	23	copilot	copilot	NOUN
aji-145	224	24	,	,	PUNCT
aji-145	224	25	etc	etc	X
aji-145	224	26	.	.	X
aji-145	224	27	)	)	PUNCT
aji-145	224	28	and	and	CCONJ
aji-145	224	29	text	text	NOUN
aji-145	224	30	-	-	PUNCT
aji-145	224	31	to	to	ADP
aji-145	224	32	-	-	PUNCT
aji-145	224	33	image	image	NOUN
aji-145	224	34	generators	generator	NOUN
aji-145	224	35	have	have	AUX
aji-145	224	36	been	be	AUX
aji-145	224	37	used	use	VERB
aji-145	224	38	during	during	ADP
aji-145	224	39	the	the	DET
aji-145	224	40	writing	writing	NOUN
aji-145	224	41	or	or	CCONJ
aji-145	224	42	editing	editing	NOUN
aji-145	224	43	of	of	ADP
aji-145	224	44	this	this	DET
aji-145	224	45	manuscript	manuscript	NOUN
aji-145	224	46	.	.	PUNCT
aji-145	225	1	competing	compete	VERB
aji-145	225	2	interests	interest	NOUN
aji-145	225	3	authors	author	NOUN
aji-145	225	4	have	have	AUX
aji-145	225	5	declared	declare	VERB
aji-145	225	6	that	that	SCONJ
aji-145	225	7	no	no	DET
aji-145	225	8	competing	compete	VERB
aji-145	225	9	interests	interest	NOUN
aji-145	225	10	exist	exist	VERB
aji-145	225	11	.	.	PUNCT
aji-145	226	1	references	reference	NOUN
aji-145	226	2	1	1	NUM
aji-145	226	3	.	.	PUNCT
aji-145	227	1	mehta	mehta	PROPN
aji-145	227	2	p	p	PROPN
aji-145	227	3	,	,	PUNCT
aji-145	227	4	grant	grant	NOUN
aji-145	227	5	lm	lm	PROPN
aji-145	227	6	,	,	PUNCT
aji-145	227	7	reddivari	reddivari	PROPN
aji-145	227	8	akr	akr	PROPN
aji-145	227	9	.	.	PUNCT
aji-145	228	1	viral	viral	ADJ
aji-145	228	2	hepatitis	hepatitis	NOUN
aji-145	228	3	.	.	PUNCT
aji-145	229	1	[	[	X
aji-145	229	2	updated	update	VERB
aji-145	229	3	2024	2024	NUM
aji-145	229	4	mar	mar	PROPN
aji-145	229	5	10	10	NUM
aji-145	229	6	]	]	PUNCT
aji-145	229	7	.	.	PUNCT
aji-145	230	1	in	in	ADP
aji-145	230	2	:	:	PUNCT
aji-145	230	3	statpearls	statpearl	NOUN
aji-145	231	1	[	[	X
aji-145	231	2	internet	internet	NOUN
aji-145	231	3	]	]	PUNCT
aji-145	231	4	.	.	PUNCT
aji-145	232	1	treasure	treasure	NOUN
aji-145	232	2	island	island	NOUN
aji-145	232	3	(	(	PUNCT
aji-145	232	4	fl	fl	PROPN
aji-145	232	5	):	):	PUNCT
aji-145	232	6	statpearls	statpearls	PROPN
aji-145	232	7	publishing	publishing	NOUN
aji-145	232	8	;	;	PUNCT
aji-145	232	9	2024	2024	NUM
aji-145	232	10	jan-	jan-	NOUN
aji-145	232	11	.	.	PUNCT
aji-145	233	1	available	available	ADJ
aji-145	233	2	:	:	PUNCT
aji-145	233	3	https://www.ncbi.nlm.nih.gov	https://www.ncbi.nlm.nih.gov	ADJ
aji-145	233	4	/	/	SYM
aji-145	233	5	boo	boo	NOUN
aji-145	233	6	ks	ks	PROPN
aji-145	233	7	/	/	SYM
aji-145	233	8	nbk554549/	nbk554549/	PROPN
aji-145	233	9	2	2	NUM
aji-145	233	10	.	.	PUNCT
aji-145	234	1	who	who	PRON
aji-145	234	2	.	.	PUNCT
aji-145	235	1	hepatitis	hepatitis	NOUN
aji-145	235	2	;	;	PUNCT
aji-145	235	3	2024	2024	NUM
aji-145	235	4	available	available	ADJ
aji-145	235	5	:	:	PUNCT
aji-145	235	6	https://www.who.int	https://www.who.int	NOUN
aji-145	235	7	/	/	SYM
aji-145	235	8	healthtopics/	healthtopics/	NUM
aji-145	235	9	hepatitis?gad_source=1&gclid	hepatitis?gad_source=1&gclid	NOUN
aji-145	235	10	=	=	NOUN
aji-145	235	11	cj0kcqjw3	cj0kcqjw3	ADJ
aji-145	235	12	vo3bhcqarisaewblcdhml9vf_y5yltn_3tdqdovu0krkpj98m5tygsguaoao3	vo3bhcqarisaewblcdhml9vf_y5yltn_3tdqdovu0krkpj98m5tygsguaoao3	NOUN
aji-145	235	13	icqgbbziaavtaealw_wcb#tab	icqgbbziaavtaealw_wcb#tab	PROPN
aji-145	235	14	=	=	PROPN
aji-145	235	15	tab_1	tab_1	PROPN
aji-145	235	16	3	3	NUM
aji-145	235	17	.	.	PUNCT
aji-145	235	18	brakenhoff	brakenhoff	PROPN
aji-145	235	19	sm	sm	PROPN
aji-145	235	20	,	,	PUNCT
aji-145	235	21	de	de	X
aji-145	235	22	man	man	PROPN
aji-145	235	23	ra	ra	PROPN
aji-145	235	24	,	,	PUNCT
aji-145	235	25	de	de	PROPN
aji-145	235	26	knegt	knegt	PROPN
aji-145	235	27	rj	rj	PROPN
aji-145	235	28	,	,	PUNCT
aji-145	235	29	bindels	bindels	PROPN
aji-145	235	30	pje	pje	PROPN
aji-145	235	31	,	,	PUNCT
aji-145	235	32	de	de	X
aji-145	235	33	schepper	schepper	X
aji-145	235	34	eit	eit	PROPN
aji-145	235	35	.	.	PUNCT
aji-145	235	36	epidemiology	epidemiology	NOUN
aji-145	235	37	and	and	CCONJ
aji-145	235	38	management	management	NOUN
aji-145	235	39	of	of	ADP
aji-145	235	40	hepatitis	hepatitis	PROPN
aji-145	235	41	b	b	PROPN
aji-145	235	42	and	and	CCONJ
aji-145	235	43	c	c	PROPN
aji-145	235	44	in	in	ADP
aji-145	235	45	primary	primary	ADJ
aji-145	235	46	care	care	NOUN
aji-145	235	47	in	in	ADP
aji-145	235	48	the	the	DET
aji-145	235	49	netherlands	netherlands	PROPN
aji-145	235	50	:	:	PUNCT
aji-145	235	51	data	datum	NOUN
aji-145	235	52	from	from	ADP
aji-145	235	53	the	the	DET
aji-145	235	54	rijnmond	rijnmond	NOUN
aji-145	235	55	primary	primary	ADJ
aji-145	235	56	care	care	NOUN
aji-145	235	57	database	database	NOUN
aji-145	235	58	.	.	PUNCT
aji-145	236	1	fam	fam	PROPN
aji-145	236	2	pract	pract	PROPN
aji-145	236	3	.	.	PUNCT
aji-145	237	1	2023	2023	NUM
aji-145	237	2	feb	feb	PROPN
aji-145	237	3	9;40(1):83	9;40(1):83	PROPN
aji-145	237	4	-	-	PUNCT
aji-145	237	5	90	90	NUM
aji-145	237	6	.	.	PUNCT
aji-145	237	7	doi	doi	NOUN
aji-145	237	8	:	:	PUNCT
aji-145	237	9	10.1093	10.1093	NUM
aji-145	237	10	/	/	SYM
aji-145	237	11	fampra	fampra	ADJ
aji-145	237	12	/	/	SYM
aji-145	237	13	cmac070	cmac070	PROPN
aji-145	237	14	.	.	PUNCT
aji-145	238	1	pmid	pmid	NOUN
aji-145	238	2	:	:	PUNCT
aji-145	238	3	35869658	35869658	NUM
aji-145	238	4	;	;	PUNCT
aji-145	238	5	pmcid	pmcid	NOUN
aji-145	238	6	:	:	PUNCT
aji-145	238	7	pmc9909667	pmc9909667	ADJ
aji-145	238	8	.	.	PUNCT
aji-145	239	1	4	4	X
aji-145	239	2	.	.	X
aji-145	239	3	world	world	PROPN
aji-145	239	4	health	health	PROPN
aji-145	239	5	organization	organization	NOUN
aji-145	239	6	.	.	PUNCT
aji-145	240	1	hepatitis	hepatitis	PROPN
aji-145	240	2	b	b	PROPN
aji-145	240	3	factsheet	factsheet	NOUN
aji-145	240	4	;	;	PUNCT
aji-145	240	5	2021	2021	NUM
aji-145	240	6	.	.	PUNCT
aji-145	241	1	[	[	X
aji-145	241	2	updated	update	VERB
aji-145	241	3	2021	2021	NUM
aji-145	241	4	july	july	PROPN
aji-145	241	5	27	27	NUM
aji-145	241	6	,	,	PUNCT
aji-145	241	7	accessed	access	VERB
aji-145	241	8	2022	2022	NUM
aji-145	241	9	july	july	PROPN
aji-145	241	10	24	24	NUM
aji-145	241	11	]	]	PUNCT
aji-145	241	12	.	.	PUNCT
aji-145	242	1	available	available	ADJ
aji-145	242	2	:	:	PUNCT
aji-145	242	3	https://www.who.int	https://www.who.int	NOUN
aji-145	242	4	/	/	SYM
aji-145	242	5	newsroom	newsroom	NOUN
aji-145	242	6	/	/	SYM
aji-145	242	7	fact	fact	NOUN
aji-145	242	8	-	-	PUNCT
aji-145	242	9	sheets	sheet	NOUN
aji-145	242	10	/	/	SYM
aji-145	242	11	detail	detail	NOUN
aji-145	242	12	/	/	SYM
aji-145	242	13	hepatitis	hepatitis	NOUN
aji-145	242	14	-	-	PUNCT
aji-145	242	15	b.	b.	PROPN
aji-145	243	1	[	[	X
aji-145	243	2	google	google	NOUN
aji-145	243	3	scholar	scholar	NOUN
aji-145	243	4	]	]	PUNCT
aji-145	244	1	[	[	X
aji-145	244	2	ref	ref	NOUN
aji-145	244	3	list	list	NOUN
aji-145	244	4	]	]	PUNCT
aji-145	244	5	https://www.ncbi.nlm.nih.gov/books/nbk554549/	https://www.ncbi.nlm.nih.gov/books/nbk554549/	ADV
aji-145	244	6	https://www.ncbi.nlm.nih.gov/books/nbk554549/	https://www.ncbi.nlm.nih.gov/books/nbk554549/	ADJ
aji-145	244	7	https://www.who.int/healthtopics/hepatitis?gad_source=1&gclid=cj0kcqjw3vo3bhcqarisaewblcdhml9vf_y5y-ltn_3tdqdovu0krkpj98m5tygsguaoao3icqgbbziaavtaealw_wcb#tab=tab_1	https://www.who.int/healthtopics/hepatitis?gad_source=1&gclid=cj0kcqjw3vo3bhcqarisaewblcdhml9vf_y5y-ltn_3tdqdovu0krkpj98m5tygsguaoao3icqgbbziaavtaealw_wcb#tab=tab_1	X
aji-145	244	8	https://www.who.int/healthtopics/hepatitis?gad_source=1&gclid=cj0kcqjw3vo3bhcqarisaewblcdhml9vf_y5y-ltn_3tdqdovu0krkpj98m5tygsguaoao3icqgbbziaavtaealw_wcb#tab=tab_1	https://www.who.int/healthtopics/hepatitis?gad_source=1&gclid=cj0kcqjw3vo3bhcqarisaewblcdhml9vf_y5y-ltn_3tdqdovu0krkpj98m5tygsguaoao3icqgbbziaavtaealw_wcb#tab=tab_1	X
aji-145	244	9	https://www.who.int/healthtopics/hepatitis?gad_source=1&gclid=cj0kcqjw3vo3bhcqarisaewblcdhml9vf_y5y-ltn_3tdqdovu0krkpj98m5tygsguaoao3icqgbbziaavtaealw_wcb#tab=tab_1	https://www.who.int/healthtopics/hepatitis?gad_source=1&gclid=cj0kcqjw3vo3bhcqarisaewblcdhml9vf_y5y-ltn_3tdqdovu0krkpj98m5tygsguaoao3icqgbbziaavtaealw_wcb#tab=tab_1	X
aji-145	244	10	https://www.who.int/healthtopics/hepatitis?gad_source=1&gclid=cj0kcqjw3vo3bhcqarisaewblcdhml9vf_y5y-ltn_3tdqdovu0krkpj98m5tygsguaoao3icqgbbziaavtaealw_wcb#tab=tab_1	https://www.who.int/healthtopics/hepatitis?gad_source=1&gclid=cj0kcqjw3vo3bhcqarisaewblcdhml9vf_y5y-ltn_3tdqdovu0krkpj98m5tygsguaoao3icqgbbziaavtaealw_wcb#tab=tab_1	X
aji-145	244	11	https://www.who.int/healthtopics/hepatitis?gad_source=1&gclid=cj0kcqjw3vo3bhcqarisaewblcdhml9vf_y5y-ltn_3tdqdovu0krkpj98m5tygsguaoao3icqgbbziaavtaealw_wcb#tab=tab_1	https://www.who.int/healthtopics/hepatitis?gad_source=1&gclid=cj0kcqjw3vo3bhcqarisaewblcdhml9vf_y5y-ltn_3tdqdovu0krkpj98m5tygsguaoao3icqgbbziaavtaealw_wcb#tab=tab_1	X
aji-145	244	12	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b	X
aji-145	244	13	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b	PROPN
aji-145	244	14	https://scholar.google.com/scholar_lookup?title=hepatitis+b+factsheet&publication_year=2021	https://scholar.google.com/scholar_lookup?title=hepatitis+b+factsheet&publication_year=2021	PROPN
aji-145	244	15	&	&	CCONJ
aji-145	244	16	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc9909667/#cit0002	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc9909667/#cit0002	PROPN
aji-145	244	17	ndukwu	ndukwu	PROPN
aji-145	244	18	and	and	CCONJ
aji-145	244	19	chinedu	chinedu	NOUN
aji-145	244	20	-	-	PUNCT
aji-145	244	21	madu	madu	NOUN
aji-145	244	22	;	;	PUNCT
aji-145	244	23	asian	asian	PROPN
aji-145	244	24	j.	j.	PROPN
aji-145	244	25	immunol	immunol	PROPN
aji-145	244	26	.	.	PROPN
aji-145	244	27	,	,	PUNCT
aji-145	244	28	vol	vol	NOUN
aji-145	244	29	.	.	PROPN
aji-145	244	30	7	7	NUM
aji-145	244	31	,	,	PUNCT
aji-145	244	32	no	no	INTJ
aji-145	244	33	.	.	NOUN
aji-145	244	34	1	1	NUM
aji-145	244	35	,	,	PUNCT
aji-145	244	36	pp	pp	ADJ
aji-145	244	37	.	.	PUNCT
aji-145	245	1	209	209	NUM
aji-145	245	2	-	-	SYM
aji-145	245	3	216	216	NUM
aji-145	245	4	,	,	PUNCT
aji-145	245	5	2024	2024	NUM
aji-145	245	6	;	;	PUNCT
aji-145	245	7	article	article	NOUN
aji-145	245	8	no.aji.125624	no.aji.125624	VERB
aji-145	245	9	215	215	NUM
aji-145	245	10	5	5	NUM
aji-145	245	11	.	.	PUNCT
aji-145	245	12	world	world	PROPN
aji-145	245	13	health	health	PROPN
aji-145	245	14	organization	organization	NOUN
aji-145	245	15	.	.	PUNCT
aji-145	246	1	hepatitis	hepatitis	PROPN
aji-145	246	2	c	c	PROPN
aji-145	246	3	factsheet	factsheet	NOUN
aji-145	246	4	;	;	PUNCT
aji-145	246	5	2021	2021	NUM
aji-145	246	6	.	.	PUNCT
aji-145	247	1	[	[	X
aji-145	247	2	updated	update	VERB
aji-145	247	3	2021	2021	NUM
aji-145	247	4	july	july	PROPN
aji-145	247	5	27	27	NUM
aji-145	247	6	,	,	PUNCT
aji-145	247	7	accessed	access	VERB
aji-145	247	8	2022	2022	NUM
aji-145	247	9	july	july	PROPN
aji-145	247	10	24	24	NUM
aji-145	247	11	]	]	PUNCT
aji-145	247	12	.	.	PUNCT
aji-145	248	1	available	available	ADJ
aji-145	248	2	:	:	PUNCT
aji-145	248	3	https://www.who.int	https://www.who.int	NOUN
aji-145	248	4	/	/	SYM
aji-145	248	5	newsroom	newsroom	NOUN
aji-145	248	6	/	/	SYM
aji-145	248	7	fact	fact	NOUN
aji-145	248	8	-	-	PUNCT
aji-145	248	9	sheets	sheet	NOUN
aji-145	248	10	/	/	SYM
aji-145	248	11	detail	detail	NOUN
aji-145	248	12	/	/	SYM
aji-145	248	13	hepatitis	hepatitis	NOUN
aji-145	248	14	-	-	PUNCT
aji-145	248	15	c.	c.	NOUN
aji-145	249	1	[	[	X
aji-145	249	2	google	google	PROPN
aji-145	249	3	scholar	scholar	NOUN
aji-145	249	4	]	]	PUNCT
aji-145	250	1	[	[	X
aji-145	250	2	ref	ref	NOUN
aji-145	250	3	list	list	VERB
aji-145	250	4	6	6	NUM
aji-145	250	5	.	.	PUNCT
aji-145	250	6	world	world	PROPN
aji-145	250	7	hepatitis	hepatitis	PROPN
aji-145	250	8	day	day	NOUN
aji-145	250	9	in	in	ADP
aji-145	250	10	nigeria	nigeria	PROPN
aji-145	250	11	;	;	PUNCT
aji-145	250	12	2020	2020	NUM
aji-145	250	13	.	.	PUNCT
aji-145	251	1	available	available	ADJ
aji-145	251	2	:	:	PUNCT
aji-145	251	3	https://www.afro.who.int	https://www.afro.who.int	NOUN
aji-145	251	4	/	/	SYM
aji-145	251	5	news	news	NOUN
aji-145	251	6	/	/	SYM
aji-145	251	7	w	w	NOUN
aji-145	251	8	orld	orld	NOUN
aji-145	251	9	-	-	PUNCT
aji-145	251	10	hepatitis	hepatitis	NOUN
aji-145	251	11	-	-	PUNCT
aji-145	251	12	day	day	NOUN
aji-145	251	13	-	-	PUNCT
aji-145	251	14	nigeria	nigeria	PROPN
aji-145	251	15	-	-	PUNCT
aji-145	251	16	estimated-20million	estimated-20million	NOUN
aji-145	251	17	-	-	PUNCT
aji-145	251	18	people	people	NOUN
aji-145	251	19	-	-	PUNCT
aji-145	251	20	are	be	AUX
aji-145	251	21	-	-	PUNCT
aji-145	251	22	chronically	chronically	ADV
aji-145	251	23	-	-	PUNCT
aji-145	251	24	infected	infect	VERB
aji-145	251	25	7	7	NUM
aji-145	251	26	.	.	PUNCT
aji-145	252	1	who	who	PRON
aji-145	252	2	.	.	PUNCT
aji-145	253	1	hepatitis	hepatitis	PROPN
aji-145	253	2	b	b	PROPN
aji-145	253	3	;	;	PUNCT
aji-145	253	4	2024	2024	NUM
aji-145	253	5	.	.	PUNCT
aji-145	254	1	available	available	ADJ
aji-145	254	2	:	:	PUNCT
aji-145	254	3	https://www.who.int	https://www.who.int	NOUN
aji-145	254	4	/	/	SYM
aji-145	254	5	newsroom	newsroom	NOUN
aji-145	254	6	/	/	SYM
aji-145	254	7	fact	fact	NOUN
aji-145	254	8	-	-	PUNCT
aji-145	254	9	sheets	sheet	NOUN
aji-145	254	10	/	/	SYM
aji-145	254	11	detail	detail	NOUN
aji-145	254	12	/	/	SYM
aji-145	254	13	hepatitisb#:~:text	hepatitisb#:~:text	PROPN
aji-145	254	14	=	=	PUNCT
aji-145	254	15	it%20can%20spread%20through	it%20can%20spread%20through	PROPN
aji-145	254	16	%	%	NOUN
aji-145	254	17	20contact	20contact	NUM
aji-145	254	18	,	,	PUNCT
aji-145	254	19	boosters%20a%20few%20we	boosters%20a%20few%20we	NOUN
aji-145	254	20	eks%20later	eks%20later	NOUN
aji-145	254	21	8	8	NUM
aji-145	254	22	.	.	PUNCT
aji-145	255	1	tripathi	tripathi	PROPN
aji-145	255	2	n	n	PROPN
aji-145	255	3	,	,	PUNCT
aji-145	255	4	mousa	mousa	NOUN
aji-145	255	5	oy	oy	NOUN
aji-145	255	6	.	.	PUNCT
aji-145	256	1	hepatitis	hepatitis	PROPN
aji-145	256	2	b.	b.	PROPN
aji-145	257	1	[	[	X
aji-145	257	2	updated	update	VERB
aji-145	257	3	2023	2023	NUM
aji-145	257	4	jul	jul	NOUN
aji-145	257	5	9	9	NUM
aji-145	257	6	]	]	PUNCT
aji-145	257	7	.	.	PUNCT
aji-145	258	1	in	in	ADP
aji-145	258	2	:	:	PUNCT
aji-145	258	3	statpearls	statpearl	NOUN
aji-145	259	1	[	[	X
aji-145	259	2	internet	internet	NOUN
aji-145	259	3	]	]	PUNCT
aji-145	259	4	.	.	PUNCT
aji-145	260	1	treasure	treasure	NOUN
aji-145	260	2	island	island	NOUN
aji-145	260	3	(	(	PUNCT
aji-145	260	4	fl	fl	PROPN
aji-145	260	5	):	):	PUNCT
aji-145	260	6	statpearls	statpearls	PROPN
aji-145	260	7	publishing	publishing	NOUN
aji-145	260	8	;	;	PUNCT
aji-145	260	9	2024	2024	NUM
aji-145	260	10	jan-	jan-	NOUN
aji-145	260	11	.	.	PUNCT
aji-145	261	1	available	available	ADJ
aji-145	261	2	:	:	PUNCT
aji-145	261	3	https://www.ncbi.nlm.nih.gov	https://www.ncbi.nlm.nih.gov	ADJ
aji-145	261	4	/	/	SYM
aji-145	261	5	boo	boo	NOUN
aji-145	261	6	ks	ks	NOUN
aji-145	261	7	/	/	SYM
aji-145	261	8	nbk555945/	nbk555945/	PROPN
aji-145	261	9	9	9	NUM
aji-145	261	10	.	.	PUNCT
aji-145	262	1	hepatitis	hepatitis	PROPN
aji-145	262	2	c.	c.	PROPN
aji-145	262	3	2024	2024	NUM
aji-145	262	4	available	available	ADJ
aji-145	262	5	:	:	PUNCT
aji-145	262	6	https://www.who.int	https://www.who.int	NOUN
aji-145	262	7	/	/	SYM
aji-145	262	8	newsroom	newsroom	NOUN
aji-145	262	9	/	/	SYM
aji-145	262	10	fact	fact	NOUN
aji-145	262	11	-	-	PUNCT
aji-145	262	12	sheets	sheet	NOUN
aji-145	262	13	/	/	SYM
aji-145	262	14	detail	detail	NOUN
aji-145	262	15	/	/	SYM
aji-145	262	16	hepatitis	hepatitis	NOUN
aji-145	262	17	-	-	PUNCT
aji-145	262	18	c	c	NOUN
aji-145	262	19	10	10	NUM
aji-145	262	20	.	.	PUNCT
aji-145	263	1	adetunji	adetunji	PROPN
aji-145	263	2	,	,	PUNCT
aji-145	263	3	blessing	blessing	NOUN
aji-145	263	4	ifeoluwa	ifeoluwa	PROPN
aji-145	263	5	,	,	PUNCT
aji-145	263	6	samuel	samuel	PROPN
aji-145	263	7	oluwatimilehin	oluwatimilehin	VERB
aji-145	263	8	adeyemi	adeyemi	ADV
aji-145	263	9	,	,	PUNCT
aji-145	263	10	eunice	eunice	PROPN
aji-145	263	11	oluwadamilola	oluwadamilola	PROPN
aji-145	263	12	adegboye	adegboye	PROPN
aji-145	263	13	,	,	PUNCT
aji-145	263	14	samuel	samuel	PROPN
aji-145	263	15	ayodeji	ayodeji	PROPN
aji-145	263	16	adetunji	adetunji	PROPN
aji-145	263	17	,	,	PUNCT
aji-145	263	18	rachel	rachel	PROPN
aji-145	263	19	oluwaseyi	oluwaseyi	PROPN
aji-145	263	20	idakwo	idakwo	NOUN
aji-145	263	21	,	,	PUNCT
aji-145	263	22	and	and	CCONJ
aji-145	263	23	stephen	stephen	PROPN
aji-145	263	24	oluwasegun	oluwasegun	NUM
aji-145	263	25	adetunji	adetunji	PROPN
aji-145	263	26	.	.	PUNCT
aji-145	264	1	prevalence	prevalence	NOUN
aji-145	264	2	of	of	ADP
aji-145	264	3	hepatitis	hepatitis	PROPN
aji-145	264	4	c	c	PROPN
aji-145	264	5	virus	virus	NOUN
aji-145	264	6	(	(	PUNCT
aji-145	264	7	hcv	hcv	PROPN
aji-145	264	8	)	)	PUNCT
aji-145	264	9	in	in	ADP
aji-145	264	10	a	a	DET
aji-145	264	11	nigerian	nigerian	ADJ
aji-145	264	12	outpatient	outpatient	NOUN
aji-145	264	13	setting	setting	NOUN
aji-145	264	14	:	:	PUNCT
aji-145	264	15	a	a	DET
aji-145	264	16	retrospective	retrospective	ADJ
aji-145	264	17	study	study	NOUN
aji-145	264	18	.	.	PUNCT
aji-145	265	1	journal	journal	NOUN
aji-145	265	2	of	of	ADP
aji-145	265	3	advances	advance	NOUN
aji-145	265	4	in	in	ADP
aji-145	265	5	microbiology	microbiology	NOUN
aji-145	265	6	.	.	PUNCT
aji-145	266	1	2022	2022	NUM
aji-145	266	2	;	;	PUNCT
aji-145	266	3	22(12):46	22(12):46	NUM
aji-145	266	4	-	-	SYM
aji-145	266	5	52	52	NUM
aji-145	266	6	.	.	PUNCT
aji-145	267	1	available	available	ADJ
aji-145	267	2	:	:	PUNCT
aji-145	267	3	https://doi.org/10.9734	https://doi.org/10.9734	PROPN
aji-145	267	4	/	/	SYM
aji-145	267	5	jamb/202	jamb/202	PROPN
aji-145	267	6	2	2	NUM
aji-145	267	7	/	/	SYM
aji-145	267	8	v22i12692	v22i12692	NOUN
aji-145	267	9	.	.	NOUN
aji-145	267	10	11	11	NUM
aji-145	267	11	.	.	PUNCT
aji-145	268	1	chikwendu	chikwendu	NOUN
aji-145	268	2	a	a	PRON
aji-145	268	3	,	,	PUNCT
aji-145	268	4	unikutelle	unikutelle	ADJ
aji-145	268	5	hl	hl	NOUN
aji-145	268	6	,	,	PUNCT
aji-145	268	7	olumide	olumide	ADV
aji-145	268	8	at	at	ADP
aji-145	268	9	.	.	PUNCT
aji-145	269	1	hepatitis	hepatitis	PROPN
aji-145	269	2	b	b	PROPN
aji-145	269	3	and	and	CCONJ
aji-145	269	4	c	c	PROPN
aji-145	269	5	virus	virus	NOUN
aji-145	269	6	prevalence	prevalence	NOUN
aji-145	269	7	among	among	ADP
aji-145	269	8	patients	patient	NOUN
aji-145	269	9	and	and	CCONJ
aji-145	269	10	healthcare	healthcare	PROPN
aji-145	269	11	workers	worker	NOUN
aji-145	269	12	'	'	PART
aji-145	269	13	prevention	prevention	NOUN
aji-145	269	14	practices	practice	NOUN
aji-145	269	15	towards	towards	ADP
aji-145	269	16	the	the	DET
aji-145	269	17	viruses	virus	NOUN
aji-145	269	18	in	in	ADP
aji-145	269	19	a	a	DET
aji-145	269	20	secondary	secondary	ADJ
aji-145	269	21	healthcare	healthcare	NOUN
aji-145	269	22	facility	facility	NOUN
aji-145	269	23	in	in	ADP
aji-145	269	24	northern	northern	PROPN
aji-145	269	25	nigeria	nigeria	PROPN
aji-145	269	26	.	.	PUNCT
aji-145	270	1	pan	pan	PROPN
aji-145	270	2	afr	afr	PROPN
aji-145	270	3	med	med	PROPN
aji-145	270	4	j.	j.	PROPN
aji-145	270	5	2023	2023	NUM
aji-145	270	6	nov	nov	NOUN
aji-145	270	7	13;46	13;46	NUM
aji-145	270	8	:	:	PUNCT
aji-145	271	1	82	82	NUM
aji-145	271	2	.	.	PUNCT
aji-145	271	3	doi	doi	NOUN
aji-145	271	4	:	:	PUNCT
aji-145	271	5	10.11604	10.11604	NUM
aji-145	271	6	/	/	SYM
aji-145	271	7	pamj.2023.46.82.40530	pamj.2023.46.82.40530	PROPN
aji-145	271	8	.	.	PUNCT
aji-145	272	1	pmid	pmid	NOUN
aji-145	272	2	:	:	PUNCT
aji-145	272	3	38314232	38314232	NUM
aji-145	272	4	;	;	PUNCT
aji-145	272	5	pmcid	pmcid	ADJ
aji-145	272	6	:	:	PUNCT
aji-145	272	7	pmc10837276	pmc10837276	ADJ
aji-145	272	8	.	.	PUNCT
aji-145	273	1	12	12	NUM
aji-145	273	2	.	.	PUNCT
aji-145	274	1	elekima	elekima	PROPN
aji-145	274	2	i	i	PROPN
aji-145	274	3	,	,	PUNCT
aji-145	274	4	mike	mike	PROPN
aji-145	274	5	-	-	PUNCT
aji-145	274	6	ogburia	ogburia	PROPN
aji-145	274	7	m	m	PROPN
aji-145	274	8	,	,	PUNCT
aji-145	274	9	omereji	omereji	PROPN
aji-145	274	10	-	-	PUNCT
aji-145	274	11	david	david	PROPN
aji-145	274	12	c	c	PROPN
aji-145	274	13	,	,	PUNCT
aji-145	274	14	moore	moore	PROPN
aji-145	274	15	-	-	PUNCT
aji-145	274	16	igwe	igwe	PROPN
aji-145	274	17	b	b	PROPN
aji-145	274	18	,	,	PUNCT
aji-145	274	19	nwokah	nwokah	PROPN
aji-145	274	20	e	e	NOUN
aji-145	274	21	,	,	PUNCT
aji-145	274	22	georgeopuda	georgeopuda	PROPN
aji-145	274	23	i	i	PROPN
aji-145	274	24	,	,	PUNCT
aji-145	274	25	agi	agi	PROPN
aji-145	274	26	n	n	CCONJ
aji-145	274	27	,	,	PUNCT
aji-145	274	28	monsi	monsi	PROPN
aji-145	274	29	t	t	PROPN
aji-145	274	30	,	,	PUNCT
aji-145	274	31	ollor	ollor	NOUN
aji-145	274	32	o	o	NOUN
aji-145	274	33	,	,	PUNCT
aji-145	274	34	okoro	okoro	PRON
aji-145	274	35	o	o	NOUN
aji-145	274	36	,	,	PUNCT
aji-145	274	37	brisibe	brisibe	NOUN
aji-145	274	38	n	n	CCONJ
aji-145	274	39	,	,	PUNCT
aji-145	274	40	ben	ben	PROPN
aji-145	274	41	-	-	PUNCT
aji-145	274	42	chioma	chioma	PROPN
aji-145	274	43	a.	a.	NOUN
aji-145	274	44	prevalence	prevalence	NOUN
aji-145	274	45	of	of	ADP
aji-145	274	46	hiv	hiv	PROPN
aji-145	274	47	,	,	PUNCT
aji-145	274	48	hepatitis	hepatitis	PROPN
aji-145	274	49	b	b	PROPN
aji-145	274	50	,	,	PUNCT
aji-145	274	51	and	and	CCONJ
aji-145	274	52	hepatitis	hepatitis	PROPN
aji-145	274	53	c	c	PROPN
aji-145	274	54	in	in	ADP
aji-145	274	55	rivers	river	NOUN
aji-145	274	56	state	state	PROPN
aji-145	274	57	university	university	PROPN
aji-145	274	58	,	,	PUNCT
aji-145	274	59	port	port	NOUN
aji-145	274	60	harcourt	harcourt	PROPN
aji-145	274	61	:	:	PUNCT
aji-145	274	62	outcome	outcome	NOUN
aji-145	274	63	of	of	ADP
aji-145	274	64	a	a	DET
aji-145	274	65	medical	medical	ADJ
aji-145	274	66	outreach	outreach	NOUN
aji-145	274	67	.	.	PUNCT
aji-145	275	1	advances	advance	NOUN
aji-145	275	2	in	in	ADP
aji-145	275	3	infectious	infectious	ADJ
aji-145	275	4	diseases	disease	NOUN
aji-145	275	5	.	.	PUNCT
aji-145	276	1	2023;13:692	2023;13:692	X
aji-145	276	2	-	-	SYM
aji-145	276	3	705	705	NUM
aji-145	276	4	.	.	PUNCT
aji-145	277	1	doi	doi	NOUN
aji-145	277	2	:	:	PUNCT
aji-145	277	3	10.4236	10.4236	NUM
aji-145	277	4	/	/	SYM
aji-145	277	5	aid.2023.134056	aid.2023.134056	PROPN
aji-145	277	6	13	13	NUM
aji-145	277	7	.	.	PUNCT
aji-145	278	1	ndukwu	ndukwu	PROPN
aji-145	278	2	,	,	PUNCT
aji-145	278	3	chidi	chidi	PROPN
aji-145	278	4	lc	lc	PROPN
aji-145	278	5	,	,	PUNCT
aji-145	278	6	jane	jane	PROPN
aji-145	278	7	u.	u.	PROPN
aji-145	278	8	chinedumadu	chinedumadu	PROPN
aji-145	278	9	.	.	PUNCT
aji-145	279	1	a	a	DET
aji-145	279	2	cross	cross	ADJ
aji-145	279	3	-	-	ADJ
aji-145	279	4	sectional	sectional	ADJ
aji-145	279	5	investigation	investigation	NOUN
aji-145	279	6	of	of	ADP
aji-145	279	7	the	the	DET
aji-145	279	8	public	public	ADJ
aji-145	279	9	health	health	NOUN
aji-145	279	10	consequences	consequence	NOUN
aji-145	279	11	of	of	ADP
aji-145	279	12	hepatitis	hepatitis	PROPN
aji-145	279	13	b	b	PROPN
aji-145	279	14	infection	infection	NOUN
aji-145	279	15	among	among	ADP
aji-145	279	16	abattoir	abattoir	NOUN
aji-145	279	17	workers	worker	NOUN
aji-145	279	18	in	in	ADP
aji-145	279	19	port	port	NOUN
aji-145	279	20	harcourt	harcourt	PROPN
aji-145	279	21	nigeria	nigeria	PROPN
aji-145	279	22	.	.	PUNCT
aji-145	280	1	asian	asian	PROPN
aji-145	280	2	journal	journal	PROPN
aji-145	280	3	of	of	ADP
aji-145	280	4	research	research	NOUN
aji-145	280	5	and	and	CCONJ
aji-145	280	6	reports	report	NOUN
aji-145	280	7	in	in	ADP
aji-145	280	8	hepatology	hepatology	NOUN
aji-145	280	9	.	.	PUNCT
aji-145	281	1	2024;6(1):37	2024;6(1):37	NUM
aji-145	281	2	-	-	SYM
aji-145	281	3	44	44	NUM
aji-145	281	4	.	.	PUNCT
aji-145	282	1	available	available	ADJ
aji-145	282	2	:	:	PUNCT
aji-145	282	3	https://journalajrrhe.com	https://journalajrrhe.com	X
aji-145	282	4	/	/	SYM
aji-145	282	5	index.p	index.p	PROPN
aji-145	282	6	hp	hp	PROPN
aji-145	282	7	/	/	SYM
aji-145	282	8	ajrrhe	ajrrhe	NOUN
aji-145	282	9	/	/	SYM
aji-145	282	10	article	article	NOUN
aji-145	282	11	/	/	SYM
aji-145	282	12	view/39	view/39	NOUN
aji-145	282	13	.	.	PUNCT
aji-145	283	1	14	14	NUM
aji-145	283	2	.	.	PUNCT
aji-145	283	3	onubi	onubi	PROPN
aji-145	283	4	j	j	PROPN
aji-145	283	5	,	,	PUNCT
aji-145	283	6	eseigbe	eseigbe	NOUN
aji-145	283	7	p	p	NOUN
aji-145	283	8	,	,	PUNCT
aji-145	283	9	agyema	agyema	PROPN
aji-145	283	10	jpa	jpa	PROPN
aji-145	283	11	,	,	PUNCT
aji-145	283	12	chima	chima	PROPN
aji-145	283	13	aag	aag	PROPN
aji-145	283	14	.	.	PROPN
aji-145	283	15	seroprevalence	seroprevalence	NOUN
aji-145	283	16	of	of	ADP
aji-145	283	17	hepatitis	hepatitis	PROPN
aji-145	283	18	b	b	PROPN
aji-145	283	19	and	and	CCONJ
aji-145	283	20	c	c	PROPN
aji-145	283	21	virus	virus	NOUN
aji-145	283	22	infections	infection	NOUN
aji-145	283	23	among	among	ADP
aji-145	283	24	healthcare	healthcare	NOUN
aji-145	283	25	seekers	seeker	NOUN
aji-145	283	26	at	at	ADP
aji-145	283	27	a	a	DET
aji-145	283	28	tertiary	tertiary	ADJ
aji-145	283	29	health	health	NOUN
aji-145	283	30	facility	facility	NOUN
aji-145	283	31	in	in	ADP
aji-145	283	32	northcentral	northcentral	PROPN
aji-145	283	33	nigeria	nigeria	PROPN
aji-145	283	34	:	:	PUNCT
aji-145	283	35	a	a	DET
aji-145	283	36	retrospective	retrospective	ADJ
aji-145	283	37	study	study	NOUN
aji-145	283	38	.	.	PUNCT
aji-145	284	1	west	west	PROPN
aji-145	284	2	afr	afr	PROPN
aji-145	284	3	j	j	PROPN
aji-145	284	4	med	med	PROPN
aji-145	284	5	.	.	PUNCT
aji-145	285	1	2023	2023	NUM
aji-145	285	2	dec	dec	PROPN
aji-145	285	3	30;40(12):13551361	30;40(12):13551361	PROPN
aji-145	285	4	.	.	PUNCT
aji-145	286	1	pmid	pmid	NOUN
aji-145	286	2	:	:	PUNCT
aji-145	286	3	38265845	38265845	NUM
aji-145	286	4	.	.	PUNCT
aji-145	287	1	15	15	NUM
aji-145	287	2	.	.	X
aji-145	287	3	faghihi	faghihi	PROPN
aji-145	287	4	sh	sh	PROPN
aji-145	287	5	,	,	PUNCT
aji-145	287	6	azarbakhsh	azarbakhsh	PROPN
aji-145	287	7	h	h	PROPN
aji-145	287	8	,	,	PUNCT
aji-145	287	9	piraee	piraee	VERB
aji-145	287	10	e.	e.	PROPN
aji-145	287	11	epidemiological	epidemiological	ADJ
aji-145	287	12	study	study	NOUN
aji-145	287	13	of	of	ADP
aji-145	287	14	hepatitis	hepatitis	PROPN
aji-145	287	15	b	b	PROPN
aji-145	287	16	and	and	CCONJ
aji-145	287	17	hepatitis	hepatitis	PROPN
aji-145	287	18	c	c	NOUN
aji-145	287	19	infection	infection	NOUN
aji-145	287	20	in	in	ADP
aji-145	287	21	kohgiluyeh	kohgiluyeh	PROPN
aji-145	287	22	and	and	CCONJ
aji-145	287	23	boyer	boyer	PROPN
aji-145	287	24	-	-	PUNCT
aji-145	287	25	ahmad	ahmad	PROPN
aji-145	287	26	province	province	PROPN
aji-145	287	27	(	(	PUNCT
aji-145	287	28	iran	iran	PROPN
aji-145	287	29	)	)	PUNCT
aji-145	287	30	from	from	ADP
aji-145	287	31	2008	2008	NUM
aji-145	287	32	to	to	ADP
aji-145	287	33	2021	2021	NUM
aji-145	287	34	:	:	PUNCT
aji-145	287	35	a	a	DET
aji-145	287	36	cross	cross	ADJ
aji-145	287	37	-	-	ADJ
aji-145	287	38	sectional	sectional	ADJ
aji-145	287	39	study	study	NOUN
aji-145	287	40	.	.	PUNCT
aji-145	288	1	health	health	PROPN
aji-145	288	2	sci	sci	PROPN
aji-145	288	3	rep	rep	PROPN
aji-145	288	4	.	.	PROPN
aji-145	288	5	2024	2024	NUM
aji-145	288	6	feb	feb	X
aji-145	288	7	7;7(2):e1812	7;7(2):e1812	NUM
aji-145	288	8	.	.	PUNCT
aji-145	289	1	doi	doi	NOUN
aji-145	289	2	:	:	PUNCT
aji-145	289	3	10.1002	10.1002	NUM
aji-145	289	4	/	/	SYM
aji-145	289	5	hsr2.1812	hsr2.1812	NOUN
aji-145	289	6	.	.	PUNCT
aji-145	290	1	pmid	pmid	NOUN
aji-145	290	2	:	:	PUNCT
aji-145	290	3	38328787	38328787	NUM
aji-145	290	4	;	;	PUNCT
aji-145	290	5	pmcid	pmcid	ADJ
aji-145	290	6	:	:	PUNCT
aji-145	290	7	pmc10848580	pmc10848580	NOUN
aji-145	290	8	.	.	PUNCT
aji-145	291	1	16	16	NUM
aji-145	291	2	.	.	PUNCT
aji-145	292	1	olaru	olaru	PROPN
aji-145	293	1	i	i	PROPN
aji-145	293	2	d	d	PROPN
aji-145	293	3	,	,	PUNCT
aji-145	293	4	beliz	beliz	PROPN
aji-145	293	5	meier	meier	PROPN
aji-145	293	6	m	m	PROPN
aji-145	293	7	,	,	PUNCT
aji-145	293	8	mirzayev	mirzayev	PROPN
aji-145	293	9	f	f	AUX
aji-145	293	10	,	,	PUNCT
aji-145	293	11	prodanovic	prodanovic	ADJ
aji-145	293	12	n	n	CCONJ
aji-145	293	13	,	,	PUNCT
aji-145	293	14	kitchen	kitchen	PROPN
aji-145	293	15	pj	pj	PROPN
aji-145	293	16	,	,	PUNCT
aji-145	293	17	schumacher	schumacher	PROPN
aji-145	293	18	sg	sg	PROPN
aji-145	293	19	,	,	PUNCT
aji-145	293	20	denkinger	denkinger	NOUN
aji-145	293	21	cm	cm	NOUN
aji-145	293	22	.	.	PUNCT
aji-145	294	1	global	global	ADJ
aji-145	294	2	prevalence	prevalence	NOUN
aji-145	294	3	of	of	ADP
aji-145	294	4	hepatitis	hepatitis	PROPN
aji-145	294	5	b	b	PROPN
aji-145	294	6	or	or	CCONJ
aji-145	294	7	hepatitis	hepatitis	NOUN
aji-145	294	8	c	c	NOUN
aji-145	294	9	infection	infection	NOUN
aji-145	294	10	among	among	ADP
aji-145	294	11	patients	patient	NOUN
aji-145	294	12	with	with	ADP
aji-145	294	13	tuberculosis	tuberculosis	NOUN
aji-145	294	14	disease	disease	NOUN
aji-145	294	15	:	:	PUNCT
aji-145	294	16	systematic	systematic	ADJ
aji-145	294	17	review	review	NOUN
aji-145	294	18	and	and	CCONJ
aji-145	294	19	metaanalysis	metaanalysis	NOUN
aji-145	294	20	.	.	PUNCT
aji-145	295	1	eclinicalmedicine	eclinicalmedicine	PROPN
aji-145	295	2	.	.	PUNCT
aji-145	296	1	2023	2023	NUM
aji-145	296	2	apr	apr	NOUN
aji-145	296	3	6	6	NUM
aji-145	296	4	;	;	PUNCT
aji-145	296	5	58:101938	58:101938	NUM
aji-145	296	6	.	.	PUNCT
aji-145	296	7	doi	doi	NOUN
aji-145	296	8	:	:	PUNCT
aji-145	296	9	10.1016	10.1016	NUM
aji-145	296	10	/	/	SYM
aji-145	296	11	j.eclinm.2023.101938	j.eclinm.2023.101938	PROPN
aji-145	296	12	.	.	PUNCT
aji-145	297	1	pmid	pmid	NOUN
aji-145	297	2	:	:	PUNCT
aji-145	297	3	37090436	37090436	NUM
aji-145	297	4	;	;	PUNCT
aji-145	297	5	pmcid	pmcid	NOUN
aji-145	297	6	:	:	PUNCT
aji-145	297	7	pmc10113747	pmc10113747	ADJ
aji-145	297	8	.	.	PUNCT
aji-145	298	1	17	17	NUM
aji-145	298	2	.	.	PUNCT
aji-145	299	1	roche	roche	NOUN
aji-145	299	2	r	r	PROPN
aji-145	299	3	,	,	PUNCT
aji-145	299	4	simmons	simmon	NOUN
aji-145	299	5	r	r	PROPN
aji-145	299	6	,	,	PUNCT
aji-145	299	7	logan	logan	PROPN
aji-145	299	8	l	l	PROPN
aji-145	299	9	,	,	PUNCT
aji-145	299	10	ledesma	ledesma	PROPN
aji-145	299	11	j	j	PROPN
aji-145	299	12	,	,	PUNCT
aji-145	299	13	sabin	sabin	PROPN
aji-145	299	14	c	c	PROPN
aji-145	299	15	,	,	PUNCT
aji-145	299	16	ijaz	ijaz	PROPN
aji-145	299	17	s	s	PROPN
aji-145	299	18	,	,	PUNCT
aji-145	299	19	mandal	mandal	PROPN
aji-145	299	20	s.	s.	PROPN
aji-145	299	21	prevalence	prevalence	NOUN
aji-145	299	22	of	of	ADP
aji-145	299	23	hepatitis	hepatitis	PROPN
aji-145	299	24	b	b	PROPN
aji-145	299	25	immunity	immunity	NOUN
aji-145	299	26	and	and	CCONJ
aji-145	299	27	infection	infection	NOUN
aji-145	299	28	in	in	ADP
aji-145	299	29	home	home	NOUN
aji-145	299	30	self	self	NOUN
aji-145	299	31	-	-	PUNCT
aji-145	299	32	sampling	sample	VERB
aji-145	299	33	hiv	hiv	PROPN
aji-145	299	34	service	service	NOUN
aji-145	299	35	users	user	NOUN
aji-145	299	36	.	.	PUNCT
aji-145	300	1	sex	sex	NOUN
aji-145	300	2	transm	transm	PROPN
aji-145	300	3	infect	infect	VERB
aji-145	300	4	.	.	PUNCT
aji-145	301	1	2022	2022	NUM
aji-145	301	2	jun;98(4):286	jun;98(4):286	PROPN
aji-145	301	3	-	-	PUNCT
aji-145	301	4	292	292	NUM
aji-145	301	5	.	.	PUNCT
aji-145	302	1	doi	doi	NOUN
aji-145	302	2	:	:	PUNCT
aji-145	302	3	10.1136	10.1136	NUM
aji-145	302	4	/	/	SYM
aji-145	302	5	sextrans-2021	sextrans-2021	NOUN
aji-145	302	6	-	-	PUNCT
aji-145	302	7	055071	055071	NUM
aji-145	302	8	.	.	PUNCT
aji-145	303	1	epub	epub	NOUN
aji-145	303	2	2021	2021	NUM
aji-145	303	3	jun	jun	PROPN
aji-145	303	4	30	30	NUM
aji-145	303	5	.	.	PUNCT
aji-145	304	1	pmid	pmid	NOUN
aji-145	304	2	:	:	PUNCT
aji-145	304	3	34193528	34193528	NUM
aji-145	304	4	;	;	PUNCT
aji-145	304	5	pmcid	pmcid	ADJ
aji-145	304	6	:	:	PUNCT
aji-145	304	7	pmc9120376	pmc9120376	NOUN
aji-145	304	8	.	.	PUNCT
aji-145	305	1	18	18	NUM
aji-145	305	2	.	.	PUNCT
aji-145	306	1	nishikawa	nishikawa	PROPN
aji-145	306	2	k	k	PROPN
aji-145	306	3	,	,	PUNCT
aji-145	306	4	kimura	kimura	PROPN
aji-145	306	5	m	m	PROPN
aji-145	306	6	,	,	PUNCT
aji-145	306	7	imamura	imamura	PROPN
aji-145	306	8	j	j	PROPN
aji-145	306	9	,	,	PUNCT
aji-145	306	10	kimura	kimura	PROPN
aji-145	306	11	k.	k.	NOUN
aji-145	306	12	prevalence	prevalence	NOUN
aji-145	306	13	of	of	ADP
aji-145	306	14	hepatitis	hepatitis	PROPN
aji-145	306	15	c	c	PROPN
aji-145	306	16	virus	virus	NOUN
aji-145	306	17	infection	infection	NOUN
aji-145	306	18	among	among	ADP
aji-145	306	19	men	man	NOUN
aji-145	306	20	who	who	PRON
aji-145	306	21	have	have	VERB
aji-145	306	22	sex	sex	NOUN
aji-145	306	23	with	with	ADP
aji-145	306	24	men	man	NOUN
aji-145	306	25	with	with	ADP
aji-145	306	26	human	human	ADJ
aji-145	306	27	immunodeficiency	immunodeficiency	NOUN
aji-145	306	28	virus-1	virus-1	ADP
aji-145	306	29	infection	infection	NOUN
aji-145	306	30	between	between	ADP
aji-145	306	31	2010	2010	NUM
aji-145	306	32	and	and	CCONJ
aji-145	306	33	2020	2020	NUM
aji-145	306	34	in	in	ADP
aji-145	306	35	japan	japan	PROPN
aji-145	306	36	:	:	PUNCT
aji-145	306	37	a	a	DET
aji-145	306	38	single	single	ADJ
aji-145	306	39	-	-	PUNCT
aji-145	306	40	center	center	NOUN
aji-145	306	41	retrospective	retrospective	ADJ
aji-145	306	42	cohort	cohort	NOUN
aji-145	306	43	study	study	NOUN
aji-145	306	44	.	.	PUNCT
aji-145	307	1	j	j	PROPN
aji-145	307	2	infect	infect	PROPN
aji-145	307	3	chemother	chemother	PROPN
aji-145	307	4	.	.	PUNCT
aji-145	308	1	2023	2023	NUM
aji-145	308	2	mar;29(3):263268	mar;29(3):263268	PROPN
aji-145	308	3	.	.	PUNCT
aji-145	308	4	doi	doi	PROPN
aji-145	308	5	:	:	PUNCT
aji-145	308	6	10.1016	10.1016	NUM
aji-145	308	7	/	/	SYM
aji-145	308	8	j.jiac.2022.11.009	j.jiac.2022.11.009	PROPN
aji-145	308	9	.	.	PUNCT
aji-145	309	1	epub	epub	NOUN
aji-145	309	2	2022	2022	NUM
aji-145	309	3	dec	dec	PROPN
aji-145	309	4	28	28	NUM
aji-145	309	5	.	.	PUNCT
aji-145	310	1	pmid	pmid	NOUN
aji-145	310	2	:	:	PUNCT
aji-145	310	3	36585274	36585274	NUM
aji-145	310	4	.	.	PUNCT
aji-145	311	1	https://www.who.int/news-room/fact-sheets/detail/hepatitis-c	https://www.who.int/news-room/fact-sheets/detail/hepatitis-c	PROPN
aji-145	311	2	https://www.who.int/news-room/fact-sheets/detail/hepatitis-c	https://www.who.int/news-room/fact-sheets/detail/hepatitis-c	PROPN
aji-145	311	3	https://scholar.google.com/scholar_lookup?title=hepatitis+c+factsheet&publication_year=2021	https://scholar.google.com/scholar_lookup?title=hepatitis+c+factsheet&publication_year=2021	PROPN
aji-145	311	4	&	&	CCONJ
aji-145	311	5	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc9909667/#cit0001	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc9909667/#cit0001	PROPN
aji-145	311	6	https://www.afro.who.int/news/world-hepatitis-day-nigeria-estimated-20-million-people-are-chronically-infected	https://www.afro.who.int/news/world-hepatitis-day-nigeria-estimated-20-million-people-are-chronically-infecte	VERB
aji-145	311	7	https://www.afro.who.int/news/world-hepatitis-day-nigeria-estimated-20-million-people-are-chronically-infected	https://www.afro.who.int/news/world-hepatitis-day-nigeria-estimated-20-million-people-are-chronically-infecte	VERB
aji-145	311	8	https://www.afro.who.int/news/world-hepatitis-day-nigeria-estimated-20-million-people-are-chronically-infected	https://www.afro.who.int/news/world-hepatitis-day-nigeria-estimated-20-million-people-are-chronically-infecte	VERB
aji-145	311	9	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b#:~:text=it%20can%20spread%20through%20contact,boosters%20a%20few%20weeks%20later	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b#:~:text=it%20can%20spread%20through%20contact,boosters%20a%20few%20weeks%20later	NOUN
aji-145	311	10	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b#:~:text=it%20can%20spread%20through%20contact,boosters%20a%20few%20weeks%20later	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b#:~:text=it%20can%20spread%20through%20contact,boosters%20a%20few%20weeks%20later	NOUN
aji-145	311	11	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b#:~:text=it%20can%20spread%20through%20contact,boosters%20a%20few%20weeks%20later	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b#:~:text=it%20can%20spread%20through%20contact,boosters%20a%20few%20weeks%20later	NOUN
aji-145	311	12	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b#:~:text=it%20can%20spread%20through%20contact,boosters%20a%20few%20weeks%20later	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b#:~:text=it%20can%20spread%20through%20contact,boosters%20a%20few%20weeks%20later	NOUN
aji-145	311	13	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b#:~:text=it%20can%20spread%20through%20contact,boosters%20a%20few%20weeks%20later	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b#:~:text=it%20can%20spread%20through%20contact,boosters%20a%20few%20weeks%20later	NOUN
aji-145	311	14	https://www.who.int/news-room/fact-sheets/detail/hepatitis-c	https://www.who.int/news-room/fact-sheets/detail/hepatitis-c	NOUN
aji-145	311	15	https://www.who.int/news-room/fact-sheets/detail/hepatitis-c	https://www.who.int/news-room/fact-sheets/detail/hepatitis-c	NUM
aji-145	311	16	https://doi.org/10.9734/jamb/2022/v22i12692	https://doi.org/10.9734/jamb/2022/v22i12692	NOUN
aji-145	311	17	https://doi.org/10.9734/jamb/2022/v22i12692	https://doi.org/10.9734/jamb/2022/v22i12692	VERB
aji-145	311	18	https://doi.org/10.4236/aid.2023.134056	https://doi.org/10.4236/aid.2023.134056	VERB
aji-145	311	19	https://journalajrrhe.com/index.php/ajrrhe/article/view/39	https://journalajrrhe.com/index.php/ajrrhe/article/view/39	PROPN
aji-145	311	20	https://journalajrrhe.com/index.php/ajrrhe/article/view/39	https://journalajrrhe.com/index.php/ajrrhe/article/view/39	PROPN
aji-145	311	21	ndukwu	ndukwu	PROPN
aji-145	311	22	and	and	CCONJ
aji-145	311	23	chinedu	chinedu	NOUN
aji-145	311	24	-	-	PUNCT
aji-145	311	25	madu	madu	NOUN
aji-145	311	26	;	;	PUNCT
aji-145	311	27	asian	asian	PROPN
aji-145	311	28	j.	j.	PROPN
aji-145	311	29	immunol	immunol	PROPN
aji-145	311	30	.	.	PROPN
aji-145	311	31	,	,	PUNCT
aji-145	311	32	vol	vol	NOUN
aji-145	311	33	.	.	PROPN
aji-145	311	34	7	7	NUM
aji-145	311	35	,	,	PUNCT
aji-145	311	36	no	no	INTJ
aji-145	311	37	.	.	NOUN
aji-145	311	38	1	1	NUM
aji-145	311	39	,	,	PUNCT
aji-145	311	40	pp	pp	ADJ
aji-145	311	41	.	.	PUNCT
aji-145	312	1	209	209	NUM
aji-145	312	2	-	-	SYM
aji-145	312	3	216	216	NUM
aji-145	312	4	,	,	PUNCT
aji-145	312	5	2024	2024	NUM
aji-145	312	6	;	;	PUNCT
aji-145	312	7	article	article	NOUN
aji-145	312	8	no.aji.125624	no.aji.125624	VERB
aji-145	312	9	216	216	NUM
aji-145	312	10	19	19	NUM
aji-145	312	11	.	.	PUNCT
aji-145	313	1	mateu	mateu	NOUN
aji-145	313	2	-	-	PUNCT
aji-145	313	3	gelabert	gelabert	NOUN
aji-145	313	4	p	p	X
aji-145	313	5	,	,	PUNCT
aji-145	313	6	sabounchi	sabounchi	NOUN
aji-145	313	7	ns	ns	NOUN
aji-145	313	8	,	,	PUNCT
aji-145	313	9	guarino	guarino	PROPN
aji-145	313	10	h	h	NOUN
aji-145	313	11	,	,	PUNCT
aji-145	313	12	ciervo	ciervo	VERB
aji-145	313	13	c	c	PROPN
aji-145	313	14	,	,	PUNCT
aji-145	313	15	joseph	joseph	PROPN
aji-145	313	16	k	k	PROPN
aji-145	313	17	,	,	PUNCT
aji-145	313	18	eckhardt	eckhardt	NOUN
aji-145	313	19	bj	bj	VERB
aji-145	313	20	,	,	PUNCT
aji-145	313	21	fong	fong	PROPN
aji-145	313	22	c	c	PROPN
aji-145	313	23	,	,	PUNCT
aji-145	313	24	kapadia	kapadia	PROPN
aji-145	313	25	sn	sn	PROPN
aji-145	313	26	,	,	PUNCT
aji-145	313	27	huang	huang	PROPN
aji-145	313	28	ttk	ttk	PROPN
aji-145	313	29	.	.	PUNCT
aji-145	314	1	hepatitis	hepatitis	PROPN
aji-145	314	2	c	c	PROPN
aji-145	314	3	virus	virus	NOUN
aji-145	314	4	risk	risk	NOUN
aji-145	314	5	among	among	ADP
aji-145	314	6	young	young	ADJ
aji-145	314	7	people	people	NOUN
aji-145	314	8	who	who	PRON
aji-145	314	9	inject	inject	VERB
aji-145	314	10	drugs	drug	NOUN
aji-145	314	11	.	.	PUNCT
aji-145	315	1	front	front	ADJ
aji-145	315	2	public	public	ADJ
aji-145	315	3	health	health	NOUN
aji-145	315	4	.	.	PUNCT
aji-145	316	1	2022	2022	NUM
aji-145	316	2	jul	jul	NOUN
aji-145	316	3	29;10	29;10	NUM
aji-145	316	4	:	:	PUNCT
aji-145	316	5	835836	835836	NUM
aji-145	316	6	.	.	PUNCT
aji-145	317	1	doi	doi	NOUN
aji-145	317	2	:	:	PUNCT
aji-145	317	3	10.3389	10.3389	NUM
aji-145	317	4	/	/	SYM
aji-145	317	5	fpubh.2022.835836	fpubh.2022.835836	NOUN
aji-145	317	6	.	.	PUNCT
aji-145	318	1	pmid	pmid	NOUN
aji-145	318	2	:	:	PUNCT
aji-145	318	3	35968435	35968435	NUM
aji-145	318	4	;	;	PUNCT
aji-145	318	5	pmcid	pmcid	ADJ
aji-145	318	6	:	:	PUNCT
aji-145	318	7	pmc9372473	pmc9372473	NOUN
aji-145	318	8	.	.	PUNCT
aji-145	319	1	20	20	NUM
aji-145	319	2	.	.	X
aji-145	319	3	mahoney	mahoney	PROPN
aji-145	319	4	bj	bj	PROPN
aji-145	319	5	,	,	PUNCT
aji-145	319	6	morford	morford	PROPN
aji-145	319	7	kl	kl	PROPN
aji-145	319	8	,	,	PUNCT
aji-145	319	9	biegacki	biegacki	VERB
aji-145	319	10	et	et	NOUN
aji-145	319	11	,	,	PUNCT
aji-145	319	12	tetrault	tetrault	VERB
aji-145	319	13	jm	jm	PROPN
aji-145	319	14	.	.	PROPN
aji-145	319	15	hepatitis	hepatitis	PROPN
aji-145	319	16	c	c	PROPN
aji-145	319	17	virus	virus	NOUN
aji-145	319	18	and	and	CCONJ
aji-145	319	19	integrated	integrate	VERB
aji-145	319	20	care	care	NOUN
aji-145	319	21	for	for	ADP
aji-145	319	22	substance	substance	NOUN
aji-145	319	23	use	use	NOUN
aji-145	319	24	disorders	disorder	NOUN
aji-145	319	25	.	.	PUNCT
aji-145	320	1	clin	clin	PROPN
aji-145	320	2	liver	liver	PROPN
aji-145	320	3	dis	dis	PROPN
aji-145	320	4	(	(	PUNCT
aji-145	320	5	hoboken	hoboken	PROPN
aji-145	320	6	)	)	PUNCT
aji-145	320	7	.	.	PUNCT
aji-145	321	1	2024	2024	NUM
aji-145	321	2	jun	jun	PROPN
aji-145	321	3	28;23(1):e0241	28;23(1):e0241	NUM
aji-145	321	4	.	.	PUNCT
aji-145	322	1	doi	doi	NOUN
aji-145	322	2	:	:	PUNCT
aji-145	322	3	10.1097	10.1097	NUM
aji-145	322	4	/	/	SYM
aji-145	322	5	cld.0000000000000241	cld.0000000000000241	X
aji-145	322	6	.	.	PUNCT
aji-145	323	1	pmid	pmid	NOUN
aji-145	323	2	:	:	PUNCT
aji-145	323	3	38952692	38952692	NUM
aji-145	323	4	;	;	PUNCT
aji-145	323	5	pmcid	pmcid	ADJ
aji-145	323	6	:	:	PUNCT
aji-145	323	7	pmc1121667	pmc1121667	NOUN
aji-145	323	8	disclaimer	disclaimer	PROPN
aji-145	323	9	/	/	SYM
aji-145	323	10	publisher	publisher	NOUN
aji-145	323	11	’s	’s	PART
aji-145	323	12	note	note	NOUN
aji-145	323	13	:	:	PUNCT
aji-145	323	14	the	the	DET
aji-145	323	15	statements	statement	NOUN
aji-145	323	16	,	,	PUNCT
aji-145	323	17	opinions	opinion	NOUN
aji-145	323	18	and	and	CCONJ
aji-145	323	19	data	datum	NOUN
aji-145	323	20	contained	contain	VERB
aji-145	323	21	in	in	ADP
aji-145	323	22	all	all	DET
aji-145	323	23	publications	publication	NOUN
aji-145	323	24	are	be	AUX
aji-145	323	25	solely	solely	ADV
aji-145	323	26	those	those	PRON
aji-145	323	27	of	of	ADP
aji-145	323	28	the	the	DET
aji-145	323	29	individual	individual	ADJ
aji-145	323	30	author(s	author(s	PROPN
aji-145	323	31	)	)	PUNCT
aji-145	323	32	and	and	CCONJ
aji-145	323	33	contributor(s	contributor(s	NOUN
aji-145	323	34	)	)	PUNCT
aji-145	323	35	and	and	CCONJ
aji-145	323	36	not	not	PART
aji-145	323	37	of	of	ADP
aji-145	323	38	the	the	DET
aji-145	323	39	publisher	publisher	NOUN
aji-145	323	40	and/or	and/or	CCONJ
aji-145	323	41	the	the	DET
aji-145	323	42	editor(s	editor(s	NOUN
aji-145	323	43	)	)	PUNCT
aji-145	323	44	.	.	PUNCT
aji-145	324	1	this	this	DET
aji-145	324	2	publisher	publisher	NOUN
aji-145	324	3	and/or	and/or	CCONJ
aji-145	324	4	the	the	DET
aji-145	324	5	editor(s	editor(s	NOUN
aji-145	324	6	)	)	PUNCT
aji-145	324	7	disclaim	disclaim	VERB
aji-145	324	8	responsibility	responsibility	NOUN
aji-145	324	9	for	for	ADP
aji-145	324	10	any	any	DET
aji-145	324	11	injury	injury	NOUN
aji-145	324	12	to	to	ADP
aji-145	324	13	people	people	NOUN
aji-145	324	14	or	or	CCONJ
aji-145	324	15	property	property	NOUN
aji-145	324	16	resulting	result	VERB
aji-145	324	17	from	from	ADP
aji-145	324	18	any	any	DET
aji-145	324	19	ideas	idea	NOUN
aji-145	324	20	,	,	PUNCT
aji-145	324	21	methods	method	NOUN
aji-145	324	22	,	,	PUNCT
aji-145	324	23	instructions	instruction	NOUN
aji-145	324	24	or	or	CCONJ
aji-145	324	25	products	product	NOUN
aji-145	324	26	referred	refer	VERB
aji-145	324	27	to	to	ADP
aji-145	324	28	in	in	ADP
aji-145	324	29	the	the	DET
aji-145	324	30	content	content	NOUN
aji-145	324	31	.	.	PUNCT
aji-145	325	1	_	_	PUNCT
aji-145	326	1	_	_	PUNCT
aji-145	327	1	_	_	PUNCT
aji-145	328	1	_	_	PUNCT
aji-145	329	1	_	_	PUNCT
aji-145	330	1	_	_	PUNCT
aji-145	331	1	_	_	PUNCT
aji-145	332	1	_	_	PUNCT
aji-145	333	1	_	_	PUNCT
aji-145	334	1	_	_	PUNCT
aji-145	335	1	_	_	PUNCT
aji-145	336	1	_	_	PUNCT
aji-145	337	1	_	_	PUNCT
aji-145	338	1	_	_	PUNCT
aji-145	339	1	_	_	PUNCT
aji-145	340	1	_	_	PUNCT
aji-145	341	1	_	_	PUNCT
aji-145	342	1	_	_	PUNCT
aji-145	343	1	_	_	PUNCT
aji-145	344	1	_	_	PUNCT
aji-145	345	1	_	_	PUNCT
aji-145	346	1	_	_	PUNCT
aji-145	347	1	_	_	PUNCT
aji-145	348	1	_	_	PUNCT
aji-145	349	1	_	_	PUNCT
aji-145	350	1	_	_	PUNCT
aji-145	351	1	_	_	PUNCT
aji-145	352	1	_	_	PUNCT
aji-145	353	1	_	_	PUNCT
aji-145	354	1	_	_	PUNCT
aji-145	355	1	_	_	PUNCT
aji-145	356	1	_	_	PUNCT
aji-145	357	1	_	_	PUNCT
aji-145	358	1	_	_	PUNCT
aji-145	359	1	_	_	PUNCT
aji-145	360	1	_	_	PUNCT
aji-145	361	1	_	_	PUNCT
aji-145	362	1	_	_	PUNCT
aji-145	363	1	_	_	PUNCT
aji-145	364	1	_	_	PUNCT
aji-145	365	1	_	_	PUNCT
aji-145	366	1	_	_	PUNCT
aji-145	367	1	_	_	PUNCT
aji-145	368	1	_	_	PUNCT
aji-145	369	1	_	_	PUNCT
aji-145	370	1	_	_	PUNCT
aji-145	371	1	_	_	PUNCT
aji-145	372	1	_	_	PUNCT
aji-145	373	1	_	_	PUNCT
aji-145	374	1	_	_	PUNCT
aji-145	375	1	_	_	PUNCT
aji-145	376	1	_	_	PUNCT
aji-145	377	1	_	_	PUNCT
aji-145	378	1	_	_	PUNCT
aji-145	379	1	_	_	PUNCT
aji-145	380	1	_	_	PUNCT
aji-145	381	1	_	_	PUNCT
aji-145	382	1	_	_	PUNCT
aji-145	383	1	_	_	PUNCT
aji-145	384	1	_	_	PUNCT
aji-145	385	1	_	_	PUNCT
aji-145	386	1	_	_	PUNCT
aji-145	387	1	_	_	PUNCT
aji-145	388	1	_	_	PUNCT
aji-145	389	1	_	_	PUNCT
aji-145	390	1	_	_	PUNCT
aji-145	391	1	_	_	PUNCT
aji-145	392	1	_	_	PUNCT
aji-145	393	1	_	_	PUNCT
aji-145	394	1	_	_	PUNCT
aji-145	395	1	_	_	PUNCT
aji-145	396	1	_	_	PUNCT
aji-145	397	1	_	_	PUNCT
aji-145	398	1	_	_	PUNCT
aji-145	399	1	_	_	PUNCT
aji-145	400	1	_	_	PUNCT
aji-145	401	1	_	_	PUNCT
aji-145	402	1	_	_	PUNCT
aji-145	403	1	_	_	PUNCT
aji-145	404	1	_	_	PUNCT
aji-145	405	1	_	_	PUNCT
aji-145	406	1	©	©	PRON
aji-145	406	2	copyright	copyright	NOUN
aji-145	406	3	(	(	PUNCT
aji-145	406	4	2024	2024	NUM
aji-145	406	5	):	):	PUNCT
aji-145	406	6	author(s	author(s	NOUN
aji-145	406	7	)	)	PUNCT
aji-145	406	8	.	.	PUNCT
aji-145	407	1	the	the	DET
aji-145	407	2	licensee	licensee	NOUN
aji-145	407	3	is	be	AUX
aji-145	407	4	the	the	DET
aji-145	407	5	journal	journal	PROPN
aji-145	407	6	publisher	publisher	NOUN
aji-145	407	7	.	.	PUNCT
aji-145	408	1	this	this	PRON
aji-145	408	2	is	be	AUX
aji-145	408	3	an	an	DET
aji-145	408	4	open	open	ADJ
aji-145	408	5	access	access	NOUN
aji-145	408	6	article	article	NOUN
aji-145	408	7	distributed	distribute	VERB
aji-145	408	8	under	under	ADP
aji-145	408	9	the	the	DET
aji-145	408	10	terms	term	NOUN
aji-145	408	11	of	of	ADP
aji-145	408	12	the	the	DET
aji-145	408	13	creative	creative	ADJ
aji-145	408	14	commons	common	NOUN
aji-145	408	15	attribution	attribution	NOUN
aji-145	408	16	license	license	NOUN
aji-145	408	17	(	(	PUNCT
aji-145	408	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-145	408	19	)	)	PUNCT
aji-145	408	20	,	,	PUNCT
aji-145	408	21	which	which	PRON
aji-145	408	22	permits	permit	VERB
aji-145	408	23	unrestricted	unrestricted	ADJ
aji-145	408	24	use	use	NOUN
aji-145	408	25	,	,	PUNCT
aji-145	408	26	distribution	distribution	NOUN
aji-145	408	27	,	,	PUNCT
aji-145	408	28	and	and	CCONJ
aji-145	408	29	reproduction	reproduction	NOUN
aji-145	408	30	in	in	ADP
aji-145	408	31	any	any	DET
aji-145	408	32	medium	medium	NOUN
aji-145	408	33	,	,	PUNCT
aji-145	408	34	provided	provide	VERB
aji-145	408	35	the	the	DET
aji-145	408	36	original	original	ADJ
aji-145	408	37	work	work	NOUN
aji-145	408	38	is	be	AUX
aji-145	408	39	properly	properly	ADV
aji-145	408	40	cited	cite	VERB
aji-145	408	41	.	.	PUNCT
aji-145	409	1	peer	peer	NOUN
aji-145	409	2	-	-	PUNCT
aji-145	409	3	review	review	NOUN
aji-145	409	4	history	history	NOUN
aji-145	409	5	:	:	PUNCT
aji-145	409	6	the	the	DET
aji-145	409	7	peer	peer	NOUN
aji-145	409	8	review	review	NOUN
aji-145	409	9	history	history	NOUN
aji-145	409	10	for	for	ADP
aji-145	409	11	this	this	DET
aji-145	409	12	paper	paper	NOUN
aji-145	409	13	can	can	AUX
aji-145	409	14	be	be	AUX
aji-145	409	15	accessed	access	VERB
aji-145	409	16	here	here	ADV
aji-145	409	17	:	:	PUNCT
aji-145	409	18	https://www.sdiarticle5.com/review-history/125624	https://www.sdiarticle5.com/review-history/125624	VERB
aji-145	409	19	https://www.sdiarticle5.com/review-history/125624	https://www.sdiarticle5.com/review-history/125624	VERB